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Despite advances in primary and secundary prevention, cardiovascular disease remains 
the leading cause of death worldwide [1-3]. In patients suspected of coronary artery 
disease (CAD), assessment of the presence and extent of coronary atherosclerosis is 
mandatory to determine the appropriate clinical management. Coronary anatomy and 
the degree of vascular pathology have traditionally been defined and identified by 
invasive coronary angiography (ICA). Nowadays, additional intracoronary pressure-
derived fractional flow reserve (FFR) can be measured in the same session to assess the 
functional significance of coronary stenoses [4]. However, the invasive nature of ICA 
carries a non-negligible risk and adds significant costs. Furthermore, the low diagnostic 
yield of ICA demonstrates the need for better selection methods using the non-invasive 
tests [5].  
 Current guidelines and appropriate use criteria documents recommend the use of 
non-invasive cardiac imaging in numerous clinical scenarios in order to provide 
diagnostic and prognostic information. The goal of such imaging is to guide therapeutic 
decision making and to enhance risk stratification, especially in patients with an 
intermediate pre-test probability [6-9]. 
 With the recent advent of combined single photon emission computed tomography 
(SPECT) and computed tomography (CT) into hybrid SPECT/CT devices, attenuation 
correction of SPECT myocardial perfusion images can now easily be obtained. More 
importantly, traditional SPECT results can now be complemented with the anatomic 
information obtained from coronary artery calcium scoring (CACS) and coronary 
computed tomography angiography (CCTA) in a single session. Although initial 
studies report a synergistic effect of this SPECT/CT combination in selected 
populations [10,11], real-world clinical data for stable low-intermediate risk patients 
are still lacking. Furthermore, the clinical implications of a stepwise approach with this 
kind of hybrid imaging are unknown. 
 
 
Non-invasive imaging in suspected stable coronary artery disease 
 
Non-invasive testing is important to exclude CAD on the one hand, and to detect the 
presence of CAD with its functional consequence on the other hand. For optimal 
decisions, high diagnostic performance of these tests is required. Non-invasive imaging 
for diagnosis of CAD is currently focused on functional imaging to assess the 
haemodynamic consequences of obstructive CAD, and on anatomical imaging to 
visualize the coronary artery tree. Traditional exercise electrocardiography testing is a 
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widely available, well-established and cost-effective means to assess ischaemic heart 
disease. However, it has a limited diagnostic accuracy and a substantial rate of 
inconclusive test results [12]. Alternatively, several non-invasive functional tests are 
currently available that may be more useful, such as myocardial perfusion imaging 
with SPECT or positron emission tomography (PET), stress echocardiography and 
cardiac magnetic resonance imaging (MRI). For anatomical imaging CACS and CCTA 
are used. An interesting recent development is the possibility to combine functional 
with anatomical tests in a single machine. The following paragraphs provide an update 
with regard to imaging by using SPECT, CACS and CCTA, and a combination of these 
tests. 
 
 
SPECT myocardial perfusion imaging 
 
Non-invasive testing with SPECT myocardial perfusion imaging is widely available 
and extensively validated in stable angina. It provides valuable diagnostic information 
with reasonable accuracy and also provides prognostic information. SPECT results 
improve patient selection for invasive angiography and coronary revascularisation [13]. 
The reported sensitivity of SPECT for the detection of angiographically relevant CAD 
is high (87–89%) [14,15], although a wide range of diagnostic performance has been 
reported. SPECT has traditionally been done with gamma cameras based on sodium 
iodide crystals and photomultipliers.  
 Recently, a new generation of gamma cameras with novel semiconductor 
cadmium-zinc-telluride (CZT) detector technology has been developed. The high 
intrinsic sensitivity and resolution of these CZT detectors allow direct digital 
conversion of scintillation events. This eliminates the need for photomultiplier tubes 
and facilitates considerable down-sizing of the gantry. The CZT detectors enable 
improved image quality and reduced imaging time because of improved count 
sensitivity and image contrast [16,17]. However, clinical experience with the CZT 
SPECT camera is limited. 
  
 
Coronary artery calcium scoring 
 
Coronary artery calcifications are highly specific for the presence of coronary 
atherosclerosis and represent the total atherosclerotic plaque burden present in the 
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epicardial coronary arteries [18]. CACS is a clinical tool used for the early non-
invasive detection of coronary atherosclerosis and has shown to be a reliable, 
independent risk predictor for cardiovascular events [19,20]. However, the role of 
CACS in symptomatic patients is currently less clear. The absence of coronary 
calcifications has a high negative predictive value to exclude obstructive CAD in 
appropriately selected patients [21,22], while high CACS values are generally 
associated with more advanced coronary sclerosis and a higher likelihood of ischaemia 
[23,24] or stenotic lesions [25].  
 
 
Coronary computed tomography angiography 
 
CCTA allows reliable visualization of the coronary arteries and is able to detect the 
presence of coronary stenosis in addition to general cardiac anatomy and anomalies. 
The high negative predictive value in low-intermediate risk patients enables a reliable 
exclusion of obstructive CAD [26]. Due to technical limitations accurate assessment of 
the degree of stenosis is difficult. An inherent limitation, therefore, remains the 
inability to predict the severity and functional relevance of intermediate grade stenoses 
and calcified lesions. Consequently, positive predictive values in detecting haemo-
dynamically relevant coronary artery stenoses vary between 32 and 60% [27].  
 
 
SPECT imaging combined with calcium scoring and/or coronary 
CT angiography  
 
The growing availability of multi-slice CT scanners and the recent advent of hybrid 
SPECT/CT and PET/CT scanners have increased the interest in simultaneous perfusion 
imaging and CACS or CCTA in patients with suspected CAD. The possible 
improvement using CZT cardiac SPECT scanners has further increased the interest in 
this hybrid approach. The CACS enables diagnosing and quantification of the degree of 
coronary atherosclerosis irrespective of MPI results, improving the detection of 
relevant CAD [28], while also providing additional long-term prognostic information 
[29-31]. Hybrid SPECT and CCTA imaging has shown to improve the diagnostic and 
prognostic performance and has the potential to enable a more appropriate selection of 
patients who may benefit from ICA with subsequent revascularization [32]. However, 
the optimal combination of these new tests is currently unclear. Important aspects in 
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combining these tests are the overall clinical effectiveness and the minimization of the 
total cost as well as radiation dose.   
 
In summary, SPECT myocardial perfusion imaging provides relevant functional 
information in patients with suspected CAD, although it does not give anatomical 
information for targeting revascularization. CCTA is able to detect coronary 
atherosclerosis at its earliest stages with a high sensitivity and negative predictive 
value, although it is unable to assess the haemodynamical relevance of depicted 
stenoses. Therefore, SPECT imaging and CCTA should be considered complementary 
approaches rather than exclusive in the evaluation of the patient at risk for CAD. In 
addition, the role of CACS in symptomatic patients in clinical daily practice remains 
unclear. 
 In 2009, we have implemented (as the first hospital in Europe) a dedicated cardiac 
hybrid 64-slice SPECT/CT device in clinical daily practice. In 2010, the gamma 
camera was upgraded with latest CZT detector technology. We have implemented a 
sequential diagnostic approach for hybrid cardiac imaging in stable low-intermediate 
risk patient starting with stress SPECT imaging and CACS as initial tests. In case of 
normal perfusion findings further testing was omitted, while additional rest SPECT 
imaging and/or CCTA were performed in those with equivocal or abnormal stress 
SPECT findings. However, the implementation of CZT SPECT detector technology 
and the real-world implications of this stepwise diagnostic algorithm required clinical 
evaluation and validation.  
 
 
Outline of the thesis 
 
The aim of this thesis was to study the clinical value and potential role of combining 
SPECT, CACS and CCTA imaging in a real-world everyday clinical setting. For this 
purpose we developed a stepwise algorithm for patients with suspected stable CAD. 
Additionally, the clinical implications of SPECT imaging by using a CZT gamma 
camera were studied. These research questions were assessed by using data from a 
large cohort registry of low-intermediate risk patients without prior CAD referred for 
non-invasive SPECT/CT imaging because of suspected stable anginal complaints. 
 
In CHAPTER 2, the impact of the CZT SPECT camera for myocardial perfusion imaging 
is described. CHAPTER 3 describes the degree of concordance between CZT SPECT 
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imaging and invasive pressure-derived fractional flow measurements in stable patients 
with intermediate degree coronary stenoses. CCTA allows reliable visualization of the 
coronary arteries and is also able to detect general cardiac anatomy and coronary 
anomalies including myocardial bridging. Myocardial bridging is a congenital coronary 
anomaly caused by muscles overlying the intramyocardial course of an epicardial 
coronary artery and may cause symptoms as chest pain due to systolic compression of 
the tunnelled segment. In CHAPTER 4, we studied the value of CCTA in assessing the 
prevalence of myocardial bridging in patients referred for a clinically indicated CCTA. 
 
CHAPTERS 5 to 8 of this thesis focus on the impact of simultaneous CACS and CCTA 
in stable low-intermediate risk patients referred for SPECT myocardial perfusion 
imaging. CHAPTER 5 describes our real-world clinical experience with an 
individualized stepwise approach for hybrid SPECT/CT imaging in stable patients with 
suspected CAD. In CHAPTER 6, we investigated the influence of CACS knowledge on 
the visual interpretation of SPECT. In CHAPTER 7, we describe the ability of a zero 
calcium score to exclude flow-limiting CAD in our homogeneous population referred 
for SPECT imaging on clinical grounds. Finally, the impact of SPECT imaging in 
symptomatic patients with extreme coronary calcifications (CACS >1000) is addressed 
in CHAPTER 8.  
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Abstract 
 
Purpose: The new ultrafast cardiac single photon emission computed tomography 
(SPECT) cameras with cadmium-zinc-telluride (CZT)-based detectors are faster and 
produce higher quality images as compared to conventional SPECT cameras. We 
assessed the need for additional imaging, total imaging time, tracer dose and 1-year 
outcome between patients scanned with the CZT camera and a conventional SPECT 
camera. 
Methods: A total of 456 consecutive stable patients without known coronary artery 
disease underwent myocardial perfusion imaging on a hybrid SPECT/CT (64-slice) 
scanner using either conventional (n=225) or CZT SPECT (n=231). All patients started 
with low-dose stress imaging, combined with coronary calcium scoring. Rest imaging 
was only done when initial stress SPECT testing was equivocal or abnormal. Coronary 
CT angiography was subsequently performed in cases of ischaemic or equivocal 
SPECT findings. Furthermore, 1-year clinical follow-up was obtained with regard to 
coronary revascularization, non-fatal myocardial infarction or death. 
Results: Baseline characteristics were comparable between the two groups. With the 
CZT camera, the need for rest imaging (35% vs 56%, p<0.001) and additional coronary 
CT angiography (20% vs 28%, p=0.025) was significantly lower as compared with the 
conventional camera. This resulted in a lower mean total administered isotope dose per 
patient (658±390 MBq vs 840±421 MBq, p<0.001), and shorter imaging time 
(6.39±1.91 vs 20.40±7.46 min, p<0.001) with the CZT camera. After 1 year, clinical 
outcome was comparable between the two groups. 
Conclusions: As compared to images on a conventional SPECT camera, stress 
myocardial perfusion images acquired on a CZT camera are more frequently 
interpreted as normal with identical clinical outcome after 1-year follow-up. This 
lowers the need for additional testing, results in lower mean radiation dose and 
shortens imaging time. 
 
 
Introduction 
 
Non-invasive testing is often employed for the detection of suspected obstructive 
coronary artery disease (CAD). Single photon emission computed tomography 
(SPECT) myocardial perfusion imaging (MPI) is widely used and has proven to 
provide valuable diagnostic and prognostic information [1-4]. A stress-only protocol 
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has been proposed to lower radiation dose and imaging time, in which rest imaging is 
omitted when the stress images are normal [5]. To improve image quality and reduce 
imaging time, a new generation of gamma cameras with novel semiconductor 
cadmium-zinc-telluride (CZT) detector technology has been developed [6,7]. However, 
clinical experience with the CZT camera is limited and there are no data on stress-only 
protocols with the CZT camera as compared with the conventional camera [8-14]. 
Using a stress-only protocol, we compared the CZT camera with the conventional 
camera with regard to the need for additional rest imaging, total imaging time, mean 
total tracer doses and the 1-year outcome. 
 
  
Materials and methods 
 
STUDY POPULATION 
From January to July 2010, a total of 456 consecutive patients with suspected CAD, 
and a low to intermediate pre-test likelihood for CAD according to Diamond and 
Forrester criteria, underwent SPECT/CT imaging using an individualized stepwise 
decision algorithm (Fig. 1) [15]. The aim of this algorithm was to provide a 
 
Fig. 1. Single-day individualized stepwise decision algorithm. SPECT single photon emission 
computed tomography, CCTA coronary computed tomography angiography. 
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comprehensive patient-tailored assessment of possible CAD in each patient in a single 
day. Results allowed rapid selection of appropriate treatment or discharge. From 
January until March 2010, patients (n=225) were scanned on a conventional 
SPECT/CT camera (Ventri-LightSpeed VCT XT, GE Healthcare), and from May until 
July 2010, patients (n=231) were scanned with a CZT-based SPECT/CT camera 
(Discovery NM/CT 570c, GE Healthcare). 
We applied an individualized approach starting with low-dose stress SPECT and 
assessment of the coronary artery calcium score (CACS) as initial screenings tests in 
all patients. After acquisition and post-processing, data were immediately analysed by 
two experienced nuclear cardiology reviewers. In case of normal stress perfusion 
further tests were omitted regardless of the CACS. However, patients with equivocal or 
abnormal stress perfusion were referred for rest SPECT. In case of equivocal or 
abnormal stress/rest SPECT results and a suitable CACS, coronary computed 
tomography angiography (CCTA) was performed in the absence of contraindications. 
The CACS was considered suitable when <1000 in the absence of multiple severely 
calcified segments. At the end of the day, the same reviewers evaluated all tests 
performed and a final conclusion was drawn. 
 
SPECT-MPI DATA ACQUISITION  
All patients underwent a 1-day 99mTc-Tetrofosmin MPI protocol. Patients were 
instructed to refrain from caffeine-containing beverages for at least 24 h before the test. 
Pharmacological stress was induced by intravenous administration of adenosine (97% 
of the patients, continuous infusion at a rate of 140 μg/kg per minute for 6 minutes) or 
dobutamine (3% of the patients, starting with 10 μg/kg per minute and increased at 3-
minute intervals to a maximum of 50 μg/kg per minute until 85% of the predicted heart 
rate had been reached). Whenever possible, patients performed additional low-level 
bicycle exercise to reduce side effects of adenosine. ECG and blood pressure were 
monitored before, throughout and following the infusion. A weight-adjusted dose of 
99mTc-Tetrofosmin (standard 370 MBq, 500 MBq for patients >100 kg) was injected 
after 3 minutes of adenosine infusion. Patients scheduled for rest imaging received a 
dose of 99mTc-Tetrofosmin (standard 740 MBq, but 1000 MBq for patients >100 kg). 
For both stress and rest SPECT images were acquired 45–60 minutes after tracer 
injection. 
On the conventional dual-detector gamma camera (Ventri, GE Healthcare), images 
were acquired using a low-energy, high-resolution collimator, a 20% symmetrical 
window at 140 keV, a 64 x 64 matrix, and an elliptical orbit with step-and-shoot 
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acquisition at 6º intervals over a 180º arc (45º anterior oblique to 45º left posterior 
oblique) with 30 steps (30 views). All patients were imaged in the supine position with 
arms placed above the head. Acquisition time was 12 minutes for the stress images and 
15 minutes for the rest images.  
The CZT-based SPECT images were acquired using a multi-pinhole camera 
(Discovery NM/CT 570c, GE Healthcare) and 19 stationary detectors simultaneously 
imaging the heart. Each detector contained 32 x 32 pixelated (2.46 x 2.46 mm) CZT 
elements. A 20% symmetrical energy window at 140.5 keV was used as previously 
described [16]. All patients were imaged in the supine position with arms placed above 
the head. Acquisition time was 5 minutes for the stress images and 4 minutes for the 
rest images. This was derived from the  recommendations of the manufacturer, 
published experience and our own qualitative assessment in heart phantom studies and 
our initial experience in patients [9,16].  
Gated SPECT analysis to calculate left ventricular volumes, ejection fraction and 
to assess wall motion abnormalities was done in nearly all patients when feasible, 
usually at stress but in some cases at rest [6,7,17]. In all 456 patients, stress and rest 
SPECT studies were followed by an unenhanced low-dose CT scan during a breath-
hold to provide the attenuation map for attenuation correction. These scans covered the 
entire chest with scanning parameters: 5.0-mm slice thickness using a reconstruction 
algorithm with a 512 x 512 matrix and 800-ms rotation times at 120 kV and 20 mA. 
Emission images as well as attenuation map data were entered in a dedicated 
reconstruction algorithm to provide 3D volume data (available in a Xeleris 
workstation, GE Healthcare). These were reorientated in the standard way and 
displayed in the three traditional cardiac axes. 
 
SPECT MPI ANALYSIS 
Teams of experienced cardiologists and nuclear medicine physicians unblindedly 
analysed the images using MPI polar maps. Segments were scored by consensus of two 
readers using a 20-segment model for the left ventricle using following 5-point scoring 
system (0 = normal, 1 = equivocal, 2 = moderate, 3 = severe reduction in radiotracer 
uptake and 4 = absence of detectable tracer in a segment) [18,19].  
Perfusion defects were identified on the stress images (a segment with a score ≥2 
was considered to have a defect). A stress study was interpreted as normal if perfusion 
was assessed to be homogeneous throughout the myocardium and less than two 
segments had stress scores >2 [18-20]. Subsequent rest imaging was performed if the 
stress images did not fulfil these criteria and were therefore deemed to be either 
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abnormal or equivocal. A reversible perfusion defect was defined as one in which a 
stress defect was associated with a rest score <1 or a stress defect score of 4 with a rest 
score of 2 [18,19]. Irreversible defects were considered scar tissue when persistent 
despite applying CT-based attenuation correction together with abnormal wall motions 
in the corresponding segments [21]. 
Image quality for all 456 stress studies was assessed retrospectively by two 
independent experienced blinded readers employing a visual 4-point grading scale (1 = 
poor, 2 = fair, 3 = good and 4 = excellent). The following parameters were considered: 
myocardial count density and uniformity, endocardial and epicardial edge definition, 
visualization and definition of the right ventricle, and background noise. 
 
CACS AND CCTA DATA ACQUISITION 
All CACS and CCTA scans were acquired using the CT of the integrated SPECT/CT 
device. All patients with heart rates >70 bpm received oral beta-blocker therapy (50 or 
100 mg metoprolol, Astra Zeneca BV, Zoetermeer, The Netherlands) prior to the 
CACS scan [22]. For the CACS scans an unenhanced, ECG-gated scan was performed 
prospectively triggered at 75% of the RR interval using the following scan parameters: 
4 x 2.5 mm, gantry rotation time 330 ms, tube voltage 120 kV and tube current 250 
mA. Post-processing of the CACS was performed on dedicated workstations 
(Advantage Windows 4.4, GE Healthcare). 
With regard to the CCTA, exclusion criteria were known hypersensitivity to 
iodinated contrast agents, renal insufficiency or irregular heart rhythms. All patients 
received a single dose of nitroglycerine (0.4 mg) just before the CCTA scan. If 
necessary, patients received oral (50–200 mg) and/or intravenous beta-blocker therapy 
(5–30 mg) in order to achieve a target heart rate below 65 bpm [23]. An unenhanced 
scan was first obtained, followed by the CT angiographic acquisition using the 
following parameters: 64 slices per rotation, 0.625-mm detector collimation, gantry 
rotation time 330 ms, effective temporal resolution 165 ms, spatial resolution 0.4 mm3, 
tube voltage 100–140 kV (depending on the patient’s body weight) and tube current of 
450–800 mA. Contrast-enhanced CCTA was acquired with prospective ECG triggering 
(86%) or helical scanning (14%). All images were acquired during an inspiratory 
breath hold of approximately 10–12 s.  
 
CACS AND CCTA ANALYSIS 
The computer software for coronary calcium scoring (Smart Score, GE Healthcare) 
automatically defined the presence of calcified lesions as those greater than 130 HU. 
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The total calcium burden in the coronary arteries was manually depicted and allocated 
to the corresponding coronary artery by an experienced reader using the Agatston 
method for quantification of the CACS [24]. 
Image interpretation of the CCTA was performed on axial images, multiplanar and 
curved reformations, and thin-slab maximum intensity projections. Coronary arteries 
were subdivided according to a 15-segment model as proposed by the American Heart 
Association [25]. Each segment was evaluated on at least two planes, and the degree of 
diameter stenosis was visually graded by consensus of the two readers. 
 
CLINICAL FOLLOW-UP 
Clinical outcome data were obtained by reviewing hospital records, by performing 
telephone interviews with the patients and by contacting patients’ general practitioners. 
The time between the stress test and the date of the final examination or consultation 
was used to determine follow-up length. Events that where noted during follow-up 
where death, non-fatal myocardial infarction and unstable angina requiring 
revascularization. The minimal follow-up duration was 9 months for those without an 
event. Clinical outcomes in patients imaged by the two cameras were categorized based 
on MPI results (normal or abnormal). 
 
STATISTICAL ANALYSIS 
Statistical analysis to compare baseline characteristics, acquisition times, injected 
tracer doses, the need for additional rest imaging and final SPECT results, was 
performed with chi-squared and one-way analysis of variance (ANOVA) as available 
in SPSS software (version 16.0 for Windows; SPSS Inc., Chicago, IL, USA). 
Comparison of continuous data between both groups was performed using the two-
sided Student’s t-test. Quantitative variables were expressed as mean±SD and 
categorical variables as frequencies or percentage. A p value of less than 0.05 was 
considered as statistically significant. 
 
 
Results 
 
BASELINE CHARACTERISTICS 
The mean age of the 456 patients was 60±12 years, 49% was male and the mean body 
mass index (BMI) was 28±5 kg/m2. The main indications for SPECT/CT imaging were 
chest pain (73%) and dyspnoea (12%). Other indications were palpitations (5%), 
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screening (3%), abnormal resting ECG (3%), syncope (2%), preoperative clearance 
(1%) or fatigue (1%). In 444 patients (97%) pharmacological stress was induced with 
adenosine and in 12 patients (3%) with dobutamine. A total of 231 patients (51%) was 
scanned with the CZT camera and 225 (49%) with the conventional camera. The 
baseline characteristics of the two groups are summarized in Table 1. 
 
 
Table 1. Baseline characteristics of 456 stable patients with suspected CAD referred for  SPECT 
imaging by either a new CZT camera or a conventional camera 
 CZT 
(n=231) 
Conventional 
(n=225) 
p value 
Age (years)   59.9±13   60.9±12 0.44 
Male gender   48   51 0.46 
Current smoker   23   16 0.06 
Diabetes    14   14 0.91 
Hypercholesterolaemia   49   52 0.51 
Hypertension   63   63 0.91 
Family history   39   44 0.20 
Aspirin   41   41 0.96 
Beta-blocker   52   50 0.71 
Statin    34   32 0.69 
Systolic BP (mmHg) 141±20 143±22 0.36 
Diastolic BP (mmHg)   85±13   88±12 0.013 
Heart rate (bpm)   71±12   74±14 0.05 
BMI (kg/m2)   28±5   28±5 0.40 
LBBB     6     4 0.56 
Creatinine level (μmol/l)   77±26   76±16 0.34 
Data are percentages or mean±standard deviation. 
SPECT, single photon emission computed tomography; CZT, cadmium zinc telluride; BP, blood pressure; BMI, 
body mass index; LBBB, left bundle branch block. 
 
 
Table 2. Results of SPECT imaging with a new CZT camera vs a conventional camera in 456 stable 
patients with suspected CAD 
 CZT 
(n=231) 
Conventional 
(n=225) 
p value 
Calcium score = 0   23   28   0.24 
Calcium score 228±597 306±661   0.76 
Normal perfusion   86   72 <0.001 
    
Fixed defect     5     7   0.38 
    
Ischaemia    
    Equivocal     3   12 <0.001 
    Definite     7   10   0.23 
Data are percentages or mean±standard deviation.  
SPECT, single photon emission computed tomography; CZT, cadmium zinc telluride. 
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IMAGING RESULTS 
Results of SPECT imaging with the CZT camera versus the conventional camera are 
summarized in Table 2. There were no differences in the calcium score between the 
two groups. Image quality of the stress scans was graded good or excellent in 210 of 
the 231 patients (91%) scanned with the CZT camera and in 179 of the 225 patients 
(80%) scanned with conventional SPECT (p=0.001). In addition, with the CZT camera, 
there were significantly more normal scans and significantly fewer equivocal scans. 
The normalcy rate in patients with a <10% likelihood of CAD was 95% for the CZT 
group (n=40) and 86% for the conventional group (n=28) (p=0.22). Table 3 
summarizes the need for additional imaging after coronary calcium score and stress 
imaging with the CZT camera as compared with the conventional camera. After use of 
the CZT camera, the need for either additional rest imaging or CCTA was significantly 
less (35% vs 56%, p<0.001). 
As a direct result, the mean total 99mTc-Tetrofosmin dose received per patient in 
the CZT group was 658±390 MBq versus 840±421 MBq in the conventional SPECT 
group (p<0.001). The mean total acquisition time for SPECT imaging per patient was 
6.39±1.91 minutes in the CZT group compared to 20.40±7.46 minutes in the 
conventional SPECT group (p<0.0001).  
 
CLINICAL FOLLOW-UP 
Follow-up was assessed in 99% of the patients. There were no deaths or patients with 
myocardial infarction during a mean follow-up of 13±3 months (Table 4). A total of 16 
patients (7%) scanned with CZT camera and 24 patients (11%) scanned with the 
conventional camera had coronary revascularization (p=0.21).  
 
 
 
Table 3. Need for additional imaging after CACS and stress imaging with a new CZT camera vs a 
conventional camera in 456 stable patients with suspected CAD 
 
 
CZT 
(n=231) 
Conventional 
(n=225) 
p value 
No additional imaging 65 44 <0.001 
Rest imaging (total) 35 56 <0.001 
Rest imaging, without CCTA 15 28   0.001 
Rest SPECT + CCTA 20 28   0.025 
Data are percentages. CACS, coronary artery calcium score; CZT, cadmium zinc telluride; CCTA, coronary 
computed tomography angiography; SPECT, single photon emission computed tomography. 
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Table 4. One-year clinical follow-up of 456 stable patients with suspected CAD referred for SPECT 
imaging by either a new CZT camera or a conventional camera 
 
 
CZT 
(n=231) 
Conventional 
(n=225) 
p value 
Normal SPECT 86 72 <0.001 
    Revascularization   2   2   0.99 
    Myocardial infarction / death   0   0 NS 
Abnormal SPECT 14 28 <0.001 
    Revascularization   5   9   0.08 
    Myocardial infarction / death   0   0 NS 
Data are percentages.  
SPECT, single photon emission computed tomography; CZT, cadmium zinc telluride; NS, not significant. 
 
 
 
 
 
Discussion 
 
This clinical study in 456 consecutive stable patients with suspected CAD showed that 
the use of a new CZT camera for myocardial perfusion imaging yields significantly 
more scans interpreted as normal reducing the need for additional imaging. This was 
mostly due to a significantly lower number of equivocal scans. The reduced need for 
additional imaging resulted in a significant reduction in mean acquisition time and 
lower radiation dose. There were no differences in 1-year clinical outcome between 
patients imaged by the new camera as compared to those imaged by the conventional 
camera. 
CZT cameras use a different imaging technique as compared to conventional 
SPECT cameras, with a stationary multi-pinhole design focused on the heart. This new 
geometric design and the new detector material combined with novel reconstruction 
algorithms led to improved diagnostic performance. Since the introduction of the novel 
dedicated cardiac CZT gamma camera in 2006, this has been confirmed in several 
clinical studies. Although the design and sample size of these studies vary and the 
number of reports is still limited, all studies including this one describe superior image 
quality with significantly shorter acquisition times because of improved count 
sensitivity and image contrast (Fig. 2) [6-12]. It seems that by using the CZT camera, 
imaging time can be shorter with the same injected dose or the injected dose can be 
reduced. Diagnostic accuracy of CZT SPECT for detecting clinically significant CAD 
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in comparison to invasive coronary angiography was demonstrated to be high [12,13]. 
Recently, the combined CZT SPECT/64-slice CT device (as used in our study)  was 
validated using invasive angiography as the reference standard [26]. Furthermore, one 
study proved the feasibility of attenuation correction in this novel CZT camera with 
strong clinical agreement as compared to attenuation correction of MPI on a 
conventional camera [14].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Attenuation corrected stress/rest CZT SPECT images demonstrate large reversible 
perfusion defects of the anterior, apical and septal walls in a 66-year-old man with atypical 
anginal chest pain. Acquisition times were 5 minutes for low-dose stress images and 4 minutes for 
high-dose rest images providing excellent image quality.  
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One of the applications of CCTA in hybrid imaging is the further analysis of 
equivocal SPECT cases [27]. The decreased frequency of equivocal results with the 
CZT camera also reduced the need for additional CCTA imaging in our study, allowing 
a more efficient use of CCTA and further reduction of the mean radiation dose. 
Nevertheless, hybrid SPECT/CCTA images are still possible with the CZT camera to 
combine anatomical and physiological findings [28]. 
Our study had several limitations. It concerned an unblinded, non-randomized 
single-centre study with a relatively small population. However, although we used a 
historical control population, both groups were very comparable concerning baseline 
characteristics. Another limitation may be that we investigated only a stable patient 
population with low or intermediate risk without known prior CAD. Furthermore, it 
must be stated that subjects in our cohort had a mean BMI of 28±5 kg and image 
quality may be substantially lower in severely obese patients. Therefore, our results 
must be read with caution when extrapolating them to populations with many obese 
subjects. However, this reflects normal clinical daily practice in a nuclear department. 
The additional diagnostic information obtained from the CCTA was not analysed and 
our findings were not externally validated by invasive angiography with fractional flow 
reserve measurement. However, in a low to intermediate risk population, it could be 
questioned whether invasive angiography for scientific validation purposes only would 
be considered ethical. Finally, although we had clinical follow-up up to 1 year 
regarding myocardial infarction, revascularization or death, data on anginal complaints 
after 1 year were not available. 
 
 
Conclusion 
 
As compared to images on a conventional SPECT camera, stress myocardial perfusion 
images acquired on a CZT camera are more frequently interpreted as normal with 
identical clinical outcome after 1-year follow-up. This lowers the need for additional 
testing, results in lower mean radiation dose and shortens imaging time. 
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Abstract 
 
Purpose: Recently introduced ultrafast cardiac SPECT cameras with cadmium zinc 
telluride-based (CZT) detectors may provide superior image quality allowing faster 
acquisition with reduced radiation doses. Although the level of concordance between 
conventional SPECT and invasive fractional flow reserve (FFR) measurement has been 
studied, that between FFR and CZT-based SPECT is not yet known. Therefore, we 
aimed to assess the level of concordance between CZT SPECT and FFR in a large 
patient group with stable coronary artery disease. 
Methods: Both invasive FFR and myocardial perfusion imaging with a CZT-based 
SPECT camera, using 99mTc-Tetrofosmin as tracer, were performed in 100 patients 
with stable angina and intermediate grade stenosis on invasive coronary angiography. 
A cut-off value of <0.75 was used to define abnormal FFR. 
Results: The mean age was 64±11 years, and 64% were male. SPECT demonstrated 
ischaemia in 31% of the patients, and 20% had FFR <0.75. The concordance between 
CZT SPECT and FFR was 73% on a per-patient basis and 79% on a per-vessel basis. 
Discordant findings were more often seen in older patients and were mainly (19%) the 
result of ischaemic SPECT findings in patients with FFR >0.75, whereas only 8% had 
an abnormal FFR without ischaemia as demonstrated by CZT SPECT.  
Conclusions: Only 20–30% of patients with intermediate coronary stenoses had 
significant ischaemia as assessed by CZT SPECT or invasive FFR. CZT SPECT 
showed a modest degree of concordance with FFR, which is comparable with previous 
results with conventional SPECT. Further investigations are particularly necessary in 
patients with normal SPECT and abnormal FFR, especially to determine whether these 
patients should undergo revascularisation. 
 
 
Introduction 
 
Non-invasive testing with single photon emission computed tomography (SPECT) 
myocardial perfusion imaging (MPI) is well-validated in stable angina and provides 
valuable diagnostic and prognostic information improving patient selection for invasive 
coronary angiography (ICA) and coronary revascularisation [1-3]. The new generation 
of SPECT cameras with semiconductor cadmium zinc telluride (CZT) detector 
technology may provide superior image quality, reduced acquisition times, lower 
radiotracer doses, and higher diagnostic accuracy as compared to ICA [4-12]. 
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Similarly, intracoronary pressure-derived fractional flow reserve (FFR) measurement is 
a well-established invasive method for the assessment of the functional significance of 
coronary stenoses, facilitating decision making regarding coronary revascularization 
[13-15]. FFR is frequently performed for determining the functional significance of 
coronary stenoses [16], and adds value to anatomical measurements on ICA. Previous 
studies have shown that the degree of concordance between conventional SPECT and 
FFR is 60–90% [17], but most studies included a limited patient population, and all 
studies were performed with conventional SPECT cameras. 
 The aim of our study was to assess the degree of concordance between CZT 
SPECT imaging and invasive FFR measurement in a larger cohort of patients with 
intermediate coronary stenoses.   
 
 
Materials and methods 
 
STUDY POPULATION 
From September 2010 to December 2012, we included 100 consecutive stable 
symptomatic patients (mean age 66±11 years, 64 men) who were (1) scheduled for 
elective FFR measurement of intermediate anatomical coronary lesions demonstrated 
by recent invasive angiography, and (2) without previous non-invasive ischaemia 
detection in a prospective registry. The study was approved by the Committee on 
Research Ethics of our hospital, and written informed consent was obtained from all 
patients. Inclusion criteria were referral for elective FFR measurement of target lesions 
with a reduction in diameter of 40–80% as determined during previous coronary 
angiography. Patients with concomitant severe coronary stenoses (>80%), serial 
coronary stenoses or prior myocardial infarction in the territory of the target lesion 
were excluded. All patients underwent SPECT using an ultrafast CZT-based gamma 
camera 1 day prior to the scheduled FFR measurement. FFR values <0.75 were 
considered positive for ischaemia and FFR values >0.75 were considered negative [13]. 
 
CLINICAL INFORMATION 
At the time of examination, all patients completed a questionnaire regarding 
demographic information, prior medical history, cardiac risk factors and current 
medication use. Hypertension was defined as a blood pressure of >140/90 mmHg or 
the use of antihypertensive medication. Hypercholesterolaemia was defined as a total 
cholesterol level of >5 mmol/l or treatment with cholesterol-lowering medication. 
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Patients were classified as having diabetes if they were receiving treatment with oral 
hypoglycaemic drugs or insulin. A positive family history of coronary artery disease 
(CAD) was defined as the presence of CAD in first-degree relatives younger than 60 
years. These data were verified and complemented with demographic and clinical 
information collected from medical records. Furthermore, information regarding 
patient age, gender, weight, height, blood pressure, heart rate and symptoms were 
prospectively obtained by a medical nurse.  
 
CZT SPECT DATA ACQUISITION  
All patients underwent a 1-day 99mTc-Tetrofosmin SPECT protocol. Patients were 
instructed to refrain from caffeine-containing beverages for at least 24 h before the test. 
In 97% of the patients, pharmacologic stress was induced by intravenous 
administration of adenosine at a continuous rate of 140 μg/kg/min for 6 min. In patients 
with a contraindication to the use of adenosine (3%), stress was induced using 
dobutamine (starting with 10 μg/kg/min and increasin at 3-minute intervals to a 
maximum of 50 μg/kg/min until 85% of the predicted heart rate had been reached). 
Whenever possible, patients performed additional low-level bicycle exercise to reduce 
side effects of adenosine. ECG and blood pressure were monitored before, throughout, 
and following the infusion. A weight-adjusted dose of 99mTc-Tetrofosmin (standard 370 
MBq, 500 MBq for patients >100 kg) was injected after 3 minutes of adenosine 
infusion. Patients scheduled for rest imaging received a dose of 99mTc-Tetrofosmin 
(standard 740 MBq, but 1000 MBq for patients >100 kg). Both stress and rest SPECT 
images were acquired 45–60 minutes after tracer injection.  
 Patients were scanned with a hybrid 64-slice SPECT/CT. The CZT-based SPECT 
images were acquired using a multi-pinhole camera (Discovery NM/CT 570c; GE 
Healthcare) and 19 stationary detectors simultaneously imaging the heart. Each 
detector contained 32 x 32 pixelated (2.46 x 2.46 mm) CZT elements. A 20% 
symmetrical energy window at 140 keV was used as previously described [9]. All 
patients were imaged in the supine position with arms placed above the head. The 
acquisition time was 5 minutes for the stress images and 4 minutes for the rest images, 
as used previously [9]. Gated SPECT analysis to calculate left ventricle ejection 
fraction and to assess wall motion abnormalities was done in nearly all patients when 
feasible, usually during stress but in some patients at rest. Attenuation correction was 
not performed.  
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CZT SPECT ANALYSIS 
Two blinded nuclear cardiac readers (each with more than 10 years experience) 
visually interpreted the images, including MPI polar maps. Segments were scored 
semiquantitatively by consensus using a 17-segment model for the left ventricle and a 
five-point scoring system (0, normal; 1, mild reduction in radiotracer uptake; 2, 
moderate reduction; 3, severe reduction; and 4, absence of detectable tracer in a 
segment) [18,19]. Perfusion defects were identified on the stress images (a segment 
with a score >2 was considered to have a defect). A stress study was interpreted as 
normal if perfusion was assessed as homogeneous throughout the myocardium and 
fewer than two segments had a stress score >2 [18,19]. An ischaemic perfusion defect 
was defined as one in which a stress defect was associated with a rest score <1 or a 
stress defect score of 4 with a rest score of 2 [18,19]. Anterior and septal perfusion 
defects were allocated to the left anterior descending coronary artery, lateral defects to 
the left circumflex coronary artery, and inferior defects to the right coronary artery 
according to current convention [20]. 
 
FFR MEASUREMENT 
By ICA, a 0.014-inch pressure monitoring wire (PressureWire®; RADI Medical 
Systems, Uppsala, Sweden) was set to zero, calibrated, advanced through a guiding 
catheter, introduced into the coronary artery and positioned distal to the stenosis under 
investigation. Adenosine (140 μg/kg/min) was infused continuously through a 5 F 
sheath in the femoral vein to obtain maximal coronary blood flow, corresponding to 
minimal distal coronary pressure. After maximal hyperaemia had been achieved, FFR 
was calculated as the ratio of the mean distal intracoronary pressure measured by the 
pressure wire to the mean arterial pressure measured through the coronary guiding 
catheter. 
 
AGREEMENT BETWEEN CZT SPECT AND FFR 
Concordance on a per-patient basis between SPECT and FFR was present if ischaemic 
changes on the stress-rest SPECT test were observed in the presence of a coronary 
lesion with a FFR value of <0.75. Concordance on a per-lesion basis between SPECT 
and FFR was present if ischaemic changes on the stress-rest SPECT test were observed 
in the perfusion territory of a coronary lesion showing a FFR value of <0.75. In 
addition, concordance was also present when no ischaemic changes were observed in 
coronary lesions with FFR values >0.75. 
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STATISTICAL ANALYSIS 
Statistical analysis was performed with a commercially available software package 
(SPSS, version 20.0, for Windows; SPSS, Inc.). Quantitative variables are expressed as 
means±SD and categorical variables as frequencies, or percentage. Quantitative data 
were compared using an unpaired two-tailed Student’s t-test or the Mann-Whitey U-
test where appropriate. Categorical data were compared using the Chi-squared test and 
one-way analysis of variance to compare baseline characteristics and end-points. 
 
 
 
 
 
 
 
Table 1. General patient characteristics in relation to the SPECT result 
 Ischaemic SPECT  
(n=31) 
Non-ischaemic SPECT  
(n=69) 
p value 
Age (years)   68±8   65±12 0.412 
Male gender   58   43 0.200 
Prior infarction or  
   revascularization 
  30   39 0.413 
    
Cardiovascular risk factors    
  Current smoking   20   19 0.867 
  Diabetes   47   24 0.027 
  Hypercholesterolaemia   57   69 0.253 
  Hypertension   70   66 0.676 
  Family history   53   60 0.536 
    
Current cardiac medication    
  Aspirin   73   79 0.568 
  Beta-blocker   77   80 0.708 
  ACEi / ARB   57   59 0.860 
  Statin   67   74 0.437 
  Blood pressure (mmHg)    
  Systolic  141±22 136±18 0.359 
  Diastolic BP   84±17   81±14 0.946 
  Heart rate (bpm)   68±12   66±12 0.707 
  BMI (kg/m2)   30±5   28±4 0.054 
Data are percentages or mean±standard deviation.  
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker. 
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Results 
 
The mean age of the patients was 64±11 years, 64% were men and the mean body mass 
index (BMI) was 28±5 kg/m2. The prevalence of coronary risk factors was high as 31% 
of patients had diabetes, 65% had hypercholesterolaemia and 67% had hypertension. 
CZT SPECT demonstrated ischaemia in 31% (31) of the patients. Patients with 
ischaemia had a higher prevalence of diabetes but other general characteristics were 
comparable between the two groups (Table 1). FFR values ranged from 0.44 to 0.99 
with a mean value of 0.83±0.09. The FFR was <0.75 in 20 patients. Differences 
between patients with and without FFR values <0.75 are shown in Table 2. Patients 
with FFR <0.75 were often men and less often had hypertension; all other general 
characteristics were comparable between the two groups. FFR was measured in 128 
lesions. 
 
 
 
 
Table 2. General patient characteristics in relation to FFR 
 FFR <0.75  
(n=20) 
FFR ≥0.75  
(n=80) 
p value 
Age (years)   66±11   66±11 0.793 
Male gender   75   41 0.007 
Prior infarction or 
revascularization 
  30   38 0.532 
    
Cardiovascular risk factors    
  Current smoking   25   18 0.444 
  Diabetes   25   33 0.517 
  Hypercholesterolaemia   40   71 0.009 
  Hypertension   50   71 0.071 
  Family history   50   60 0.418 
    
Current cardiac medication    
  Aspirin   70   79 0.406 
  Beta-blocker   80   79 0.902 
  ACEi / ARB   55   59 0.761 
  Statin   60   75 0.181 
  Blood pressure (mmHg)    
  Systolic  142±20 137±20 0.168 
  Diastolic BP    87±17   81±15 0.033 
  Heart rate (bpm)   67±12   67±12 0.750 
  BMI (kg/m2)   29±5   28±4 0.911 
Data are percentages or mean±standard deviation. 
ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker. 
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According to FFR, 20% (20) of the patients were considered to have ischaemia. 
On a per-patient basis, there was concordance between SPECT and FFR in 73% (Fig. 
1). On a per-vessel basis, the concordance between SPECT and FFR was 79%. The 
concordances between SPECT and FFR on a per-patient basis and on a per-vessel basis 
were 70% and 76%, respectively, using a cut-off FFR value of <0.80 for abnormality. 
The mean FFR in patients with ischaemic SPECT was 0.77±0.12 as compared to 
0.83±0.07 in patients without ischaemia on SPECT (p=0.001). Patients with discordant 
findings were older (69±9 years vs. 64±11 years, p=0.043), but other general 
characteristics were comparable. Among the 27 patients with discordant findings 7 
were found to have serial stenoses, and 20 had a focal stenosis. Also after reviewing 
images after FFR measurement, there remained clear differences between SPECT and 
FFR (Fig. 2). Patients with abnormal FFR values without ischaemia on SPECT were 
less likely to have hypertension (25% vs 71%, p=0.015). In contrast, CZT SPECT 
showed ischaemia in 19 patients with FFR values >0.75. These patients had a higher 
BMI (31±5 vs. 28±4, p=0.027).  
  All patients with concordant ischaemic SPECT and abnormal FFR findings 
underwent subsequent coronary revascularization. None of the patients with 
concordant non-ischaemic SPECT and FFR findings underwent coronary 
revascularization. Seven of eight patients with discordant abnormal FFR values without 
 
Fig. 1. Concordance between CZT SPECT and FFR results in 100 patients with intermediate 
coronary stenoses. 
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ischaemia on SPECT underwent coronary revascularization. Six of 19 patients with 
discordant ischaemic SPECT with FFR values >0.75 (all with FFR value <0.80) 
underwent coronary revascularization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Discordance between nonischaemic stress-rest CZT SPECT perfusion images and FFR 
positivity of a lesion of the left anterior descending coronary artery (FFR 0.61) in a patient with 
single-vessel disease. 
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Discussion 
 
In this observational study in 100 patients with stable angina and intermediate 
anatomical coronary lesions without previously detected ischaemia, only 20–30% had 
ischaemia as assessed by either CZT SPECT imaging or invasive FFR measurement. 
The concordance between CZT-based SPECT and FFR was comparable with previous 
results with conventional SPECT cameras. Discordance was most often the result of 
abnormal SPECT but normal FFR (19%) and less frequently the result of normal 
SPECT with abnormal FFR (8%). 
MPI is the best validated non-invasive imaging modality, has proven diagnostic 
and prognostic value, and may be a gatekeeper in patients with intermediate risk stable 
angina [1-3]. The recently introduced CZT camera may produce better image quality 
with reduced acquisition times and lower tracer doses because of improved count 
sensitivity and image contrast [4-12]. However, the performance of the CZT camera 
has been less well studied than that of the conventional camera. In particular, it is not 
yet known how well results with the CZT camera agree with those from invasive 
measuring of the severity of a coronary stenosis. Of course, because SPECT and FFR 
are two different methods, there will always be discordance between them [17]. The 
rate of discordance of relative MPI PET imaging was found to be 27%, but quantitative 
PET analysis with absolute myocardial blood flow quantification had a substantially 
higher concordance rate of 92% [21]. These results together suggest an intrinsic factor 
as the main cause of discordance between FFR and MPI by either SPECT or PET. This 
can be easily understood as MPI provides a measure of relative tissue perfusion, which 
is physiologically quite different from a poststenotic pressure difference in an 
epicardial vessel. This may also provide an explanation as to why discordances are 
usually the result of ischaemic SPECT (tissue) with limited stenotic pressure 
difference.  
 In addition, both FFR and SPECT have limitations. FFR may be less accurate in 
patients with collateral circulation, serial stenoses, microvascular disease, prior 
myocardial infarction, elevated central venous pressure or left ventricle hypertrophy 
[16,22]. SPECT may be more difficult in obese patients and CT-based attenuation 
correction may result in improved images [23,24]. Furthermore, discordant findings 
have been found more often in patients with multivessel disease [25,26]. Melikian et al. 
studied the correlation between SPECT and FFR in patients with multivessel disease 
and found concordance in 61% on a per-patient basis [26]. They concluded that SPECT 
tends to ‘underestimate’ or ‘overestimate’ the functional importance of coronary 
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stenoses using FFR as the reference test. However, it should be emphasized again that 
this reference test (FFR) was initially validated against non-invasive tests including 
thallium SPECT imaging in which discordant results have also been reported in single-
vessel disease (22%) [13]. Unfortunately, the clinical significance of such discrepant 
findings is not yet known.   
        An important finding in our study was that only 20–30% of patients had ischaemia 
as assessed by either CZT SPECT or invasive FFR, confirming previous observations 
[27]. Several studies have shown only an improved clinical outcome after 
revascularization in patients with proven functionally relevant CAD based on SPECT 
or FFR, while coronary interventions can be safely deferred in patients without 
ischaemia [28-31]. However, despite guidelines and recommendations, approximately 
half of the patients referred for elective coronary revascularization have no objective 
proof of ischaemia [32-34]. Although both SPECT and FFR may independently 
provide information about ischaemia, it remains unknown which technique is better for 
determining whether revascularization should be performed. Despite this uncertainty, 
FFR measurement is considered by many cardiologists to be the most accurate test for 
depicting ischaemia, while also providing additional prognostic information [16,28-
31]. Therefore, FFR plays a major role in patient selection for coronary 
revascularization, especially in those with intermediate coronary stenoses with 
undetermined functional significance. However, the invasive nature of FFR 
measurement accompanies a non-negligible risk with incremental procedure times. It 
also adds significant costs with a low diagnostic yield in patients with intermediate 
degree coronary stenosis [29], as also shown in this study.  
Our study had several limitations. Although the study sample was larger than in 
many previous studies, the study cohort was too small to perform subanalyses in 
specific patient groups. Furthermore, with our sample size it was not possible to 
perform long-term follow-up, to determine whether specific patients (such as those 
with abnormal FFR but normal SPECT) have a different prognosis. Another limitation 
was that seven of the study patients selected had serial stenoses, and therefore we 
cannot exclude the possibility that results may be different in a less selected patient 
population. We did not compare the results obtained using the CZT camera with those 
obtained using a conventional camera in our patients. Also, comparison of the results 
obtained using other non-invasive methods of ischaemia detection, such as PET or MR 
perfusion, could have been of value. In addition, only a small number of patients in our 
study had an abnormal FFR and the presence of microvascular disease in our patients 
cannot be excluded. Finally, the potential impact of attenuation correction in CZT 
SPECT imaging was not assessed. As long as no single test can be considered a perfect 
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gold standard, long-term outcome studies are warranted, particularly in patients with 
discrepant SPECT and FFR findings.  
 
 
Conclusion 
 
In only 20–30% of patients with intermediate coronary stenosis was the stenosis 
functionally relevant as assessed by CZT SPECT or invasive FFR. CZT SPECT and 
FFR were concordant in 73% on a per-patient basis and in 79% on a per-vessel basis, 
which is comparable with previous results with conventional SPECT cameras. Findings 
were most discordant in patients with ischaemia on SPECT but normal FFR. Further 
investigations are necessary particularly in patients with normal SPECT and abnormal 
FFR, especially to determine whether these patients should have revascularisation. 
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Abstract 
 
Background: Coronary computed tomography angiography (CCTA) can be used to 
detect myocardial bridging (MB) of coronary arteries. However, most published 
studies included small cohorts and did not collect data about predictors. We 
investigated prevalence and predictors of MB in an Indonesian population. 
Methods: All patients who had CCTA at Cinere Hospital, Jakarta, Indonesia between 
2006 and 2009 were included in a prospective registry. MB was defined when at least 
half of the coronary artery was imbedded within the myocardium with a normal 
epicardial course of the proximal and distal portion. 
Results: Of the 934 patients (mean age 53 years, 37.8% female), MB could be 
observed in 152 patients (16.3%). Patients with MB were younger compared with those 
without MB. Coronary risk factors were not different between the two groups. 
Coronary calcifications and moderate to severe coronary stenoses were less prevalent 
in patients with MB, also after adjusting for differences in age. At the time of 
diagnosis, only a few patients with MB were treated with beta-blockers (35%) or 
calcium-channel blockers (13%). 
Conclusions: Prevalence of myocardial bridging as detected by CCTA is relatively 
high. Patients with MB were younger and had a lower prevalence of coronary sclerosis. 
MB could be the cause of their unexplained symptoms. Follow-up studies are 
necessary to assess the symptoms of these patients, their response to treatment and the 
incidence of (coronary) events. CCTA can be used to identify patients for potential 
new treatment strategies. 
 
 
Introduction 
 
Although mortality and morbidity of coronary artery disease is usually caused by 
atherosclerotic processes, congenital anomalies of coronary arteries may also cause 
symptoms in a subset of patients. Myocardial bridging (MB) of coronary arteries is 
caused by muscles overlying the intramyocardial course of an epicardial coronary 
artery. It is characterised by systolic compression of the tunnelled segment, commonly 
affecting the mid-portion of the left anterior descending coronary artery (LAD). 
Although, in general, MB is a benign condition, it may cause symptoms as chest pain 
and has been associated with impairment in endothelium-dependent vasorelaxation [1] 
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and clinical events such as myocardial infarction [2]. The deep intramural LAD has 
even been associated with sudden death [3]. 
Previously, the diagnosis of MB was made by coronary angiography with a typical 
angiographic ‘milking effect’. Also intravascular ultrasound (IVUS) and intracoronary 
Doppler (ICD) can be helpful in diagnosing the severity of MB [4]. Interestingly, IVUS 
studies have shown that despite the strong association between MB and endothelial 
dysfunction, bridging segments are relatively spared from atherosclerotic plaque 
formation [5]. However, non-invasive imaging may detect the existence of MB even 
better than coronary angiography with lower risks for general patients [6,7]. Although 
there are now several publications on MB in patients who underwent coronary 
computed tomography angiography (CCTA) of the heart, most studies had a small 
sample size (<300–400). Furthermore, most studies did not collect data on predictors or 
risk factors [8,9]. Data about prevalence and predictors in an Indonesian population are 
not available. The aim of our study was to assess the prevalence and predictors of MB 
in a large cohort of consecutive patients who had undergone CCTA at a non-university 
hospital in Indonesia.  
 
 
Methods 
 
All consecutive patients who were referred to our hospital for non-invasive 
angiography of coronary arteries by CCTA for suspected or known coronary artery 
disease were eligible for this prospective registry. At baseline, eligible patients 
completed a questionnaire on current medication use and risk factors for coronary 
artery disease. Height, weight, blood pressure and pulse were measured. In addition, 
data on treadmill ECG stress testing performed before the CCTA examination where 
collected when available. 
 
CCTA IMAGING 
A beta-blocker was administered to all patients with a heart rate over 65 beats/min 
(metroprolol 100 mg orally or 5 to 10 mg intravenously, 1 hour or immediately before 
scanning, respectively). A coronary computed tomographic angiography was obtained 
with a 64-slice multidetector CT scanner (Brilliance 64, Philips Medical Systems). 
Non-enhanced CT for calcium scoring was performed from 1 cm below the level of the 
tracheal bifurcation to the diaphragm in a craniocaudal direction. Contrast medium 
(Iopamiro 370/100) of 100 ml was injected intravenously at a rate of 5–6 ml/s.  
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CCTA ANALYSIS 
The CCTA data were analysed by an experienced cardiologist at the site (JW) and 
independently also by second investigators. If the diagnoses were different, the pictures 
were re-assessed. Disagreement was solved by a consensus reading.  
 The calcium scoring study was evaluated using an established analysis program 
(Heartbeat-CS, EBW, Philips Medical Systems). Agatston scores were determined and 
recorded on case report forms. Using retrospective electrocardiographic gating, 
reconstructions were performed routinely at 75% phases of the R-R interval period. 
Depending on the coronary morphology and quality of the scan other phases were 
applied to assess the coronary arteries. Analysis of scans was performed on a dedicated 
workstation (Philips Extended Brilliance Workspace). The dataset was evaluated in 
terms of contrast opacification, assessability, stenoses and plaques. Coronary arteries 
were assessed using axial and multi-planar reconstructions. Coronary stenosis was 
graded according to severity. Coronary stenosis was defined as absent (no coronary 
stenosis), mild stenosis (<40%), moderate stenoses (40–70%) and severe stenosis 
(>70%).  
 MB was defined when at least half of the coronary arterial diameter was imbedded 
within the myocardium and with the proximal and distal portions of the coronary artery 
coursing through epicardial fat. Arterial segments located in a deep gorge but covered 
only by a thin layer of muscle or fibrous-fatty tissue were included because it was 
reported that they may also be compressed during systole by the surrounding muscle. 
 The length and depth of the MB was measured: depth was defined as the diameter 
of the coronary artery in the MB plus the muscle width. 
 
STATISTICAL ANALYSIS  
Statistical analysis was performed with the Statistical Package for the Social Sciences 
(SPSS Inc., Chicago, IL, USA) version 15.0.1). Continuous data were expressed as 
mean±standard deviation and categorical data as percentage, unless otherwise denoted. 
Differences between continuous data were performed by Student’s t-test and the Chi-
squared or Fisher’s exact test were used as appropriate for dichotomous data. Binary 
logistic regression analysis was performed to test the independent association between 
several characteristics and MB. Analysed variables that were significant are reported 
with their respective odd ratios and 95% confidence intervals. For all analyses, 
statistical significance was assumed when the two-tailed probability value was <0.05. 
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Table 1. Coronary location of myocardial bridging in 152 patients as measured by 64-slice CCTA 
 Location of bridging 
% (n=152)* 
  Proximal LAD 13.2 
  Mid LAD 77.6 
  Distal LAD   9.2 
  Proximal RCX   0.7 
  Mid RCX   2.6 
  Distal RCX   2.6 
  RCA   0 
  Intermediate branch   2 
* Some patients had MB on more locations. 
LAD, left anterior descending coronary artery; RCX, ramus circumflexus; RCA, right coronary artery. 
 
 
 
Results 
 
During the study period, a total of 934 patients were referred to our hospital for CCTA 
imaging. Mean age was 53 years (range 23–82), 37.8% were female and 13.4% had 
diabetes. Mean systolic blood pressure before CCTA was 132 mmHg (±18.4) and 
mean diastolic blood pressure 82 mmHg (±10.7). Beta-blockers were used by 43% of 
patients and 13% of the patients used calcium antagonists. MB could be observed in 
152 patients (16.3%). The distribution of the coronary location of MB is listed in Table 
1. The majority of MB was located in the LAD, particularly in the mid-LAD. There 
were no patients with MB of the right coronary artery (RCA). 
 Differences between patients with and without MB are summarized in Table 2. 
Patients with MB were younger than those without MB. There were no differences in 
traditional coronary risk factors, including diabetes, smoking, dyslipidaemia and 
hypertension, between patients with and without MB. The clinical symptoms were 
comparable between the two patient groups. There were significant differences in the 
prevalence of atherosclerosis between patients with and without MB. Coronary 
sclerosis as assessed by coronary calcification was less prevalent in patients with MB 
and the presence of moderate to severe coronary stenoses was also significantly lower 
in this patient group (Tables 2 and 3). After adjustments for age, MB was still strongly 
associated with a lower prevalence of moderate to severe coronary stenoses (HR 0.37; 
95%CI: 0.22–0.61, p< 0.001).  
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Table 2. Differences between patients with and without bridging as measured by 64-slice CCTA 
 Without bridging 
(n=782) 
With bridging 
(n=152) 
p value 
  Age (years)   53.6±11.0   51.3±9.3   0.015 
  BMI   25.9±4.1   25.9±3.8   0.89 
  Male   63%   60%   0.62 
  Systolic blood pressure (mmHg) 132±18 129±19   0.08 
  Diastolic blood pressure (mmHg)   82±10   81±12   0.81 
  Diabetes   13.5%   13.2%   0.91 
  Family history of heart disease    35%   37.5%   0.57 
  High lipids   44%   51%   0.09 
  Hypertension   28%   24%   0.29 
  Smoking   21%   16%   0.18 
    
Complaints for referral    
   Atypical chest pain   46%   40%   0.21 
   Dizziness     7.3%     4.3%   0.24 
   Dyspnoea     9.9%   10.7%   0.79 
   Palpitations   10.6     9.2   0.64 
   Typical chest pain   18.5   21.8   0.40 
    
Medication    
   Beta-blocker   44.6   35   0.05 
   Calcium-channel blocker   19   13   0.11 
    
Total calcium score 152±423 127±769   0.57 
Calcium score = zero   50%   62%   0.007 
Calcium score >400   11%     3%   0.003 
    
Moderate / severe stenosis   34.0%   14.7% <0.001 
 
 
  
 
 
 
 
Of the 934 patients, 668 (72%) underwent treadmill ECG stress testing because of 
suspected coronary artery disease prior to referral for non-invasive coronary 
angiography by CT, of whom 181 (27%) had a positive ECG stress test. Treadmill 
ECG stress test was positive for ischaemia in 34 of 119 patients (29%) with MB 
compared with 147 of 549 patients (27%) without MB (p=0.69). 
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Table 3. Percentage of moderate and severe stenosis in patients with and without bridging as 
measured by 64-slice CT scan 
 Without bridging 
(n=782) 
With bridging 
(n=152) 
p value 
  LAD   0.001 
         Moderate stenosis 22.4 7.9  
         Severe stenosis   6.7 2.6  
  RCX   0.06 
         Moderate stenosis   7.7 4.6  
         Severe stenosis   2.4 0.7  
  RCA   0.008 
         Moderate stenosis   9.2 5.3  
         Severe stenosis    5.3 1.3  
LAD, left anterior descending coronary artery; RCX, ramus circumflexus; RCA, right coronary artery. 
 
 
 
 
 
Discussion 
 
In this large cohort, it is demonstrated that CCTA is an easy and reliable tool for 
comprehensive in vivo diagnosis of the intramuscular course of coronary arteries. We 
found a prevalence of MB as detected by CCTA of 16.3%. Patients with MB were 
younger than those without MB. There were no differences in coronary risk factors or 
stress testing results between patients with and without MB, but the prevalence of 
coronary artery disease was higher. After adjustments for differences in age, patients 
with MB still had less coronary stenoses. 
 
PREVIOUS STUDIES 
The estimated frequency that has been reported varies from 1.5 to 16% when assessed 
by coronary angiography, but in some autopsy series, it is as high as 80% [10,11]. 
Kramer et al. reviewed 658 normal coronary angiograms of patients with normal left 
ventricular function and found that 81 (12%) had a myocardial bridge of the LAD [12]. 
In a larger study, assessing 7467 consecutive coronary angiograms, only 61 (<1%!) of 
the patients had a myocardial bridge of the LAD [13]. 
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 A few studies investigated the association between traditional coronary 
angiography and CCTA in detecting MB [6,7,14]. It was shown that the diagnosis of 
MB was more often made with CCTA, suggesting that CCTA is superior to traditional 
angiography although differences in the definition of MB may play a role. With CCTA, 
different prevalences of MB have been reported (Table 4), ranging from 5.7% tot 33% 
[6-8,14-32].  
 We did not find MB in the RCA in any of our patients. Although MB of RCA has 
been described [33], it is probably very rare. 
 
 
 
 
 
Table 4. Prevalence of myocardial bridging as reported in different CCTA studies 
First author [reference] Number of patients Prevalence (%) 
Leschka [6]   150 28.7 
Lu [7]     53 30.2 
De Rosa [8]   242 18.7 
Lubarsky [9]   300 33 
Kim [14]   311 58.0 
Cademartiri [15]   543 10.9 
Ko [16]   401   5.7 
Konen [17]   118 30.5 
Kawawa [18)   148 15.8 
Johansen (19]   152 32.2 
Jacobs [20]   506 10.5 
Wang [21]     51 54.9 
Duran [22]   725   4.0 
Kantarci [23]   626   3.5 
La Grutta [24]   254 28.7 
Hwang [25] 1275 42.0 
Koşar [26]   700 37.0 
La Grutta [27]   277 29.6 
Rodríguez-Granillo [28]   577 17.3 
Liu [29] 3011   5.8 
Atar [30]     169 17 
Kim [31]   607   6 
Chen [32]   276   8.7 
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MYOCARDIAL BRIDGING AND CORONARY LESIONS 
In our study, the number of stenoses in the different coronary arteries was lower in 
patients with MB. There may be several explanations for these findings. Patients with 
MB were younger. However, after correction for age the association between bridging 
and a lower prevalence of coronary artery disease remains evident. Another 
explanation might be that MB was responsible for chest pain complaints, which led to 
the decision to perform a CCTA. In patients without MB, coronary artery disease as a 
cause for chest pain complaints is more likely. An alternative explanation could be that 
MB might be protective for the development of coronary artery disease. Several 
pathology studies have been performed assessing the extent of atherosclerosis, 
particularly within the bridge, in patients with MB [34]. Altogether, the data suggest 
that MB is associated with the decreased development of atherosclerosis under and 
proximal to the tunnelled artery, although it is unclear whether this is an independent 
factor [35]. It seems that MB located within 5 cm from the left coronary ostium may 
prevent atherosclerosis in the proximal part of LAD [36]. 
 
 
MYOCARDIAL BRIDGING AND STRESS TESTING 
Although several prior studies have assessed the frequency of MB detected by invasive 
angiography and CCTA, only limited data are available describing the relationship 
between MB and non-invasive stress test results. In our study, 29% of the patients with 
MB had a positive exercise stress test, which is in line with previous work by Bourassa 
et al. [37], who reported ischaemic ECG findings in 28–67%. However, higher rates 
were found by others, especially in the presence of left ventricular hypertrophy or 
severely bridged coronary segments [38,39]. 
 
TREATMENT 
It may be difficult to decide what to do with patients with MB as diagnosed by CCTA, 
particularly if they have symptoms. In general, therapeutic approaches that have been 
attempted for myocardial bridging include beta-blockers, calcium-channel blockers, 
stents, coronary artery bypass grafting (CABG), percutaneous coronary interventions 
(PCI) and surgical myotomy. In a small study (n=29), it was shown that coronary stent 
placement for medically refractory symptomatic myocardial bridging failed to relieve 
severe angina and was associated with high clinical restenosis [40]. In emergency 
situations, as in patients with myocardial infarction due to occlusion of the coronary 
vessel at the site of MB, percutaneous coronary intervention can be performed [41]. 
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 Nitrates should be avoided because they may increase the angiographic degree of 
systolic narrowing and can lead to worsening of the symptoms. Until now, no specific 
treatments have been proven to be beneficial in randomised controlled trials. It is 
possibly that now more patients have a diagnosis of MB, as demonstrated by non-
invasive imaging, randomised controlled trials will be performed with as endpoint both 
clinical events and symptoms. 
 
LIMITATIONS 
We have no follow-up data of our patients and did not perform routine invasive 
coronary angiography. We have no specific data with regard to the location of coronary 
stenosis in relation to the location of myocardial bridging. Furthermore, the presence of 
inducible ischaemia on myocardial perfusion imaging was not assessed and we did not 
study the relationship between the depth of the bridges and the severity of complaints. 
 Although we describe a large cohort, we could not perform subgroup analyses, 
such as in females or those with hypertension. 
 
 
Conclusions 
 
CCTA offers a good possibility to diagnose MB. The prevalence is about 16%. Patients 
with MB may appear to have a lower prevalence of coronary stenosis, but this should 
be confirmed in other studies. Also, follow-up studies should be performed to find 
subsets of patients with MB who are at risk of complications. Finally, randomised 
controlled trials are necessary to assess which treatment should be given. 
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Abstract 
 
Purpose: Hybrid cardiac imaging with single photon emission computed tomography 
(SPECT) combined with coronary CT angiography (CCTA) allows detection of 
anatomical coronary abnormalities and their physiologic consequences in a single 
setting offering improved diagnostic information. We aimed to prospectively assess the 
feasibility of a single-day individualized stepwise approach for hybrid SPECT/CT 
imaging in consecutive stable patients with suspected coronary artery disease (CAD). 
Methods: Between January 2009 and July 2011 a total of 2411 patients without known 
CAD were referred for hybrid SPECT/CT imaging. Patients underwent initial stress 
SPECT imaging and coronary calcium scoring. In case of normal perfusion findings 
further tests were omitted regardless of the calcium score. Additional rest SPECT and 
CCTA (when feasible) were performed in those with abnormal stress SPECT. In 
addition, clinical follow-up was recorded with regard to coronary revascularization, 
nonfatal myocardial infarction and death. 
Results: Of the 2411 patients (mean age 61±12 years, 43% male) calcium scoring was 
performed in 2339 (97%) and 53% had normal stress SPECT findings in whom 
additional testing could be omitted. Among the 1144 patients who underwent 
additional rest imaging, SPECT was still considered to be normal in 555 patients 
(49%). Additional CCTA was performed in 618 patients (26%) ruling out obstructive 
CAD in 73% of patients with abnormal SPECT findings, including 50% of the patients 
with ischaemic SPECT results. After a median follow-up of 29 months (25th–75th 
percentile 18–38), annual cardiac event rate was 0.5% for the stress-only group, 3.4% 
for patients who underwent additional rest imaging without CCTA, and 4.8% for 
patients who underwent complete SPECT with CCTA imaging (p<0.001).   
Conclusions: Our individualized approach, using flexible SPECT/CT imaging 
provides both anatomical and functional information in a single session. This method 
can be preferred over methods employing SPECT alone, CCTA alone, or a fixed 
combination of stress/rest SPECT and CCTA in all patients. Moreover, in this 
approach SPECT and CCTA seem to compensate each other’s shortcomings. 
 
 
Introduction 
 
Accurate detection of functionally relevant coronary artery disease (CAD) remains a 
challenging task. Therefore, great efforts have been made to develop new non-invasive 
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approaches for imaging. Stress myocardial perfusion imaging (MPI) using single 
photon emission computed tomography (SPECT) is an established method for 
assessment of the functional significance of coronary stenoses and risk stratification, 
although it does not give anatomical information for targeting revascularization [1-3]. 
More recently, coronary computed tomography angiography (CCTA) is increasingly 
being used as an alternative diagnostic tool allowing visualisation of the coronary 
arteries and stenosis with a high negative predictive value (NPV) although it does not 
provide functional information on lesion severity [4,5].  
 With the recent advent of hybrid SPECT/CT devices, attenuation corrected MPI 
scans can be complemented with anatomical information obtained from coronary artery 
calcium scoring (CACS) and CCTA in a single session [6]. The improved diagnostic 
and prognostic performance of hybrid SPECT/CT imaging has the potential to enable a 
more appropriate selection of patients who may benefit from revascularization [7-9]. 
For overall clinical effectiveness and minimization of the total cost and radiation dose a 
sequential diagnostic approach seems most practical for clinical practice. However, 
clinical data are limited [10]. Therefore, the aim of the present study was to 
prospectively assess the feasibility of an individualized stepwise approach for hybrid 
SPECT/CT imaging starting with low-dose stress SPECT and CACS as initial 
screenings tests in consecutive new stable patients with suspected CAD.  
   
    
Materials and methods 
 
STUDY POPULATION 
From January 2009 to July 2011, a total of 2411 consecutive patients with suspected 
but unconfirmed CAD, and a low to intermediate pre-test likelihood for CAD 
according to Diamond and Forrester criteria [11], underwent SPECT/CT imaging using 
an individualized stepwise decision algorithm. Patients were referred from the 
cardiology outpatient clinics of our hospital, which is a large cardiovascular center with 
a local, regional, and supraregional catchment area. The aim of this algorithm was to 
provide a comprehensive patient-tailored assessment of possible CAD in each patient 
in a single day. Results allowed rapid selection of appropriate treatment or discharge. 
From January 2009 until April 2010, patients (n=977) were scanned on a conventional 
SPECT/CT camera (Ventri-LightSpeed VCT XT, GE Healthcare), and from May 2010 
until July 2011, patients (n=1434) were scanned with a cadmium zinc telluride (CZT)-
based SPECT/CT camera (Discovery NM/CT 570c, GE Healthcare).  
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 We applied an individualized approach starting with low-dose stress SPECT and 
assessment of the CACS as initial screenings tests in all patients. After acquisition and 
post-processing, data were immediately analyzed by two experienced nuclear 
cardiology reviewers. In case of unequivocally normal stress perfusion further tests 
were omitted regardless of the CACS. All patients with equivocal or abnormal stress 
perfusion were referred for rest SPECT with or without CCTA. However, CCTA was 
only performed in case of a suitable CACS and absence of any contra-indications. The 
CACS was considered suitable when <1000 in the absence of large clustered calcified 
segments. At the end of the day, the same reviewers evaluated all performed tests and a 
final conclusion was drawn. All procedures were performed in accordance with the 
Declaration of Helsinki. The study was approved by the Committee on Research Ethics 
of our hospital, and written informed consent was obtained from all patients. 
 
CLINICAL INFORMATION 
At the time of examination, all patients completed a questionnaire regarding demographic 
information, prior medical history, cardiac risk factors and current medication use. These 
data were verified and complemented with demographic and clinical information 
collected from medical records. Furthermore, information regarding patient age, gender, 
weight, height, blood pressure, heart rate and symptoms were prospectively obtained 
by a medical nurse. Pre-test likelihood of CAD was assigned according to Diamond 
and Forrester criteria, with a risk threshold of <13.4% for low risk, between 13.4 and 
87.2% for intermediate risk, and >87.2% for high risk [11].  
 
SPECT-MPI DATA ACQUISITION  
All patients underwent a 1-day 99mTc-Tetrofosmin MPI protocol. Patients were 
instructed to refrain from caffeine-containing beverages for at least 24 hours before the 
test. Pharmacologic stress was induced by intravenous administration of adenosine 
(continuous infusion at a rate of 140 μg/kg/min for 6 minutes) or dobutamine in case of 
contra-indication for adenosine (starting with 10 μg/kg/min and increased at 3-minute 
intervals to a maximum of 50 μg/kg/min until 85% of the predicted heart rate had been 
reached). Whenever possible, patients performed additional low-level bicycle exercise 
to reduce side-effects of adenosine. ECG and blood pressure were monitored before, 
throughout, and following the infusion. A weight-adjusted dose of 99mTc-Tetrofosmin 
(standard 370 MBq, 500 MBq for patients >100 kg) was injected after 3 minutes of 
adenosine infusion. Patients scheduled for rest imaging received a dose of 99mTc-
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Tetrofosmin (standard 740 MBq, but 1000 MBq for patients >100 kg). For both, stress 
and rest SPECT images were acquired 45–60 min after tracer injection. 
 On the conventional dual-detector gamma camera (Ventri, GE Healthcare), images 
were acquired using a low-energy, high-resolution collimator, a 20% symmetrical 
window at 140 keV, a 64 x 64 matrix, and an elliptical orbit with step-and-shoot 
acquisition at 6º intervals over a 180º arc (45º anterior oblique to 45º left posterior 
oblique) with 30 steps (30 views). All patients were imaged in supine position with 
arms placed above the head. Acquisition time was 12 minutes for the stress images and 
15 minutes for the rest images.  
 The CZT-based SPECT images were acquired using a multi-pinhole camera 
(Discovery NM/CT 570c, GE Healthcare) and 19 stationary detectors simultaneously 
imaging the heart. Each detector contained 32 x 32 pixelated (2.46 x 2.46 mm) CZT 
elements. A 20% symmetrical energy window at 140 keV was used as previously 
described [12]. All patients were imaged in supine position with arms placed above the 
head. Acquisition time was 5 minutes for the stress images and 4 minutes for the rest 
images [12]. Gated SPECT analysis to calculate left ventricular volumes, ejection 
fraction and to assess wall motion abnormalities was done in nearly all patients when 
feasible, usually at stress but in some cases at rest. In all 2411 patients, stress and rest 
SPECT studies were followed by an unenhanced low-dose CT scan during a breath-
hold to provide the attenuation map for attenuation correction. These scans covered the 
entire chest with scanning parameters: 5.0-mm slice thickness using a reconstruction 
algorithm with a 512 x 512 matrix, and 800 ms rotation times at 120 kV and 20 mA. 
Emission images as well as attenuation map data were entered in a dedicated 
reconstruction algorithm to provide 3D volume data (available in a Xeleris 
workstation, GE Healthcare). These were reorientated in the standard way and 
displayed in the three traditional cardiac axes. 
 
SPECT MPI ANALYSIS 
Two experienced nuclear cardiac readers interpreted the images including MPI polar 
maps.  Segments were scored by consensus of two readers using a 17-segment model 
for the left ventricle using following five-point scoring system (0, normal; 1, mild; 2, 
moderate; 3, severe reduction in radiotracer uptake; and 4, absence of detectable tracer 
in a segment) [13,14].  
 Perfusion defects were identified on the stress images (a segment with a score >2 
was considered to have a defect). A stress study was interpreted as normal if perfusion 
was assessed to be homogeneous throughout the myocardium and less than two 
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segments had stress scores >2 [13,14]. Subsequent rest imaging was performed if the 
stress images did not fulfill these criteria and were therefore deemed to be either 
abnormal or equivocal. A reversible perfusion defect was defined as one in which a 
stress defect was associated with a rest score <1 or a stress defect score of 4 with a rest 
score of 2 [13,14]. Reversible defects not meeting these criteria were considered 
equivocal for ischaemia as previously described [15]. Irreversible defects were 
considered scar tissue when persistent despite applying CT based attenuation correction 
together with abnormal wall motions in the corresponding segments [16]. Radiation dose 
for SPECT MPI was calculated as 99mTc-tetrofosmin activity times 7.9 mSv/GBq. 
 
CACS AND CCTA DATA ACQUISITION 
All CACS and CCTA scans were acquired using the CT of the integrated SPECT/CT 
device. All patients with heart rates >70 beats/minute received oral beta-blocker 
therapy (50 or 100 mg Metoprolol tartrate, Astra Zeneca BV, Zoetermeer, The 
Netherlands) prior to the CACS scan. If the final heart rate was >70 beats /min, CACS 
measurement was not performed. For the CACS scans an unenhanced, ECG-gated scan 
was performed prospectively triggered at 75% of the RR-interval using the following 
scan parameters: 48 sections and 2.5-mm section thickness; gantry rotation time 330 
ms; tube voltage 120 kV; and a tube current ranging from 125 to 250 mA, depending 
on patient size. Post-processing of the CACS was performed on dedicated workstations 
(Advantage Windows 4.4, GE Healthcare).    
 With regard to the CCTA, exclusion criteria were known hypersensitivity to 
iodinated contrast agents, renal insufficiency or irregular heart rhythms. All patients 
received a single dose of nitroglycerine (0.4 mg) just before the CCTA scan. If 
necessary, patients received oral (50 to 200 mg) and/or intravenous beta-blocker 
therapy (5 to 30 mg) in order to achieve a target heart rate below 65 beats/minute [17]. 
A scout view of the chest was first obtained, followed by the CT angiographic 
acquisition using the following parameters; 64 slices per rotation, 0.625 mm detector 
collimation, gantry rotation time 330 ms, effective temporal resolution 165 ms, spatial 
resolution 0.4 mm3, tube voltage 100–140 kV (depending on the patient’s body 
weight), tube current of 450–800 mA. Contrast-enhanced CCTA was acquired with 
prospective ECG triggering (70%) at 75% of the RR interval or with retrospective data 
acquisition (30%) with ECG-based tube current modulation (full tube current was 
applied from 40–80% of the RR interval). All images were acquired during an 
inspiratory breath hold of approximately 10 to 12 seconds. Effective radiation dose for 
CCTA was estimated as dose-length product times a conversion coefficient for the 
chest k (0.017 mSv/mGy/cm). 
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CACS AND CCTA ANALYSIS 
The computer software for coronary calcium scoring (Smart Score, GE Healthcare) 
automatically defined the presence of calcified lesions as those greater than 130 
Hounsfield Units. The total calcium burden in the coronary arteries was manually 
depicted and allocated to the corresponding coronary artery by an experienced reader 
using the Agatston method for quantification of the CACS [18].  
 Image interpretation of the CCTA was performed on axial images, multiplanar and 
curved reformations, and thin-slab maximum intensity projections. Coronary arteries 
were subdivided according to a 15-segment model as proposed by the American Heart 
Association [19]. Each segment was evaluated on at least two planes according to 
Society of Cardiovascular Computed Tomography guidelines [20], and the degree of 
diameter stenosis was visually graded by consensus of the two readers. Obstructive 
CAD was defined when narrowing of the coronary lumen was 50% or greater. 
 
HYBRID IMAGE FUSION 
Images of patients who underwent complete SPECT MPI with CCTA could be fused 
into hybrid three-dimensional SPECT/CT images, using the CardiQ Fusion software 
package (GE Healthcare) as described in the literature [21]. The use of the fusion 
software was left to the discretion of the readers.   
 
CLINICAL FOLLOW-UP 
Clinical outcome data were obtained by reviewing hospital records, by performing 
telephone interviews with the patients and by contacting patients’ general practitioners. 
Event free survival was defined as survival without myocardial infarction or coronary 
revascularization. The time between the stress test and the date of the final examination 
or consultation was used to determine follow-up length. Events that where noted during 
follow-up where death, nonfatal myocardial infarction and unstable angina requiring 
revascularization. Minimal follow-up time was 1 year for those without an event.  
 
STATISTICAL ANALYSIS 
Statistical analysis was performed with a commercially available software package 
(SPSS, version 20.0 for Windows; SPSS Inc., Chicago, IL, USA). Quantitative 
variables are expressed as mean±SD and categorical variables as frequencies, or 
percentages. Quantitative data were compared using an unpaired two-tailed Student’s t-
test or the Mann-Whitney U-test where appropriate. Categorical data were compared 
using Chi-squared test or Fisher’s exact test as appropriate. Differences in event-free 
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survival over time were analyzed by the Kaplan-Meier method. The log-rank test was 
used to compare the survival curves. We calculated annualized event rates on the basis 
of events per patient-year. Two sided p values of less than 0.05 were considered to 
indicate a significant difference. 
 
 
Results 
 
BASELINE CHARACTERISTICS 
Of the 2411 patients, mean age was 61±12 years, 43% were male, 14% were diabetic 
and the mean body mass index (BMI) was 28±5 kg/m2. The main indications for 
referral were atypical chest pain and dyspnea. Pre-test likelihood was considered to be 
low in 212 patients (9%), intermediate in 1738 (72%) and high in 461 patients (19%). 
Pharmacologic stress was induced by intravenous administration of adenosine in 2339 
patients (97%) and by administration of dobutamine in 72 patients (3%). The mean 
effective radiation dose for the entire cohort was 8.9±5.7 mSv. The mean total effective 
radiation dose in patients who underwent stress-only imaging was 4.4±0.4 mSv and 
14.0±4.6 mSv in patients who underwent additional imaging (p<0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Additional imaging in patients after stress SPECT and coronary artery calcium scoring 
SPECT: single photon emission computed tomography; CACS: coronary artery calcium score; 
CCTA: coronary computed tomography angiography 
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IMAGING RESULTS 
CACS was assessed in 2339 patients (97%) whereas stress MPI was performed in all 
patients. In 72 patients (3%) CACS was not assessed because of elevated heart rate. 
Mean CACS of our cohort was 280±579, median CACS was 35 (interquartile range 
0.01–265). A zero CACS was found in 606 patients (26%), 198 patients (9%) had 
CACS >1000. Stress SPECT revealed unequivocally normal myocardial perfusion 
findings in 1267 patients (53%). After the initial measurements and evaluation, these 
patients with normal SPECT were immediately discharged, while the remaining 1144 
patients (47%) were scheduled for additional imaging (Fig. 1). Patients who underwent 
additional testing were more likely to be male, to have more cardiovascular risk 
factors, higher CACS, higher BMI, were more often scanned with a conventional 
SPECT camera, and to have more often left bundle branch block (LBBB, Table 1).  
     
 
 
Table 1. Comparison between patients with stress-only imaging versus patients requiring additional 
imaging 
 
Total cohort 
(n=2411) 
Stress-only SPECT 
(n=1267) 
Additional testing 
(n=1144) 
p value 
Age (yrs)    59.2±12    62.0±12  <0.001 
Male gender    36   51 <0.001 
Current smoker    15   17 0.09 
Diabetes     11   18 <0.001 
Hypercholesterolaemia    43   45   0.455 
Hypertension    59   65   0.001 
Family history    48   50   0.746 
Mean number risk factors      1.8±1.1     1.9±1.1   0.008 
Systolic BP (mmHg)  137±21 141±20 <0.001 
Diastolic BP (mmHg)    84±12   83±12   0.323 
Heart rate (bpm)    72±13   71±12   0.015 
BMI (kg/m2)    27±4   29±5 <0.001 
LBBB      1     7 <0.001 
Creatinine level (μmol/l)    76±45   80±37   0.028 
CACS (mean)  168±428 405±690 <0.001 
Abnormal SPECT      0   51 <0.001 
CZT SPECT    71   46 <0.001 
 
Data are percentages or mean±standard deviation.  
SPECT, single photon emission computed tomography; BP, blood pressure; bpm: beats per minute; BMI,  body 
mass index; LBBB,  left bundle branch block; CACS,  coronary artery calcium score; CZT,  cadmium zinc 
telluride.  
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Table 2. Comparison between patients with SPECT imaging without CCTA versus patients who 
underwent complete SPECT with CCTA imaging 
 
 Stress-rest SPECT,  
no CCTA 
(n=526) 
Stress-rest SPECT  
with CCTA 
(n=618) 
p value 
Age (yrs)   60.8±12    59.6±11    0.006 
Male gender   40   53 <0.001 
Current smoker   14   21 <0.001 
Diabetes    14   13   0.374 
Hypercholesterolaemia   44   44   0.900 
Hypertension   62   61   0.503 
Family history   49   50   0.743 
Mean number risk factors     1.87±1.1     1.89±1.1   0.005 
Systolic BP (mmHg) 139±20 139±19   0.161 
Diastolic BP (mmHg)   84±12   83±11   0.007 
Heart rate (bpm)   72±13   70±11   0.001 
BMI (kg/m2)   28±5   28±5   0.197 
LBBB     3     7 <0.001 
Creatinine level (μmol/l)   78±47   76±15   0.016 
CACS (mean) 315±639 180 ± 339 <0.001 
 
Data are percentages or mean ± standard deviation. SPECT: single photon emission computed tomography; 
CCTA: coronary computed tomography angiography; BP: blood pressure; bpm: beats per minute. BMI: body mass 
index; LBBB: left bundle branch block; CACS: coronary artery calcium score.  
 
 
 
Among all 1144 patients who underwent additional rest SPECT imaging 555 patients 
(49%) had normal perfusion results and 589 patients abnormal stress-rest SPECT 
imaging findings. A total of 165 patients (14%) showed irreversible perfusion defects, 
203 patients (18%) had equivocally reversible SPECT findings and 221 patients (19%) 
had findings clearly suggestive for ischaemia. 
 Additional CCTA was performed in 618 patients referred for rest imaging. 
Patients who underwent CCTA were more likely to be male and smokers and they had 
a lower heart rate, lower creatinine values and lower CACS, while they were less likely 
to have diabetes or hypertension as compared to patients who underwent additional rest 
SPECT imaging without CCTA (Table 2). Additional CCTA was performed in 351 
(60%) of 589 patients with abnormal stress-rest SPECT imaging findings. In the 
remaining 238 patients CCTA was not performed because of extensive coronary 
atherosclerosis (n=132), renal insufficiency (n=40), irregular or elevated heart rate 
(n=38), or the presence of small atypical perfusion defects suspicious for an artefact 
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(n=28). In those patients who underwent additional CCTA, the presence of obstructive 
CAD was ruled in 73% of patients with abnormal SPECT findings, including 50% of 
the patients with ischaemic SPECT results. Conversely, CCTA revealed obstructive 
coronary lesions with ≥50% lumen obstruction in 45 of 264 patients (17%) with normal 
SPECT findings, in 13 of the 101 patients (13%) with persistent SPECT defects, in 24 
of 132 patients (18%) with equivocally reversible defects and in 60 of 121 patients 
(50%) with ischaemic SPECT findings.  
 
FOLLOW-UP 
Follow-up was assessed in 2393 patients (99%). The mean follow-up period was 29±12 
months (median follow-up 29 months, interquartile range 18–38 months). During 
follow-up 447 patients (19%) underwent invasive coronary angiography (ICA), 317 
patients (13%) early (≤60 days) after non-invasive imaging and 130 patients (5.4%) 
late (>60 days). Coronary revascularization was performed in 198 patients (8.2%), 
including 21 patients from the stress-only group. Nonfatal myocardial infarction 
occurred in 11 patients (0.5%), including 4 patients from the stress-only group. In total 
6 patients (0.2%) died from a cardiac cause, including 2 patients from the stress-only 
group.  
 A choice to perform ICA was more common in the group with additional imaging 
(31%) as compared to patients in the stress-only group (7.1%, p<0.001). In addition, 
referral for ICA occurred more often in men and in those with diabetes, hypertension or 
dyslipidaemia, and in patients with abnormal SPECT perfusion results. Of these 
patients who underwent ICA, obstructive CAD was demonstrated in 29% in the stress-
only group versus 54% in the group who underwent additional testing (p<0.001). 
Coronary revascularization was performed in 21 (1.7%) patients in the stress-only 
group and in 177 (15%) patients in the additional testing group (p<0.001). Among 
patients with abnormal perfusion results, coronary revascularization was performed 
more frequently (32% of the patients) when CCTA was not acquired as compared to 
patients who underwent additional CCTA (8.4% of the patients, p<0.001). Among the 
patients with abnormal perfusion results who underwent additional CCTA coronary 
revascularization during follow-up was performed in 0.8% of the patients (2 of 257) 
without obstructive CAD at CCTA as compared to 29% (28 of 97) of the patients with 
obstructive CAD at CCTA (p<0.001).     
 In patients from the stress-only group, the annual total cardiac event rate was 
0.5%, whereas for patients who underwent additional rest SPECT imaging without 
CCTA and patients who underwent complete SPECT/CCTA imaging, the respective 
values were 3.4 and 4.8% (p<0.001, Fig. 2).  
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The annual total cardiac event rates for all patients in our cohort with normal SPECT 
perfusion results was 0.8%, whereas for patients with equivocal findings and patients 
with abnormal SPECT results, the respective values were 3.9% and 8.8% (p<0.001, 
Fig. 3).  
 Among patients with normal SPECT perfusion findings, those who underwent 
stress-only imaging had a lower annual event rate (0.5%) as compared to the patients 
who required additional rest SPECT imaging (1.5%, p=0.003).    
 
Figure 2.  Kaplan Meier analysis of event-free survival (without coronary revascularization, 
myocardial infarction and death) based on performed imaging tests (Log rank p<0.001). SPECT: 
single photon emission computed tomography; CCTA: coronary computed tomography 
angiography. 
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Discussion 
 
This large prospective observational study shows that a one-day stepwise algorithm for 
hybrid cardiac SPECT/CT imaging with additional imaging for patients with equivocal 
or abnormal findings is feasible and allows an ‘all-in-one’ approach in a single day. 
Such an approach provides anatomical and functional information in a single-session 
allowing stress-only imaging with an excellent short-term prognosis in more than half 
of all patients. Simultaneous CACS in patients referred for MPI has the potential to 
increase readers‘ interpretative certainty [22], provides incremental diagnostic and 
prognostic information [23-27], and may influence medical treatment strategy [28,29]. 
Furthermore, this algorithm allows acquisition of an additional CCTA in the same 
 
Figure 3.  Kaplan Meier analysis of event-free survival (without coronary revascularization, 
myocardial infarction and death) based on SPECT results (Log rank p<0.001). SPECT: single 
photon emission computed tomography; CCTA: coronary computed tomography angiography. 
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setting for patients with equivocal or abnormal MPI findings that has the potential to 
depict false positive MPI findings [30,31].  
 Several studies have documented the complementary information provided by 
CCTA and SPECT MPI. Additional MPI provides functional information about 
obstructive coronary stenoses found in patients referred for CCTA [10,32,33]. 
Conversely, CCTA for symptomatic low-intermediate risk patients with abnormal MPI 
results is able to depict patients without obstructive CAD in whom a potential ICA can 
be deferred [26,27] and may result in significant cost savings [34]. The improved 
diagnostic and prognostic performance of hybrid imaging allows a more appropriate 
patient selection for coronary revascularization [7-10,33].  
 For overall clinical and economical effectiveness of non-invasive hybrid imaging 
a sequential diagnostic approach seems most practical for daily clinical practice. 
Several diagnostic algorithms for hybrid cardiac imaging have been proposed 
[10,35,36]. However, so far the best initial test remains unknown and may depend on 
the population studied. The ability to correctly rule out CAD renders CCTA an 
attractive tool for starting the diagnostic algorithm in low-intermediate risk patients. 
However, approximately 50% of the patients require additional SPECT or PET 
perfusion imaging after initial CCTA [10,33]. Furthermore, in clinical practice up to 
30% of the segments may be non-evaluable for the readers on CCTA [37,38] and 
extensive coronary atherosclerosis may hamper a reliable evaluation of coronary lesion 
severity [39]. 
 Therefore, we have implemented an algorithm starting with stress SPECT and 
CACS first. In our study, stress SPECT could be assessed in all patients while CACS 
was feasible in 97%. Interestingly, in 53% of all patients further tests could be omitted 
after an unequivocally normal stress MPI with an excellent short-term prognosis. This 
reflects the high NPV for coronary revascularization or hard cardiac events of SPECT, 
which was demonstrated in earlier studies [1,3]. In our cohort, additional imaging 
could be more often omitted in younger patients, women, those with a low CACS, 
those scanned with a CZT SPECT camera, and in patients without diabetes or LBBB. 
Such patients may benefit from a stress-only SPECT protocol as a potential alternative 
to CCTA for the exclusion of CAD. 
 Although complete hybrid imaging with both CCTA and MPI provides optimal 
diagnostic and prognostic information, the high cumulative effective radiation dose and 
cost restrict the large scale use in clinical practice. Furthermore, several studies have 
shown that hybrid imaging provides additional information only in selected patients 
[10,33]. Recent technical improvements in hardware and software for CCTA and 
SPECT MPI have enabled high quality imaging with reduced radiation dose [12,40-
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43]. As a result, hybrid imaging can now be achieved with an effective radiation dose 
even lower than that for traditional MPI or retrospectively gated CCTA [44,45]. 
Similarly, the mean total effective radiation dose per patient in our entire cohort was 
lower as compared to the average radiation dose associated with traditional stress-rest 
SPECT MPI [46].   
 Although our study reflects a real-world experience and all consecutive patients 
were studied, we have to acknowledge several limitations. First, this was a single 
centre study in patients without prior CAD predominantly at low or intermediate pre-
test likelihood. Therefore, our findings must be read with caution when extrapolating 
them to other populations. Furthermore, our findings were not externally validated by 
ICA with fractional flow reserve measurement. However, in a low to intermediate risk 
population, it could be questioned whether ICA for scientific validation purposes only 
would be considered ethical. In addition, we obtained clinical follow-up in the cohort 
in our study with low event-rates for patients with normal SPECT findings. We do, 
however, recognize that the relatively short follow-up may have resulted in under-
reporting of adverse cardiac events. Patient referrals, clinical postimaging medical 
management and downstream utilization of invasive testing were left to discretion of 
the treating physicians, each with their own opinions and backgrounds. Therefore it 
was not standardized and revascularization during follow-up may have been influenced 
by other factors. We have included a relatively small population relating to a low risk 
population. Furthermore, appropriate selection of patients in the cohort in our study 
who would benefit from additional CCTA could have been improved by implementing 
an additional evaluation immediately after the rest SPECT scan. Finally, we did not 
perform a head to head comparison with a CCTA first approach and the cost-
effectiveness of this algorithm still has to be studied. 
 
 
Conclusion 
 
We evaluated a one-day stepwise approach for hybrid cardiac SPECT/CT imaging in 
stable symptomatic low-intermediate risk patients starting with stress MPI and CACS. 
Such an approach provides anatomical and functional information in a single-session 
allowing stress-only imaging with an excellent prognosis in more than half of all 
patients. Acquisition of an additional CCTA for patients with equivocal or abnormal 
MPI findings has great potential to depict false positive MPI findings improving 
patient selection for coronary revascularization. 
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Abstract 
 
Purpose: Coronary artery calcium (CAC) scores influence the pre-test likelihood of 
ischaemia in patients undergoing myocardial perfusion imaging (MPI). We 
investigated the influence of CAC score knowledge on the visual interpretation of MPI 
in patients referred for the diagnostic work-up of suspected coronary artery disease. 
Methods: We retrospectively analyzed symptomatic patients who were referred for 
MPI. For the current analysis, we selected 151 patients who underwent SPECT MPI 
with simultaneous CAC scoring. MPI was visually interpreted in two separate sessions, 
first without and then with knowledge of the CAC score. MPI results were classified 
into four groups: normal, fixed defects, ischaemia, and equivocal.  
Results: Mean age of the patients was 64±11 years, 56% were male. Without 
knowledge of the CAC score MPI was evaluated as normal in 36%, compared to 40% 
with knowledge of the CAC score (p=0.636). Overall, the addition of the CAC score 
changed the interpretation of MPI in 56 patients (37%). Importantly, the frequency of 
equivocal MPI interpretations decreased from 21% without knowledge of CAC score 
to 9% with knowledge of CAC score (p=0.002).  
Conclusions: Knowledge of the CAC score has a major impact on the interpretation of 
MPI,  increasing the interpretative certainty. 
 
 
Introduction 
 
Myocardial perfusion imaging (MPI) using single photon emission computed 
tomography (SPECT) provides valuable diagnostic and prognostic information in 
patients referred for non-invasive detection of myocardial ischaemia [1-4]. However, 
image quality may influence both readers’ diagnostic certainty and overall diagnostic 
accuracy [5-7]. Availability of additional (clinical) data and knowledge of the pre-test 
likelihood of ischaemia can improve reading [8].  
 The coronary artery calcium (CAC) score is a relatively new technique to estimate 
the amount of coronary atherosclerosis [9-11]. Simultaneous CAC scoring with SPECT 
may offer incremental diagnostic and prognostic information over SPECT imaging 
alone [12-15]. This is of particular importance as concomitant CAC scoring will 
become increasingly available with the recent introduction of both hybrid positron 
emission tomography (PET)/CT and SPECT/CT devices. We hypothesized that 
knowledge of CAC score can influence reading of SPECT images, with a higher 
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diagnostic certainty of interpretation. Therefore, the aim of our study was to assess the 
influence of CAC scores on the visual interpretation of SPECT images in a population 
referred for the diagnostic work-up of suspected coronary artery disease (CAD). 
 
 
Materials and methods 
 
STUDY POPULATION 
For this study we selected patients who were referred to our hospital over a 1-year 
period (January 2009 to December 2009) for a clinically indicated MPI, and out of 
these we retrospectively selected patients without a previous history of CAD who 
underwent simultaneous CAC scoring using a hybrid 64-slice SPECT/CT device 
(n=151). All procedures were performed in accordance with the Declaration of 
Helsinki. The study was approved by the Committee on Research Ethics of our 
hospital, and written informed consent was obtained from all patients. 
 
CLINICAL INFORMATION 
At the time of examination, all patients completed a questionnaire regarding 
demographic information, prior medical history, cardiac risk factors and current 
medication use. These data were verified and complemented with demographic and 
clinical information collected from medical records. Furthermore, information 
regarding patient age, gender, weight, height, blood pressure, heart rate and symptoms 
were prospectively obtained by a medical nurse. Pre-test likelihood of CAD was 
assigned according to Diamond and Forrester criteria, with a risk threshold of <13.4% 
for low risk, between 13.4 and 87.2% for intermediate risk, and >87.2% for high risk 
[16]. 
 
SPECT-MPI DATA ACQUISITION  
All patients underwent a 1-day 99mTc-Tetrofosmin MPI protocol. Patients were 
instructed to refrain from caffeine-containing beverages for at least 24 hours before the 
test. In 149 patients (99%) pharmacologic stress was induced by intravenous 
administration of adenosine (continuous infusion at a rate of 140 μg/kg/min for 6 
minutes), while dobutamine was used in two patients (1%) with a contra-indication for 
adenosine (starting with 10 μg/kg/min and increased at 3-minute intervals to a 
maximum of 50 μg/kg/min until 85% of the predicted heart rate had been reached). 
Whenever possible, patients performed additional low-level bicycle exercise to reduce 
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side effects of adenosine. ECG and blood pressure were monitored before, throughout, 
and following the infusion. A weight-adjusted dose of 99mTc-Tetrofosmin (standard 370 
MBq, 500 MBq for patients >100 kg) was injected after 3 minutes of adenosine 
infusion. Patients scheduled for rest imaging received a dose of 99mTc-Tetrofosmin 
(standard 740 MBq, but 1000 MBq for patients >100 kg). For both, stress and rest 
SPECT images were acquired 45–60 minutes after tracer injection.  
 For SPECT/CT imaging we used a dual-detector gamma camera (Ventri, GE 
Healthcare) equipped with a 64-slice CT scanner (LightSpeed VCT XT, GE 
Healthcare). SPECT images were acquired using a low-energy, high-resolution 
collimator, a 20% symmetrical window at 140 keV, a 64 x 64 matrix, and an elliptical 
orbit with step-and-shoot acquisition at 6º intervals over a 180º arc (45º anterior 
oblique to 45º left posterior oblique) with 30 steps (30 views) [17]. All patients were 
imaged in supine position with arms placed above the head. Acquisition time was 12 
minutes for the stress images and 15 minutes for the rest images. Gated SPECT 
analysis was done in nearly all patients when feasible at high-dose rest acquisition in 
order to assist the readers in discerning artifacts from perfusion abnormalities. In all 
patients, stress and rest SPECT studies were followed by an unenhanced low-dose CT 
scan during a breath-hold to provide a map for attenuation correction. These scans 
covered the entire chest with scanning parameters: 5.0 mm slice thickness using a 
reconstruction algorithm with a 512 x 512 matrix, and 800 ms rotation times at 120 kV 
and 20 mA. Emission images as well as attenuation map data were entered in a 
dedicated reconstruction algorithm to provide 3D volume data (available in a Xeleris 
workstation, GE Healthcare). These were reorientated in the standard way and 
displayed in the 3 traditional cardiac axes. 
 
CAC IMAGING 
All cardiac CT studies were acquired using the 64-slice CT scanner of the integrated 
SPECT/CT device. All patients with heart rates >70 beats/minute received oral beta-
blocker therapy (50 or 100 mg metoprolol tartrate, Astra Zeneca BV, Zoetermeer, The 
Netherlands) prior to the CAC scan. For the CAC scans an unenhanced, ECG-gated 
scan was performed prospectively triggered at 75% of the RR-interval using the 
following scan parameters: A section thickness of 2.5 mm; gantry rotation time 330 
ms; tube voltage 120 kV; and a tube current ranging from 125–250 mA depending on 
patient size. Post-processing of the CAC scan was performed on dedicated 
workstations (Advantage Windows 4.4, GE Healthcare). 
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 The computer software for CAC scoring (Smart Score, GE Healthcare) 
automatically defined the presence of calcified lesions as those greater than 130 
Hounsfield Units. The total calcium burden in the coronary arteries was manually 
depicted and allocated to the corresponding coronary artery by an experienced reader 
using the Agatston method for quantification of the CAC [18].  
 
SPECT MPI INTERPRETATION AND DATA ANALYSIS 
Two experienced nuclear cardiac readers (each with >10 years of experience in reading 
MPI) qualitatively analyzed the attenuation corrected SPECT MPI images in two 
separate reading sessions. The total set of 151 SPECT studies was displayed in random 
order to avoid bias. During the first session the readers were asked to read the SPECT 
scans without knowledge of the CAC scores. During the second reading session (after 
8 weeks), the readers (also blinded to their initial MPI interpretations) received 
information on the total CAC score and the distribution of CAC per coronary vessel. 
The blinded interpreters scored the SPECT studies in consensus in both sessions as 
normal, equivocal, or abnormal with discrepancies resolved by a third reader. An 
equivocal result was defined as persistent diagnostic uncertainty whether the scan 
could be regarded definitely normal or abnormal, as agreed upon by both readers. If the 
study was considered abnormal, the presence of reversible or irreversible defects was 
recorded. Both readers had >3 years of experience in coronary CT angiography.  
Importantly, the readers were not further instructed how to handle CAC values or cut-
off levels and the synthesis of imaging results with CAC score information was left to 
their individual discretion. 
 We analyzed changes in diagnostic interpretation between the two reading 
sessions. The changes induced by the knowledge of CAC score were defined as minor 
or major depending on the type of change in interpretation. Major changes were 
defined as a change in the overall conclusion of the study, e.g., a conclusion changing 
from ‘ischaemia’ to ‘no ischaemia’ or vice versa was considered a major change. Other 
changes were considered minor.  
 
FOLLOW-UP 
Data regarding downstream invasive angiography within 6 months were obtained for 
patients with a change in MPI interpretation by reviewing hospital records, by 
performing telephone interviews with the patients and by contacting patients’ general 
practitioners. Patients were referred for invasive coronary angiography on clinical 
grounds or for research purposes. Invasive angiography was performed according to 
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standard clinical protocols. Angiograms were evaluated by certified interventional 
cardiologists who were aware of the SPECT and CAC imaging results. The presence of 
obstructive CAD was defined as >70% luminal narrowing in a major coronary vessel 
or >50% stenosis in the left main coronary artery. 
 
STATISTICAL ANALYSIS 
Statistical analysis was performed with a commercially available software package 
(SPSS version 18.0 for Windows; SPSS Inc., Chicago, IL, USA). Quantitative 
variables were expressed as mean±SD and categorical variables as frequencies, or 
percentage. Comparisons were performed with unpaired Student’s t-tests, Fisher’s 
exact tests or Chi-square tests, as appropriate. Two-sided p values of less than 0.05 
were considered as statistically significant. 
 
 
Results    
 
BASELINE CHARACTERISTICS 
Mean age of the 151 patients was 64±11 years, 56% were male and the mean body 
mass index (BMI) was 29±5 kg/m2. Baseline characteristics are summarized in Table 1. 
 
 
Table 1. Characteristics of patients 
Characteristic All patients  
(n=151) 
Age (years), mean±SD 64±11 
Male  84 (56) 
Body mass index, kg/m2, mean±SD 29±5 
CAC score, median (interquartile range) 307 (111–926) 
Diabetes mellitus  33 (22) 
Hypercholesterolaemia 69 (46) 
Hypertension  117 (77) 
Current smoker 30 (20) 
Former smoker 81 (54) 
First degree relative <60 years with CAD 83 (55) 
Pre-test likelihood*  
  Low 6 (4) 
  Intermediate 88 (58) 
  High 57 (38) 
Data are numbers (percentages) of patients, unless otherwise indicated. CAC, coronary artery calcification; CAD, 
coronary artery disease. * Pre-test likelihood according to Diamond & Forrester criteria [16]. 
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IMPACT OF CAC SCORES ON MPI INTERPRETATIONS 
Availability of the CAC score altered the initial diagnostic interpretation in 37% of the 
cases (56/151, p<0.0001), with a major change in 39 patients (26%). There was a 59% 
decrease in the number of equivocal SPECT findings, a 9% increase in the number of 
scans interpreted as normal, a 26% increase in the number of scans interpreted as 
positive for ischaemia and a 17% decrease in the number of scans with persistent 
perfusion defects (Fig. 1). The addition of the CAC scores reduced the number of 
equivocal SPECT findings from 32 (21%) to 13 (9%, p=0.002). Baseline 
characteristics in patients with equivocal findings or change in MPI interpretation were 
similar as compared to those with unequivocal findings or unchanged MPI reading, 
respectively. 
 A CAC score of zero was found in ten patients, of which two were interpreted as 
having a definitely normal scan during the first reading, changing to seven after the 
 
Fig. 1. Interpretation of myocardial perfusion scans in 151 patients without and with knowledge 
of CAC scores. Data are percentages. MPI, myocardial perfusion imaging; CAC, coronary artery 
calcium; NS, not significant. 
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second reading when CAC scores were available (p=0.07). Conversely, thirty patients 
had a CAC score >1000, of whom 15 patients had findings definitely suggestive for 
ischaemia during the first reading, changing to 23 in the second session with 
knowledge of the CAC score (p=0.06). Four patients with CAC score >1000 and initial 
equivocal SPECT interpretation were reclassified as having ischaemia when the CAC 
scores were presented.   
 Follow-up revealed that all 56 patients with an altered SPECT interpretation 
underwent invasive angiography within 6 months after SPECT on clinical grounds or 
for research purposes. The changes induced by CAC score knowledge and the findings 
at subsequent invasive angiography are presented in Table 2. Among the 39 patients in 
which the change was considered major, 24 readings improved and 15 readings 
deteriorated. 
 
 
 
Table 2. Changes in SPECT interpretation induced by CAC score knowledge and findings at invasive 
coronary angiography 
No. CAC score SPECT without  
CAC score 
SPECT with  
CAC score 
Obstructive CAD at 
invasive angiography* 
  1 4186 normal ischaemia yes 
  2     87 equivocal ischaemia no 
  3   108 ischaemia normal no 
  4       0 ischaemia normal no 
  5   581 equivocal ischaemia yes 
  6     46  ischaemia normal yes 
  7   395 ischaemia normal yes 
  8   987 equivocal ischaemia yes 
  9       5 equivocal fixed defect yes 
10   187 ischaemia equivocal yes 
11   437 ischaemia normal yes 
12       0 equivocal ischaemia no 
13   730 normal ischaemia yes 
14 5103 equivocal ischaemia yes 
15       0 fixed defect normal no 
16   175 equivocal normal yes 
17 1849 equivocal normal yes 
18   625 normal equivocal no 
19      0 fixed defect equivocal no 
20   215 normal fixed defect no 
21   439 equivocal ischaemia yes 
22 3043 fixed defect ischaemia yes 
23   520 normal ischaemia no 
Table continues on next page. 
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Table 2 continued from previous page. 
No. CAC score SPECT without  
CAC score 
SPECT with  
CAC score 
Obstructive CAD at 
invasive angiography* 
24 1936 equivocal ischaemia yes 
25     34 normal equivocal no 
26   545 ischaemia equivocal no 
27   210 equivocal ischaemia no 
28   246 equivocal ischaemia yes 
29   112 equivocal normal yes 
30   779 equivocal fixed defect no 
31   111 equivocal normal no 
32   835 ischaemia equivocal yes 
33       0 equivocal normal no 
34     25 normal equivocal yes 
35   192 equivocal ischaemia no 
36   971 equivocal ischaemia yes 
37   926 normal ischaemia yes 
38       3 ischaemia normal no 
39   542 equivocal ischaemia yes 
40       0 ischaemia normal no 
41   460 equivocal ischaemia no 
42   258 equivocal normal yes 
43 1923 normal ischaemia no 
44   430 equivocal ischaemia no 
45 3268 equivocal ischaemia yes 
46 1130 normal ischaemia yes 
47 1327 normal equivocal no 
48       0 ischaemia normal no 
49   258 normal ischaemia yes 
50   810 normal ischaemia yes 
51 1935 equivocal normal no 
 
 
 
 
 
Discussion  
 
Our study shows that knowledge of clinical data, in our case the CAC score, influences 
interpretation of myocardial perfusion scans in patients without a history of coronary 
artery disease. Most importantly, the changes in our study triggered by CAC score 
knowledge have a major effect on final interpretation in 26% of the cases and leads to a 
significant reduction of equivocal SPECT interpretations. These data suggest a 
potential role for simultaneous CAC scoring to improve the interpretative diagnostic 
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certainty, however, the implications for diagnostic accuracy of MPI in detecting 
obstructive CAD and eventual patient management still need to be studied. 
 The widespread availability of multi-slice CT scanners and the recent advent of 
hybrid SPECT/CT and PET/CT scanners have increased the interest in understanding 
the direct impact of simultaneous CAC scoring in patients referred for MPI. The CAC 
score enables diagnosing and quantification of the degree of coronary atherosclerosis 
irrespective of MPI results, providing additional diagnostic and prognostic information 
that could improve post-imaging clinical management and patient behaviour [12-
15,19]. However, future studies are warranted to elucidate whether the aggressive 
management of risk factors based on CAC scores averts future adverse cardiovascular 
events.  
 We tried to extend the potential role of simultaneous CAC scoring by assessing 
the direct impact of CAC score knowledge on the interpretation of myocardial 
perfusion scans. Equivocally abnormal SPECT findings may be reclassified as normal 
when accompanied by a very low CAC score due to the high NPV of CAC scoring [20-
23]. Also in a recent study from our center, none of the patients with equivocal or 
abnormal SPECT findings had obstructive CAD at subsequent invasive follow-up 
when the CAC score was zero [24]. On the other hand, very high CAC scores may 
depict obstructive CAD undetected by SPECT [12,25]. Readers might interpret 
borderline SPECT findings as abnormal, therefore increasing sensitivity of their 
interpretation in the presence of very high CAC scores. In our study readers were not 
instructed how to handle equivocal findings when CAC score values were also present, 
so this study also describes our initial experience in handling CAC score. In case of 
CAC scores below 100 and over 1500 the interpreters tend to adjust indefinite MPI 
conclusions toward definitely normal and definitely abnormal respectively. However, 
this obviously requires more study. 
 One could question whether interpretation of myocardial perfusion scans (or other 
diagnostic imaging test) should be done independently of clinical data. However, use 
of clinical data may improve sensitivity of radiological studies [26,27]. Similarly, 
knowledge of routine clinical data influences MPI interpretation [8]. Hence, guidelines 
recommend to consider inclusion of clinical data in the interpretation of myocardial 
perfusion scans [28]. 
 The small patient number, the retrospective design and the highly selected 
population represent the major limitations of current study. In addition, the extreme 
selection bias and lack of comparison with invasive fractional flow reserve 
measurements in all patients impede a reliable calculation of the sensitivity and 
specificity as reflection of the diagnostic performance. However, the aim of this study 
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was to assess the influence of CAC scores on the visual interpretation of SPECT. The 
relatively high number of equivocal findings may be perceived as possible limitation. 
We cannot completely exclude an underlying bias (although unlikely) to interpret more 
studies as equivocal during first reading session. In addition, the interpretation of MPI 
images without the availability of raw SPECT data or gated SPECT data may lead to a 
strong bias in favor of additional CAC scoring. As another limitation, we performed an 
additional scan for CAC scoring that accompanies an additional radiation exposure of 
1.1 mSv [29]. However, attenuation maps from CAC scans allow accurate attenuation 
correction of MPI [30] and CAC can be visually assessed from low-dose attenuation 
CT scans [31]. In this way additional radiation exposure can be minimized, yet 
delivering valuable additional anatomical information. Although our main focus was to 
assess the changes induced by CAC scoring on the SPECT interpretations, the main 
question should of course be whether use of clinical data, including CAC score, leads 
by improving diagnostic accuracy of MPI to better patient outcome. Additional 
prospective studies with a larger sample size should address this question. 
 
 
Conclusion    
 
Knowledge of the CAC score has a major impact on the interpretation of MPI,  
increasing the interpretative certainty. 
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Abstract 
 
Purpose: To assess the capability of a zero coronary artery calcium (CAC) score to 
help exclude flow-limiting coronary artery disease (CAD) in a homogeneous 
population with stable anginal complaints and a low-to-intermediate pretest likelihood.  
Materials and methods: The study protocol had institutional ethics committee 
approval, with written informed consent from all patients. Between 2009 and 2011, a 
total of 3501 consecutive stable patients without known CAD underwent prospectively 
simultaneous myocardial perfusion imaging and CAC scoring on a hybrid, 64-section 
single photon emission computed tomography (SPECT)/computed tomography (CT) 
scanner. In 868 (25%) of 3501 patients, the CAC score was zero, and these patients 
constituted the current study population. When feasible, additional coronary CT 
angiography was performed in those with abnormal SPECT findings. Clinical follow-
up was recorded with regard to invasive coronary angiography, coronary 
revascularization, non-fatal myocardial infarction, or death. Results were analyzed by 
using descriptive statistics.  
Results: In 868 patients (mean age, 54 years ±11 [standard deviation]; 610 [70%] 
female, 258 [30%] male), SPECT findings were normal in 766 (88%) and abnormal in 
102 (12%), with equivocal results in 41 (5%), persistent defect in 35 (4%), and 
ischaemia in 26 (3%). In the group with abnormal SPECT findings, additional coronary 
CT angiography was performed in 93 patients (91%), showing non-obstructive CAD in 
eight patients (9%) and normal coronary arteries in 85 patients (91%). In the other nine 
patients (9%), invasive angiography was used to exclude obstructive CAD. At a 
median follow up of 17 months (25th percentile, 11; 75th percentile, 24 months), no 
coronary events were recorded.  
Conclusions: A CAC score of zero in stable patients at low or intermediate risk 
excludes flow-limiting CAD. These findings support the possibility of CAC scoring as 
a simple and safe tool to select patients for additional testing or discharge, as 
recommended in the literature.  
 
 
Introduction 
 
Coronary artery calcium (CAC) scoring is a well-validated clinical tool for the early 
detection of coronary artery atherosclerosis and provides valuable prognostic 
information [1,2]. In symptomatic patients, the absence of measurable CAC has a high 
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negative predictive value for the exclusion of obstructive anatomic coronary artery 
disease (CAD) [3-4]. The absence of CAC also helps exclude inducible ischaemia at 
functional testing such as myocardial perfusion positron emission tomography (PET) in 
patients at low or intermediate risk of CAD [5]. Consequently, a clinical expert 
consensus report states that the absence of measurable CAC may be an effective 
selection tool in symptomatic patients before further testing, such as stress nuclear 
imaging, invasive diagnostic coronary angiography, and hospital admission [6]. In their 
guidelines, the Chest Pain Guideline Development Group [7] recommends CAC 
scoring as the initial test in stable patients when the likelihood of CAD is 10–29%, and 
they recommend no further testing when the CAC score is zero. 
 Despite these guidelines, investigators in several studies [8-12] again questioned 
the capability of CAC scoring to help rule out obstructive CAD. In these studies [8-12], 
higher rates of obstructive non-calcified plaques (6–39%) or inducible ischaemia 
(16%) were reported, especially in populations at higher risk and in patients with 
unstable chest complaints who present themselves at the emergency department. Many 
of these studies included heterogeneous populations or were conducted retrospectively. 
Prospective clinical studies in which CAC scoring with myocardial perfusion imaging 
was compared in large homogeneous groups of symptomatic stable patients with low 
or intermediate likelihood of CAD are limited [5]. Hence, data on the prevalence of 
flow-limiting CAD in patients with a CAC score of zero in such groups are largely 
lacking; therefore, the aim of our study was to assess the capability of a zero CAC 
score to help exclude flow-limiting CAD in a homogeneous population with stable 
anginal complaints and a low to intermediate pretest likelihood of CAD. 
 
 
Materials and methods 
 
STUDY POPULATION 
From January 2009 to December 2011, a total of 3501 consecutive stable patients 
(mean age, 61 years ±12 [standard deviation]; 1983 [57%] female patients; 1518 [43%] 
male patients) who were suspected of having CAD but in whom it was unconfirmed 
and who had a low to intermediate pretest likelihood for CAD, according to Diamond 
and Forrester [13] criteria, underwent myocardial perfusion imaging on a hybrid 64-
section single photon emission computed tomography/computed tomography 
(SPECT)/computed tomography (CT) scanner with simultaneous assessment of the 
CAC score in all. Patients were referred from the cardiology outpatient clinics of our 
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hospital, which is a large cardiovascular center with a local, regional, and supraregional 
catchment area. In the case of equivocal or abnormal stress-rest SPECT findings, 
coronary CT angiography was performed afterward in the absence of contraindications. 
Experienced nuclear cardiac reviewers (A.H.J.O., P.L.J., S.K. and J.P.O., all with more 
than 10 years of experience, and J.R.T., with more than 5 years of experience) 
evaluated all test results and drew a final conclusion. In total, 868 patients (25% of 
3501) had a CAC score of zero. These patients constitute the population of the current 
study. All procedures were performed in accordance with the Declaration of Helsinki. 
The study was approved by the Committee on Research Ethics of our hospital, and 
written informed consent was obtained from all patients. 
 
CLINICAL INFORMATION 
Demographic and clinical information were collected from medical records. 
Furthermore, information in regard to age, sex, weight, height, blood pressure, heart 
rate, current medication use, and symptoms was obtained prospectively by a medical 
nurse. Pretest likelihood of CAD was assigned according to Diamond and Forrester 
(13) criteria, with a risk threshold of less than 13.4% for low risk, a risk threshold 
between 13.4% and 87.2% for intermediate risk, and a risk threshold of more than 
87.2% for high risk. 
 
SPECT MYOCARDIAL PERFUSION DATA ACQUISITION  
All patients underwent imaging with a 1-day technetium 99m (99mTc)-Tetrofosmin 
myocardial perfusion imaging protocol. Patients were instructed to refrain from 
drinking caffeine-containing beverages for at least 24 hours before the test. In 98% 
(851 of 868) of the patients, pharmacologic stress was induced by means of 
intravenous administration of adenosine at a continuous rate of 140 μg/kg of body 
weight per minute for 6 minutes. In the case of contraindication for adenosine (17 [2%] 
of 868), dobutamine was administered, starting with 10 μg/kg per minute, and the dose 
was increased at 3-minutes intervals to a maximum of 50 μg/kg per minute, until 85% 
of the predicted heart rate had been reached. Whenever possible, patients performed 
additional low-level bicycle exercise to reduce the adverse effects of adenosine. 
Electrocardiographic measurements and blood pressure were monitored before, during, 
and after the infusion. A weight-adjusted dose of 99mTc-Tetrofosmin (standard dose, 
370 MBq; dose for patients >100 kg, 500 MBq) was injected after 3 minutes of 
adenosine infusion.  
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 Patients scheduled for rest imaging received a dose of 99mTc-Tetrofosmin 
(standard dose, 740 MBq; dose for patients >100 kg, 1000 MBq ). Stress and rest 
SPECT images were acquired 45 to 60 minutes after tracer injection. Patients 
underwent scanning with a conventional gamma camera (before May 1, 2010, n=289) 
or with a cadmium zinc telluride (CZT) gamma camera (after May 1, 2010, n=579).  
 With the conventional dual-detector gamma camera (Ventri; GE Healthcare, 
Milwaukee, WI, USA), images were acquired using a low-energy, high-resolution 
collimator, a 20% symmetrical window at 140 keV, a 64 x 64 matrix, and an elliptical 
orbit with step-and-shoot acquisition at 6º intervals over a 180º arc (45º anterior 
oblique to 45º left posterior oblique) with 30 steps (30 views). All patients underwent 
imaging in a supine position with arms placed above the head. Acquisition time was 12 
minutes for the stress images and 15 minutes for the rest images.  
 The CZT-based SPECT images were acquired using a multi-pinhole camera 
(Discovery NM/CT 570c; GE Healthcare) and 19 stationary detectors simultaneously 
imaging the heart. Each detector contained 32 x 32 pixelated (2.46 x 2.46 mm) CZT 
elements. A 20% symmetrical energy window at 140 keV was used [14]. All patients 
underwent imaging in a supine position with arms placed above the head. Acquisition 
time was 5 minutes for the stress images and 4 minutes for the rest images.  
 Gated SPECT analysis to calculate left ventricular volumes and ejection fraction 
and to assess wall motion abnormalities was performed in nearly all patients when 
feasible, usually at stress but in some patients at rest [14]. In all patients, stress and rest 
SPECT studies were followed by unenhanced low-dose CT scan during a breath hold 
to provide the attenuation map for attenuation correction. These scans covered the 
entire chest, with the following scanning parameters: 5.0-mm section thickness by 
using a reconstruction algorithm with a 512 x 512 matrix, and 800-ms rotation times at 
120 kV and 20 mA. Typical dose-length product was 34 mGy·cm and typical volume 
CT dose index was 1.4 mGy. Emission images and attenuation map data were entered 
in a dedicated reconstruction algorithm to provide three-dimensional volume data 
available at a workstation (Xeleris; GE Healthcare). These were reorientated in the 
standard way and displayed in the three traditional cardiac axes. 
 
SPECT MYOCARDIAL PERFUSION IMAGING ANALYSIS 
Two experienced nuclear cardiac readers (P.L.J., A.H.J.O., S.K., each with more than 
10 years of experience) interpreted the images, including myocardial perfusion imaging 
polar maps. Segments were scored in consensus by using a 20-segment model for the 
left ventricle using a five-point scoring system: score 0, normal; score 1, mild; score 2, 
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moderate; score 3, severe reduction in radiotracer uptake; and score 4, absence of 
detectable tracer in a segment) [15,16].  
 Perfusion defects were identified on the stress images (a segment with a score >2 
was considered to have a defect). Stress study results were interpreted as normal if 
perfusion was assessed to be homogeneous throughout the myocardium and fewer than 
two segments had stress scores of two or greater [15,16]. An ischemic perfusion defect 
was defined as one in which a stress defect was associated with a rest score of one or 
less or a stress defect score of four with a rest score of two [15,16]. Reversible defects 
that did not meet these criteria were considered equivocal for ischaemia, as previously 
described [17]. Irreversible defects were considered as scar tissue when they were 
persistent despite CT-based attenuation correction together with abnormal wall motions 
in the corresponding segments [18]. 
 
CAC SCAN ACQUISITION 
All cardiac CT studies were performed by using the 64-section CT scanner of the 
integrated SPECT/CT scanner (LightSpeed VCT XT; GE Healthcare). All patients with 
heart rates greater than 70 beats per minute received oral β-blocker therapy, with 50 or 
100 mg of metoprolol tartrate (Astra Zeneca, Zoetermeer, The Netherlands) before to 
the CAC scan. For the CAC scans, an unenhanced, electrocardiographically gated scan 
was obtained prospectively, triggered at 75% of the R-R interval by using the 
following scanning parameters: 40 sections and 2.5–mm section thickness; gantry 
rotation time, 330 msec; tube voltage, 120 kV; and a tube current ranging from 125–
250 mA, depending on patient size. Postprocessing of the CAC scan was performed at 
a dedicated workstation (Advantage Windows 4.4; GE Healthcare). 
 
CAC SCAN INTERPRETATION 
The CAC scoring computer software (Smart Score; GE Healthcare) automatically 
defined the presence of calcified lesions as those greater than 130 HU. The total 
calcium burden in the coronary arteries was depicted manually and allocated to the 
corresponding coronary artery by an experienced reader by using the Agatston method 
for quantification of the CAC [19].  All CAC scans were read by two nuclear cardiac 
readers (P.L.J., S.K., J.P.O., A.H.J.O. or J.R.T., all with more than 3 years of 
experience in CAC scoring) at the time of SPECT interpretation.  
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CORONARY CT ANGIOGRAPHY ACQUISITION    
With regard to coronary CT angiography, exclusion criteria were known hyper-
sensitivity to iodinated contrast agents, pregnancy, renal insufficiency, or irregular 
heart rhythm. All patients received a single dose of nitroglycerine (0.4 mg) just before 
coronary CT angioraphy. If necessary, patients received oral (50–200 mg) and/or 
intravenous (5–30 mg) β-blocker therapy (metoprolol) to achieve a target heart rate 
below 65 beats per minute. A scout view of the chest  was obtained first during an 
inspiratory breath hold followed by the CT angiographic acquisition with the following 
parameters: 64 sections per rotation; detector collimation, 0.625 mm; gantry rotation 
time, 330 ms; effective temporal resolution, 165 ms; spatial resolution, 0.4 mm3; tube 
voltage, 100 to 140 kV (depending on the patient’s body weight); and tube current, 450 
to 800 mA. All images were acquired during an inspiratory breath hold of 
approximately 10–12 s. Contrast material-enhanced (Optiray 350; Mallinckrodt 
Medical BV, Petten, The Netherlands) coronary CT angiography was acquired with 
prospective electrocardiographic triggering (71 [76%] of 93 patients) at 75% of the R-
R interval or with retrospective data acquisition (22 [24%] of 93 patients) with 
electrocardiographically based tube current modulation (full tube current was applied 
from 40% to 80% of the R-R interval) .  
 
CORONARY CT ANGIOGRAPHIC IMAGE INTERPRETATION 
Image interpretation of coronary CT angiographic results was performed (P.L.J., S.K., 
J.P.O., A.H.J.O. or J.R.T., all with more than 3 years of experience in coronary CT 
angiography) by using axial images, multiplanar and curved reformations, and thin-
slab maximum intensity projections according to Society of Cardiovascular Computed 
Tomography guidelines [20]. Each segment was evaluated on at least two planes, and 
the degree of diameter stenosis was graded visually with the consensus of two readers 
as none (0% luminal stenosis), mild (1% to 49% luminal stenosis), moderate (50% to 
69% luminal stenosis), or severe (>70% luminal stenosis). Obstructive CAD was 
defined when narrowing of the coronary lumen was 50% or greater. 
 
CLINICAL FOLLOW-UP 
Clinical outcome data were obtained by reviewing hospital records, performing 
telephone interviews with the patients, and contacting patients’ general practitioners. 
The interval between the examination date and the date of the final consultation was 
used to determine the follow-up length. Events that were recorded were invasive 
diagnostic coronary angiography, coronary revascularization, non-fatal myocardial 
infarction, and death.  
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STATISTICAL ANALYSIS 
Statistical analysis to compare baseline characteristics was performed with Chi-squared 
and one-way analysis of variance (ANOVA) (SPSS,version 18.0 for Windows; SPSS, 
Chicago, Ill). Quantitative variables were expressed as mean±standard deviations, and 
categorical variables were expressed as frequencies or percentage. Normality of data 
distribution was assessed by using the Kolmogorov-Smirnov test. Differences in age 
between men and women were compared by using the unpaired two-tailed Student’s t- 
test, as appropriate. Two-sided p values of less than 0.05 were considered to indicate a 
significant difference. 
 
 
 
 
 
 
Table 1. Baseline characteristics in 868 stable patients suspected of having CAD 
Age (years)a   54±11 
Sexb  
   Female 610 (70) 
   Male 258 (30) 
Current smokerb 151 (17) 
Diabetesb    61 (7) 
Hypercholesterolemiab 295 (34) 
Hypertensionb 451 (52) 
Family historyb 495 (57) 
Medication useb  
  Aspirin 269 (31) 
  Beta-blocker 391 (45) 
  Statin  200 (23) 
Blood pressure (mmHg)a  
  Systolic  131±18 
  Diastolic   82±12 
Heart rate (beats/min)a   71±12 
Body mass index (kg/m2)a   26±4 
Left bundle branch blockb   26 (3) 
Creatinine level (μmol/l)a   72±19 
Pre-test likelihoodc  
  Low 260 (30) 
  Intermediate 608 (70) 
Note: The patients had a CAC score of zero and were referred for SPECT imaging. 
a Data are the means ± standard deviations. 
b Data are the numbers of patients; numbers in parentheses are percentages, and percentages were rounded. 
c Data are the numbers of patients; numbers in parentheses are percentages. Pretest likelihood according to 
  Diamond & Forrester [13] criteria. 
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Results 
 
The mean age of the 868 patients who were suspected of having CAD was 54 years 
±11 (age range, 27–91 years); 610 (70%) were women and 258 (30%) were men, and 
the mean body mass index (BMI) was 26 kg/m2  ±4. The mean age for women was 55 
years ±11 (age range, 28–91 years) compared with a mean age of 50 years ±11 (age 
range, 27–78 years) for men (p<0.001). The baseline characteristics are summarized in 
Table 1.  
    The results of SPECT in 868 patients with a CAC score of zero are summarized in 
Table 2. Seven hundred sixty-six (88%) of 868 patients had normal SPECT myocardial 
perfusion findings. Persistent perfusion defects were found in 35 (4%), equivocal 
results in 41 (5%), and ischaemia in 26 (3%) of 868 patients. Patients who underwent 
scanning with the CZT camera had fewer equivocal SPECT findings (15 [3%] of 579 
patients) than did patients who underwent scanning with the conventional gamma 
camera (28 [10%] of 289 patients, p<0.001). Subsequent coronary CT angiography was 
performed in 93 (91%) of 102 patients with equivocal or abnormal SPECT findings 
and revealed normal coronary arteries in 85 (91%) patients and non-obstructive CAD 
in the remaining eight patients (9% of those with abnormal SPECT findings), 
excluding obstructive CAD in all of these patients. The nine patients (9%) with 
equivocal or abnormal SPECT findings in whom coronary CT angiography could not 
be performed were referred subsequently for invasive coronary angiography, which 
revealed normal coronary arteries in all of them. 
 
 
 
 
 
 
Table 2. SPECT results  in 868 stable patients with a CAC score of zero 
Normal   766 (88) 
Persistent defect 35 (4) 
Equivocal 41 (5) 
Ischaemia 26 (3) 
Note: Data are the numbers of patients; numbers in parentheses are percentages, and percentages were rounded. 
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Complete follow-up data were available in 858 (99%) of 868 patients. The results in 10 
patients were missing. The median follow-up was 17 months (25th and 75th 
percentiles, 11 and 24 months, respectively). There were no patients with myocardial 
infarction during this period, and two patients died from a non-cardiac cause. Including 
the previously mentioned nine patients, 31 (4%) of 868 patients were referred for 
invasive coronary angiography during follow-up, and the findings thereof helped to 
exclude the presence of obstructive CAD in all 31 patients. No patients in this cohort 
had flow-limiting CAD (95% confidence interval: 0–0.01%). 
 
 
Discussion  
 
This single-centre, observational study in a large and homogeneous group of stable 
symptomatic patients at low to intermediate risk for CAD showed that a CAC score of 
zero excludes flow-limiting CAD in all patients without a single exception. Although 
SPECT myocardial perfusion imaging findings were abnormal in 12% (102 of 868) of 
the patients, including reversible defects in 3% (26 of 868 patients), no obstructive 
stenoses were found in the coronary arteries at coronary CT angiography or invasive 
angiography in these patients. These findings support the use of CAC scoring as a first-
line test in stable patients at low to intermediate risk for CAD, as has been suggested 
[6,7]. 
 The prevalence of obstructive CAD in the presence of a CAC score of zero 
depends strongly on the population studied. An overview is provided in Table 3. In 
asymptomatic patients with a CAC score of zero the prevalence of obstructive CAD is 
lower than 1% [31]. Similarly, in symptomatic patients, a CAC score of zero is 
associated with a low likelihood (1–3%) of obstructive CAD in several studies [3,4]. 
On the other hand, in groups that contain patients presenting at emergency departments 
or groups of patients with unstable angina or acute coronary syndromes, higher 
prevalences of obstructive CAD were reported. However, in none of the prior studies 
did the investigators assess the hemodynamic significance of lesions detected in 
patients with a CAC score of zero [3,4,8-11,22-31]. Furthermore, the long-term 
prognostic effect of these lesions remains unclear, although several studies did not 
show increased rates of hard cardiac events (non-fatal myocardial infarction or death) 
at mid-term (3 year) follow-up [4,27]. 
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Although there remains some controversy about the capability of CAC scoring to help 
rule out obstructive CAD, when strictly implemented in stable patients at low to 
intermediate risk, as suggested by the guidelines, the CAC score still may function as 
an effective first-line selection tool before further diagnostic evaluation. The negative 
predictive value of a CAC score of zero is even higher than the negative predictive 
value of exercise testing [23] and of myocardial perfusion imaging with PET [5]. 
Because exercise and nuclear stress testing are well accepted first-line diagnostic 
modalities in populations at low to intermediate risk for CAD in which patients have 
stable chest complaints, CAC scoring is an attractive alternative. A zero CAC score in 
patients with intermediate risk that is based on conventional risk assessment could be 
used to reclassify such patients into a low-risk category [32]. However, we believe 
additional testing is still necessary in patients with unstable complaints, in patients with 
acute problems at emergency departments, in patients with possible coronary spasms or 
patients who are suspected of having coronary anomalies, and in patients with a 
substantially higher pretest probability [8-11,21-23].  
 We acknowledge several limitations of our study. First, because only patients with 
equivocal or abnormal SPECT findings underwent additional coronary CT 
angiography, the prevalence of non-calcified plaque could not be assessed in patients 
with normal SPECT findings, and potential critical stenoses accompanied by false-
negative SPECT findings theoretically could have been missed. However, our results 
are in line with those of Esteves et al. [5] who also found normal myocardial perfusion 
imaging findings in patients without detectable CAC. Furthermore, it is questionable 
whether performing complete SPECT with coronary CT angiography only for 
scientific validation purposes in a population at low risk would have been ethical and 
clinically acceptable. As a partial solution for this potential problem, we obtained data 
on clinical follow-up in the cohort in our study, and we did not find any cardiac events 
that could have been related to potentially false-negative SPECT findings. In addition, 
a normal myocardial perfusion scan confers an excellent short-term prognosis [33], and 
patients with a CAC score of zero have slow progression of CAD across time [34]. 
Although false-negative SPECT findings remain possible in the cohort in our study 
with relatively short follow-up, we still believe our findings to be valid, but more 
studies are welcomed to confirm these findings and also to assess the influence of non-
calcified plaques on patient treatment and long-term prognosis.  
 Second, we used the Diamond and Forrester [13] criteria to determine the pretest 
likelihood of CAD in the patients in our study. However, results from one study 
showed that such traditional criteria for assessing the pretest probability (although 
recommended by several guidelines [7,35] evidently led to overestimation of the actual 
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prevalences found in patients referred for non-invasive coronary CT angiography [36]. 
Therefore, our results may have been influenced by the fact that the population in our 
study possibly had a lower risk than we had defined before testing. This issue is of 
paramount interest because a uniform definition of the pretest probability appears 
crucial in the appropriate selection of patients for whom CAC scoring may be an 
effective first-line test. In addition, future prospective cost-effectiveness studies are 
warranted. 
 In conclusion, the absence of coronary calcification in stable patients at low or 
intermediate risk helps exclude flow-limiting CAD. These findings support published 
recommendations and the usefulness of CAC scoring as a simple and safe tool to select 
patients for additional testing or discharge. 
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Abstract 
 
Purpose: High coronary artery calcium (CAC) scores are associated with a high 
likelihood of ischaemia and obstructive coronary disease. Myocardial perfusion 
imaging (MPI) is a key investigation to determine the need for revascularization. 
However, the value of MPI in presence of extensive CAC has so far only been 
demonstrated in asymptomatic patients, whereas its value in symptomatic patients 
remains largely unclear. Therefore, we studied the impact of MPI in symptomatic 
patients with a CAC score >1000. 
Methods: We included 282 patients (mean age 69±9 years, 63% men) without a history 
of coronary disease with suspected stable angina referred for MPI and with a CAC 
score >1000. On follow-up at 18 months invasive angiography, coronary 
revascularization, non-fatal myocardial infarction and death were recorded. 
Results: MPI was normal in 54%, equivocal in 10% and abnormal in 37% (fixed defect 
9% and ischaemia 28%). More abnormal MPI findings were observed in men, smokers 
and those with even higher CAC scores. During follow-up, 1 patient (with non-
ischaemic MPI) died of cardiac cause, 1 patient (with ischaemic MPI) suffered a 
myocardial infarction and 92 patients (33%) underwent revascularization. Ischaemia on 
MPI was a strong predictor of coronary revascularization (odds ratio 13.1; 95% CI 7.1–
24.3; p<0.001). 
Conclusions: Ischaemia on MPI is observed in approximately 30% of patients with a 
CAC score >1000, and is a strong predictor of coronary revascularization. However, 
non-ischaemic MPI does not exclude revascularization, and patients with persisting 
complaints should be considered for invasive angiography. 
 
 
Introduction 
 
Myocardial perfusion imaging (MPI) using single photon emission computed 
tomography (SPECT) provides valuable diagnostic and prognostic information in 
patients referred for non-invasive detection of myocardial ischaemia [1,2]. However 
the presence or absence of atherosclerosis remains undetected. Furthermore, the 
diagnostic accuracy of MPI may be impaired in patients with balanced ischaemia due 
to flow-limiting three-vessel coronary artery disease (CAD) or left main stenosis [3], 
while this group is particularly prone to adverse cardiac events [4,5]. 
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 Coronary artery calcium (CAC) scoring is a clinical tool for the early non-invasive 
detection of coronary atherosclerosis [6,7]. Higher CAC scores are generally associated 
with more advanced coronary sclerosis and a higher likelihood of ischaemia [8,9] or 
stenotic lesions [10]. Nevertheless, according to several studies, the presence of 
extreme CAC scores is accompanied by a normal MPI in the majority of both 
asymptomatic and symptomatic patients [11,12]. Recent studies indicate that patients 
with normal MPI but with high CAC scores are at increased risk for future coronary 
events as compared to patients with no CAC. Such patients may have obstructive CAD 
despite normal MPI results [9,13,14]. With the recent advent of hybrid SPECT/CT 
devices, MPI and CAC scoring can be easily combined and performed in a single 
session. However, the value of MPI in symptomatic patients with a very high CAC 
score and the resulting implications for treatment and short-term prognosis remain 
largely unclear.       
 Therefore, the aims of this study were to assess the impact of MPI in patients with 
a low/intermediate risk of a coronary event with suspected but unconfirmed CAD who 
subsequently presented with a high CAC score (>1000) and to evaluate the resulting 
clinical and prognostic implications. 
 
 
Materials and methods 
 
STUDY POPULATION 
We retrospectively evaluated all patients who presented to our hospital over a 3-year 
period (January 2009 to December 2011) for a clinically indicated MPI with a hybrid 
64-slice SPECT/CT device. Only patients without a previous history of CAD, and a 
low to intermediate pre-test likelihood of CAD with a very high CAC score (>1000) 
were included in the current analysis. All procedures were performed in accordance 
with the Declaration of Helsinki. The study was approved by the Committee on 
Research Ethics of our hospital, and written informed consent was obtained from all 
patients. 
 
CLINICAL INFORMATION 
At the time of examination, all patients completed a questionnaire regarding 
demographic information, prior medical history, cardiac risk factors and current 
medication use. These data were verified and complemented with demographic and 
clinical information collected from medical records. Furthermore, information 
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regarding patient age, gender, weight, height, blood pressure, heart rate and symptoms 
were prospectively obtained by a medical nurse. The pretest likelihood of CAD was 
assigned according to the criteria of Diamond and Forrester, with a risk threshold of 
<13.4% for low risk, between 13.4 and 87.2% for intermediate risk, and >87.2% for 
high risk [15]. 
 
SPECT-MPI DATA ACQUISITION  
All patients underwent a 1-day 99mTc-Tetrofosmin MPI protocol. Patients were 
instructed to refrain from caffeine-containing beverages for at least 24 hours before the 
test. Pharmacological stress was induced by intravenous administration of adenosine 
(continuous infusion at a rate of 140 μg/kg/min for 6 minutes). In patients with a 
contraindication for adenosine, stress was induced using dobutamine (starting with 10 
μg/kg/min and increased at 3-minute intervals to a maximum of 50 μg/kg/min until 
85% of the predicted heart rate had been reached). Whenever possible, patients 
performed additional low-level bicycle exercise to reduce the side effects of adenosine. 
ECG and blood pressure were monitored before, throughout, and following the 
infusion. A weight-adjusted dose of 99mTc-Tetrofosmin (standard 370 MBq, 500 MBq 
for patients >100 kg) was injected after 3 minutes of adenosine infusion. Patients 
scheduled for rest imaging received a dose of 99mTc-Tetrofosmin (standard 740 MBq, 
but 1000 MBq for patients >100 kg). Both stress and rest SPECT images were acquired 
45–60 minutes after tracer injection. Patients were scanned with a hybrid 64-slice 
SPECT/CT device that included a conventional gamma camera (before 1 May 2010, 85 
patients) or a cadmium-zinc-telluride (CZT) gamma camera (after 1 May 2010, 197 
patients).  
 With the conventional dual-detector gamma camera (Ventri; GE Healthcare), 
images were acquired using a low-energy, high-resolution collimator, a 20% 
symmetrical window at 140 keV, a 64 x 64 matrix, and an elliptical orbit with step-and-
shoot acquisition at 6º intervals over a 180º arc (45º anterior oblique to 45º left 
posterior oblique) with 30 steps (30 views). All patients were imaged in the supine 
position with arms placed above the head. Acquisition time was 12 minutes for the 
stress images and 15 minutes for the rest images.  
 The CZT-based SPECT images were acquired using a multipinhole camera 
(Discovery NM/CT 570c; GE Healthcare) and 19 stationary detectors simultaneously 
imaging the heart. Each detector contained 32 x 32 pixelated (2.46 x 2.46 mm) CZT 
elements. A 20% symmetrical energy window at 140 keV was used as previously 
described [16]. All patients were imaged in the supine position with arms placed above 
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the head. Acquisition time was 5 minutes for the stress images and 4 minutes for the 
rest images as previously reported [16]. Gated SPECT analysis to calculate left 
ventricular volumes and ejection fraction, and to assess wall motion abnormalities was 
done in nearly all patients when feasible, usually during stress but in some cases during 
rest. Stress and rest SPECT studies were followed by an unenhanced low-dose CT scan 
during breath-hold to provide the attenuation map for attenuation correction. These 
scans covered the entire chest with the following scanning parameters: 5.0-mm slice 
thickness using a reconstruction algorithm with a 512 x 512 matrix, and 800 ms 
rotation times at 120 kV and 20 mA. Emission images as well as attenuation map data 
were entered into a dedicated reconstruction algorithm to provide 3D volume data 
(available in a Xeleris workstation; GE Healthcare). These were reorientated in the 
standard way and displayed in the three traditional cardiac axes. 
 
SPECT MPI ANALYSIS 
Experienced nuclear cardiac readers (each with more than 10 years experience) non-
blindly interpreted the images including MPI polar maps. Segments were scored by 
consensus of two readers using a 20-segment model for the left ventricle using the 
following five-point scoring system: 0, normal; 1, equivocal; 2, moderate reduction in 
radiotracer uptake; 3, severe reduction in radiotracer uptake; 4, no detectable tracer in a 
segment) [17,18].  
 Perfusion defects were identified on the stress images (a segment with a score >2 
was considered to have a defect). A stress study was interpreted as normal if perfusion 
was assessed to be homogeneous throughout the myocardium and fewer than two 
segments had a stress score >2 [17-19]. Subsequent rest imaging was performed if the 
stress images did not fulfil these criteria and were therefore deemed to be either 
abnormal or equivocal. A reversible perfusion defect was defined as one in which a 
stress defect was associated with a rest score <1 or a stress defect score of 4 with a rest 
score of 2 [17,18]. Irreversible defects were considered scar tissue when persistent 
despite applying CT-based attenuation correction together with abnormal wall motions 
in the corresponding segments [20]. 
 
UNENHANCED CAC SCAN ACQUISITION 
All cardiac CT studies were acquired in a single session immediately after MPI using 
the 64-slice CT scanner of the integrated SPECT/CT device (LightSpeed VCT XT; GE 
Healthcare). All patients with a heart rate >70 beats/minute received oral beta-blocker 
therapy (50 or 100 mg metoprolol; Astra Zeneca BV, Zoetermeer, The Netherlands) 
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prior to the CAC scan. For the CAC scans an unenhanced, ECG-gated scan was 
performed prospectively triggered at 75% of the RR interval using the following scan 
parameters: 4 x 2.5 mm, gantry rotation time 330 ms, tube voltage 120 kV, and a tube 
current ranging from 125–250 mA depending on patient size. Postprocessing of the 
CAC scan was performed on dedicated workstations (Advantage Windows 4.4; GE 
Healthcare). 
 
UNENHANCED CAC SCAN INTERPRETATION 
The computer software for CAC scoring (Smart Score; GE Healthcare) automatically 
defined the presence of calcified lesions as those with radiodensity greater than 130 
HU. The total calcium burden in the coronary arteries was manually depicted and 
allocated to the corresponding coronary artery by an experienced reader using the 
Agatston method for quantification of CAC [21].  
 
CLINICAL FOLLOW-UP 
Clinical outcome data were obtained by reviewing hospital records, by performing 
telephone interviews with the patients and by contacting patients’ general practitioners. 
The time between the examination date and the date of the final consultation was used 
to determine follow-up length. Events that were recorded during follow-up were 
diagnostic invasive coronary angiography (ICA), coronary revascularization, non-fatal 
myocardial infarction and death. 
 
STATISTICAL ANALYSIS 
Statistical analysis to compare baseline characteristics was performed with Chi-squared 
and one-way analysis of variance (ANOVA) as available in SPSS software (version 
18.0 for Windows; SPSS Inc., Chicago, IL, USA). Comparison of continuous data 
between groups was performed using the two-sided Student’s t-test. Quantitative 
variables are expressed as means±SD and categorical variables as frequencies, or 
percentage. p values of less than 0.05 were considered statistically significant. 
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Results 
 
BASELINE CHARACTERISTICS 
The baseline characteristics of the patients are shown in Table 1. The mean age of the 
entire cohort of 282 patients was 69±9 years, 63% were men and their mean body mass 
index (BMI) was 28±5 kg/m2. In 269 patients (95%) pharmacological stress was 
induced with adenosine and in 13 patients (5%) with dobutamine. The mean CAC 
score for the entire cohort was 1857±862 (median 1586, interquartile range 1235–
2169). The mean CAC score in patients >70 years of age (1959±898) was higher than 
that in patients <70 years (1754±814, p=0.046). 
 
 
Table 1. Baseline characteristics of 282 stable patients with suspected CAD and CAC score >1000 
referred for SPECT imaging 
Age (years), mean±SD   69±9 
Male gender (%)   63 
  
Cardiovascular risk factors (%)  
   Current smoking   16 
   Diabetes    28 
   Hypercholesterolaemia   53 
   Hypertension   71 
   Family history   48 
   Number of risk factors, mean±SD      2.2±1.2 
  
Current cardiac medication (%)  
   Aspirin   55 
   Beta-blocker   63 
   Angiotensin converting enzyme inhibitor /  
      angiotensin receptor blocker 
  52 
   Statin    56 
  
Pretest likelihood a  
   Low   12 
   Intermediate   88 
  
Blood pressure (mmHg), mean±SD  
   Systolic 147±21 
   Diastolic   84±13 
   Heart rate (bpm), mean±SD   72±12 
   Body mass index (kg/m2), mean±SD   28±5 
   Left bundle branch block (%)     4 
   Creatinine level (μmol/l), mean±SD   86±48 
a According to the criteria of Diamond and Forrester [15]. 
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SPECT RESULTS 
SPECT revealed normal perfusion in 151 patients (54%). Stress-only imaging was 
performed in 73 patients (26%) with unequivocally normal stress SPECT findings. 
Additional rest SPECT imaging was performed in 209 patients (74%). The mean left 
ventricle ejection fraction was 62±12%. Equivocal findings were found in 27 patients 
(10%), while abnormal perfusion was found in 104 patients (37%), of whom  26 (9%) 
showed fixed defects and 78 (28%) had findings suggestive of ischaemia. Patients with 
abnormal findings were more likely to be men, to be a current smoker and to have an 
even higher CAC score (Table 2). Patients who underwent scanning with the CZT 
camera had fewer equivocal SPECT findings (6% vs 18%, p=0.002) and more often 
underwent stress-only imaging (30% vs 16%, p=0.0018). 
 
 
 
Table 2. Comparison between normal and abnormal SPECT findings in patients with CAC  
scores >1000 
Total cohort 
(n=282) 
Normal 
SPECT 
(n=151) 
Abnormal 
SPECT 
(n=131) 
p value 
Age (years), mean±SD     69.5±9     68.9±9 0.585 
Male gender (%)     55     72 0.004* 
Current smoker (%)     12     21 0.047* 
Diabetes (%)     27     28 0.838 
Hypercholesterolaemia (%)     56     50 0.378 
Hypertension (%)     70     73 0.488 
Family history (%)     48     50 0.746 
Number risk factors, mean±SD        2.1±1.1       2.2±1.2 0.433 
    
Current medication (%)    
   Aspirin     52     60 0.184 
   Beta-blocker     60     66 0.351 
   Angiotensin converting enzyme  
      inhibitor / angiotensin receptor blocker 
    53     51 0.758 
   Statin     58     53 0.481 
    
Blood pressure (mmHg), mean±SD    
   Systolic   149±21   144±21 0.098 
   Diastolic     85±13     83±12 0.277 
   Heart rate (bpm), mean±SD     72±12     71±12 0.542 
   Body mass index (kg/m2), mean±SD     29±6     28±5 0.548 
   Left bundle branch block (%)     3       4 0.819 
   Creatinine level (μmol/l), mean±SD     90±63     81±17 0.151 
   CAC score, mean±SD  1761±737 1969±977 0.043* 
*p<0.05. 
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REFERRAL FOR CARDIAC CATHETERIZATION, REVASCULARIZATION RATES, AND 
CARDIAC EVENTS 
Follow-up examinations were performed in 281 patients (99%). The minimal follow-up 
time was 1 year, with a mean of 24±11 months (median 23 months, interquartile range 
16–31 months). Overall, 132 patients (47%) underwent ICA during follow-up, of 
whom 93 (33%) were referred for early (<60 days) ICA and 39 (14%) for late (>60 
days) ICA. ICA was chosen more commonly in patients with ischaemic SPECT 
findings (86%) than in those with non-ischaemic SPECT findings (32%, p<0.001). 
 Of the 204 patients with non-ischaemic SPECT findings, 65 (32%) underwent 
ICA because of persisting complaints, of whom 39 (19%) were early and 26 (13%) late 
referrals. Of these 65 patients, 22 had non-significant CAD and 43 had obstructive 
CAD (defined as >70% luminal narrowing in a major coronary vessel, >50% stenosis 
in the left main coronary artery or fractional flow reserve value <0.80). Subsequent 
revascularization was performed in 35 patients. Single-vessel disease was found in 16 
patients, two-vessel disease in 9 and three-vessel disease in 18. Left main stem stenosis 
was found in 2 patients. Among the 78 patients with ischaemic SPECT findings, 67 
(86%) were referred for ICA, of whom 54 (69%) underwent early and 13 (17%) late 
ICA. Of these patients who underwent ICA, obstructive CAD was confirmed in 60, of 
whom 57 underwent revascularization. Single-vessel disease was found in 15 patients, 
two-vessel disease in 13 and three-vessel disease in 31. Isolated left main stem stenosis 
was found in one other patient, while four patients had concurrent left main 
involvement. Ischaemia on MPI was a very strong predictor of coronary 
revascularization (odds ratio 13.1, 95%CI 7.1–24.3; p<0.001) during follow-up.  
 In patients with confirmed obstructive CAD the revascularization rate was higher 
in the group with ischaemia (95% vs 81%, p=0.048). After excluding early 
revascularizations, there were 13 late revascularizations in the cohort with non-
ischaemic SPECT findings compared to 10 late revascularization in those with 
ischaemic SPECT findings (p=0.077). One patient without ischaemia on MPI died of 
acute myocardial infarction, while one patient with ischaemia on MPI suffered an acute 
myocardial infarction requiring primary percutaneous intervention. Six patients died 
from a non-cardiac cause. Analysis of event-free survival is shown in Fig. 1.  
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Discussion  
 
In this single-centre, observational study in symptomatic stable patients with suspected 
CAD and a very high CAC score, myocardial perfusion was normal in more than 50% 
of the patients. Of the 32% of patients with non-ischaemic MPI who were referred for 
ICA, 54% underwent subsequent revascularization. The proportion of downstream 
invasive testing and revascularization following a non-ischaemic MPI study in this 
highly selected cohort was higher than in a similar population with lower CAC scores 
[16], again confirming the value of CAC scoring combined with MPI. Now the 
question is what should be the strategy in patients with normal myocardial perfusion 
but very high CAC score. 
 The relation between MPI and CAC has been studied, but most of the previous 
studies focused mainly on asymptomatic cohorts and included only few patients with 
CAC scores >1000. In four studies that included predominantly asymptomatic subjects, 
 
Fig. 1.  Kaplan-Meier analysis of event-free survival (without coronary revascularization, 
myocardial infarction and death). 
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the probability of myocardial ischaemia increased with higher CAC scores, but as in 
our study, the majority of those with a high CAC scores had normal perfusion [8,22-
24]. A lower frequency (29%) of normal MPI results among 28 asymptomatic diabetic 
subjects with CAC scores >1000 was observed, probably indicating the higher-risk 
profile in that cohort [25]. In three large studies that included symptomatic patients, the 
MPI findings were normal in the majority of the patients with CAC scores >1000 (Fig. 
2) [9,11,12]. Summarizing all studies, the majority of patients without prior CAD but a 
high CAC score have normal MPI, with a higher prevalence of abnormal MPI in 
symptomatic patients and high-risk groups.  
 Several studies have assessed the prognostic value of CAC scoring over MPI 
alone. Patients with both a high CAC score and high-risk MPI findings show higher 
mortality rates than patients with only a high CAC score [24]. Similar higher long-term 
event rates have been found among asymptomatic individuals with normal SPECT and 
more extensive atherosclerosis. With regard to the short-term, higher risk cohorts with 
a CAC score >1000 suffer more adverse events [9,25]. Conversely, as in our study, 
patients with a low/intermediate risk have a low annual severe short-term event rate 
even in the presence of elevated CAC scores [12,23,24]. Time-point analysis indeed 
showed an initially low annual event rate in subjects with normal SPECT and a severe 
CAC score with separation of the survival curves for total cardiac events at 3 years and 
for death/myocardial infarction at 5 years after initial testing [23]. Therefore, it may be 
hypothesized that MPI could provide better short-term risk assessment, while CAC 
scoring may provide a better estimate longer-term prognosis because of its ability to 
detect varying degrees of coronary atherosclerosis before the development of stress-
induced myocardial ischaemia [23]. Summarizing the published studies, in patients 
with a low/intermediate risk with a very high CAC score a normal MPI confers a 
benign short-term prognosis, while the long-term risk of a severe cardiac event is 
increased.   
 Potentially, CAC scoring could improve postimaging clinical management and 
patient behaviour. Two prior studies have investigated whether the knowledge of 
present coronary atherosclerotic burden affects medical treatment strategy in patients 
without evidence of abnormal myocardial perfusion. In consecutive patients with non-
ischaemic MPI findings who underwent CAC scoring in the same setting or shortly 
after MPI, subsequent initiation or optimization of medical therapy for CAD was more 
likely to occur in those found to have CAC as compared to those without CAC [26,27]. 
However, whether the aggressive management of risk factors induced by CAC scores 
averts future adverse cardiovascular events, especially in patients with extensive CAC, 
is currently unclear.  
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The question arising from our results is why patients with extensive CAC and normal 
MPI findings are frequently referred for downstream invasive testing with subsequent 
coronary revascularization despite the lack of ischaemia. The detection of very high 
CAC scores is associated with a high likelihood of ischaemia and obstructive CAD [8-
10]. Therefore, these patients may have a higher pretest likelihood than we defined 
prior to testing. As for most diagnostic tests, a normal MPI study in such patients with 
a high pretest probability should be interpreted with caution. This may be particularly 
relevant in patients with suspected three-vessel CAD or left main stenosis. Visual 
analysis of MPI images provides information on relative rather than absolute perfusion 
for each myocardial region. Therefore, global but uniform reduction in coronary 
vasodilator reserve may result in a homogeneous distribution of radiotracer, potentially 
leading to false-negative MPI results [28,29]. In addition, the collateral circulation 
could maintain adequate myocardial perfusion, leading to underestimation of the 
angiographic severity of coronary lesions. Several other factors may contribute to 
 
Fig. 2. Prevalence of normal myocardial perfusion in symptomatic patients with coronary artery 
calcium scores >1000 in our study and three previous studies (Schenker et al. [9], Berman et al. 
[11], Rozanski et al. [12]). 
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false-negative MPI findings including insufficient coronary vasodilatation due to 
unrecognized ingestion of caffeine-containing products, attenuation and motion 
artifacts and plateauing of myocardial tracer uptake at high flow rates [29-36]. 
 Although the incorporation of several non-perfusion imaging findings seems to 
significantly improve the detection of balanced ischaemia [37], a recent study still 
found obstructive CAD in 76% of patients with extensive CAC and a normal MPI [14]. 
Interestingly, in less than one-third of these patients three-vessel disease was found as a 
possible explanation for the lack of perfusion defects. Similarly, in our study in only 
42% of patients with obstructive CAD despite the non-ischaemic MPI findings could 
the CAD be attributed to three-vessel coronary disease. 
 In summary, the high probability of obstructive CAD in symptomatic patients with 
extreme CAC scores, the possibility of false-negative MPI findings, and the 
recommendation for coronary revascularization for any stenosis >50% in patients with 
limiting angina unresponsive to optimal medical treatment could be explanations for 
the high referral rate for ICA despite the absence of objective ischaemia [38]. Based on 
our findings, we do not believe that all symptomatic patients with a very high CAC 
score and non-ischaemic MPI result should routinely undergo invasive testing. 
However, in  patients with persistent symptoms in whom clinical suspicion would 
places them at a higher risk of significant CAD ICA should be considered. 
 Our study had several limitations. First, this was a retrospective study. Second, we 
used SPECT rather than PET imaging that may have a higher diagnostic accuracy, 
especially in relation to the well-known difficulty in finding balanced ischaemia. 
However, SPECT is more widely available and there is longer experience with its use. 
Further, the use of pharmacological stress and a 20-segment model for the left ventricle 
instead of the recommended 17-segment model could be a limitation. Furthermore, 
since this was a single centre study in a selected MPI referral cohort with no prior CAD 
at low or intermediate pre-test likelihood, our findings must be read with caution 
before extrapolating to other populations. Patient referrals, clinical postimaging 
medical management and downstream utilization of invasive testing were left to the 
discretion of the treating physicians, which could have been a source of bias. However, 
the findings do reflect general cardiac patient care. Another limitation includes the 
definition of obstructive CAD and the determination of the need for revascularization. 
They were mainly based on visual assessment of the severity of coronary stenoses on 
ICA, as pressure-derived fractional flow reserve measurement was only used in a few 
patients. Finally, we also recognize that the relatively short follow-up period may have 
resulted in under-reporting of adverse cardiac events.  
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Conclusion 
 
Approximately 50% of the symptomatic patients with a high CAC score have normal 
MPI. In most of those with ischaemia on MPI, ICA confirms coronary obstructions. In 
patients without ischaemia on MPI but persisting complaints, the prevalence of 
obstructive CAD as demonstrated by ICA is also high. In all symptomatic patients with 
a high CAC score, the incidence of cardiac events is low, whereas the occurrence of 
coronary revascularization is high. However, more prospective studies are needed to 
assess the long-term prognostic value of severe CAC in symptomatic patients referred 
for MPI. 
 
 
 
 
 
Myocardial perfusion imaging in patients with extreme calcium scores 
___________________________________________________________________ 
126 
 
References 
 
1. Shaw JL, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl 
 Cardiol 2004;11:171-85. 
2. Marcassa C, Bax JJ, Bengel F, et al. Clinical value, cost-effectiveness, and safety of myocardial 
 perfusion scintigraphy: a position statement. Eur Heart J 2008;29:557-63. 
3. Chamuleau SA, Meuwissen M, Koch KT, et al. Usefulness of fractional flow reserve for risk 
 stratification of patients with multivessel coronary artery disease and an intermediate stenosis. 
 Am J Cardiol 2002;89:377-80. 
4. Lopes NH, da Silva Paulitsch F, Gois AF, et al. Impact of number of vessels disease on outcome 
 of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, 
 and bypass Surgery Study (MASS). Eur J Cardiothorac Surg 2008 33:349-54.  
5. Jones EL, King SB 3rd, Craver JM, et al. The spectrum of left main coronary artery disease: 
 variables affecting patient selection, management, and death. J Thorac Cardiovasc Surg 
 1980;79:109-16. 
6. Simons DB, Schwarz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Noninvasive 
 definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a 
 quantitative pathologic comparison study. J Am Coll Cardiol 1992;20:1118-26. 
7. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: 
 observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70. 
8. He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam 
 computed tomography predicts silent myocardial ischemia. Circulation 2000;101:244-51.   
9. Schenker MP, Dorbala S, Hong EC, et al. Interrelation of coronary calcification, myocardial 
 ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a 
 combined positron emission tomography/computed tomography study. Circulation 2008; 
 117:1693-1700. 
10. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four 
 racial or ethnic groups. N Eng J Med 2008;358:1336-45. 
11. Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial 
 ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll Cardiol 
 2004;44:923-30. 
12. Rozanski A, Gransar H, Wong ND, et al Clinical outcomes after both coronary calcium 
 scanning and exercise myocardial perfusion scintigraphy. J Am Coll Cardiol 2007;49:1352-
 61.  
13. Schepis T, Gaemperli O, Koepfli P, et al. Added value of coronary artery calcium scores as an 
 adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk 
 population. J Nucl Med 2007;48:1424-30. 
14. Ghadri JR, Pazhenkottil AP, Nkoulou RN, et al. Very high coronary calcium score unmasks 
 obstructive coronary artery disease in patients with normal SPECT MPI. Heart 2011;97:998-
 1003. 
15. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of 
 coronary-artery disease. N Eng J Med 1979;300:1350-58.  
 
Chapter 8 
___________________________________________________________________ 
127 
 
16. Mouden M, Timmer JR, Ottervanger JP, et al. Impact of a new ultrafast CZT SPECT camera for 
 myocardial perfusion imaging: fewer equivocal results and lower radiation dose. Eur J Nucl 
 Med Mol Imaging 2012;39:1048-55.  
17. Berman DS, Kiat H, van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99m sestamibi 
 in the assessment of chronic coronary artery disease. Semin Nucl Med 1991;21:190-212. 
 Review.  
18. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress 
 technetium-99m sestamibi dual isotope myocardial perfusion single-photon emission computed 
 tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.  
19. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients 
 with known or suspected ischemic heart disease: a basis for optimal utilization of exercise 
 technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. 
 J Am Coll Cardiol 1995;26: 639-47.  
20. Fleischmann S, Koepfli P, Namdar M, Wyss CA, Jenni R, Kaufmann PA. Gated (99m) Tc-
 tetrofosmin SPECT for discriminating infarct from artefact in fixed myocardial perfusion 
 defects. J Nucl Med 2004;45:754-9. 
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification 
 of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 
 1990;15;15:827-32. 
22. Moser KW, O’Keefe JH Jr, Bateman TM, McGhie IA. Coronary calcium screening in 
 asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion 
 imaging. J Nucl Cardiol 2003;10:590-8. 
23. Chang SM, Nabi F, Xu J, et al The coronary artery calcium score and stress myocardial 
 perfusion imaging provide independent and complementary prediction of cardiac risk. J Am 
 Coll Cardiol 2009;54:1872-82. 
24. Ramakrishna G, Miller TD, Breen JF, Araoz PA, Hodge DO, Gibbons RJ. Relationship and 
 prognostic value of coronary artery calcification by electron beam computed tomography to 
 stress-induced ischemia by single-photon emission computed tomography. Am Heart J 
 2007;153:807-14.  
25. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: 
 prospective evaluation of the combined use of coronary artery calcium imaging and selective 
 myocardial perfusion scintigraphy. Eur Heart J 2006;27:713-21. 
26. Thompson RC, McGhie AI, Moser KW, et al. Clinical utility of coronary calcium  scoring after 
 nonischemic myocardial perfusion imaging. J Nucl Cardiol 2005;12:392-400. 
27. Bybee KA, Lee J, Markiewicz R, et al. Diagnostic and clinical benefit of combined coronary 
 calcium and perfusion assessment in patients undergoing PET/CT myocardial stress 
 perfusion imaging. J Nucl Cardiol 2010;17:188-96. 
28. Lima RS, Goode AR, Siadaty MS, et al. Incremental value of combined perfusion and  function 
 over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe 
 three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70. 
29. Aernoudse WH, Botman KJ, Pijls NH. False-negative myocardial scintigraphy in balanced  
 three-vessel disease, revealed by coronary pressure measurement. Int J CardiovascIntervent 
 2003;5:67-71. 
 
Myocardial perfusion imaging in patients with extreme calcium scores 
___________________________________________________________________ 
128 
 
30. Travin M. Is it possible for myocardial perfusion imaging to avoid missing any patients with 
 high-risk coronary disease? J Nucl Cardiol 2007;14:492-6. 
31. Heller GV, Ahmed I, Tilkemeier PL, et al. Influence of exercise intensity on the presence, 
 distribution, and size of thallium-201 defects. Am Heart J 1992;123:909-16. 
32. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 
 tomographic imaging in detecting coronary artery disease: analysis of  461 patients. J Am Coll 
 Cardiol 1989;14:1477-86. 
33. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of 
 coronary artery disease by dipyridamole stress thallium-201 single-photon emission 
 computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am 
 Coll Cardiol 1998;31:1540-6. 
34. Smits P, Corstens FH, Aengevaeren WR, Wackers FJ, Thien T. False-negative dipyridamole 
 thallium-201 myocardial imaging after caffeine infusion. J Nucl Med 1991;32:1538-41. 
35. Travin MI, Katz MS, Moulton AW, Miele NJ, Sharaf BL, Johnson LL. The accuracy of 
 dypiridamole SPECT to identify individual coronary stenoses and multivessel disease in women 
 versus men. J Nucl Cardiol 2000;7:213-20. 
36. Duvernoy CS, Ficaro EP, Karabajakian MZ, Rose PA, Corbett JR. Improved detection of left 
 main coronary artery disease with attenuation-corrected SPECT. J Nucl Cardiol 2000;7:639-48. 
37. Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated  SPECT 
 myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 
 2007;14:521-8. 
38. Wijns W, Kolh P, Danchin N, et al. Guidelines of myocardial revascularization. Task Force on 
 Myocardial Revascularization of the European Society of Cardiology (ESC) and the European 
 Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous 
 Cardiovascular Interventions (EAPCI). Eur Heart J 2010;31:2501-55. 
 
 
 
 
 
 
  
 
CHAPTER 9 
 
 
 
Summary, Conclusion 
and  
Future perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
Chapter 9 
___________________________________________________________________ 
131 
 
The correct identification of patients who may benefit from invasive coronary 
revascularization requires both anatomical and functional information [1]. The non-
negligible procedural risk, high costs and low diagnostic yield associated with 
conventional ICA demonstrates the need for improvement in non-invasive testing for 
appropriate patient-selection [2,3]. Currently, each cardiac imaging modality has its 
own advantages and limitations and none can be considered suitable for all patients. 
 The non-invasive clinical assessment of CAD and subsequent patient management 
can be improved with complementary information obtained from SPECT, CACS and 
CCTA. Although initial studies have shown incremental diagnostic and prognostic 
value, real-world clinical data for multimodality and hybrid imaging in stable low-
intermediate risk patients are still lacking. Furthermore, the clinical implications of a 
one-day stepwise approach for cardiac hybrid imaging are unknown, and clinical 
experience with recently introduced high-speed SPECT gamma cameras with CZT 
detector technology is limited. 
 Therefore, the aims of this thesis were to study the clinical value and potential role 
of combining SPECT, CACS and CCTA in daily practice using a stepwise algorithm 
for patients with suspected stable CAD, and to assess the clinical implications of a 
recently introduced CZT-based SPECT gamma camera. 
 
In CHAPTER 1, the general introduction provides a brief introduction on the subject and 
the background of the thesis. 
    
The latest gamma cameras equipped with CZT detector technology provide superior 
image quality and allow shorter acquisition times because of improved count 
sensitivity and image contrast. However, CZT cameras are dedicated to perfusion 
imaging of the heart and are more expensive, while the incremental clinical value 
remains unknown. Therefore, in CHAPTER 2, we compared the clinical implications of 
SPECT imaging using the new CZT-based SPECT camera with a conventional SPECT 
camera. A total of 456 consecutive stable patients underwent stress-first SPECT 
imaging. The first half was studied using conventional SPECT (n=225), the second half 
using CZT SPECT (n=231). We found out that additional rest SPECT imaging was 
performed in only 35% of the patients scanned with CZT SPECT, whereas in those 
scanned with conventional SPECT, rest imaging was concluded to be necessary in 56% 
(p<0.001). From these data it was calculated that the mean amount administered 
radioactive dose per patient was 22% lower in those scanned with the new camera: 
658±390 MBq in the CZT group and 840±421 MBq in the conventional group 
(p<0.001). The mean total imaging time per patient was also significantly shorter with 
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the new camera: 6.39±1.41 minutes in the CZT group and 20.40±7.46 minutes in the 
conventional group (p<0.001). After 1 year, clinical outcome was comparable between 
both highly comparable groups.  
 These findings show that stress SPECT images acquired with a CZT camera are 
more frequently interpreted as normal with identical clinical outcome. As a result, CZT 
SPECT imaging lowers the need for additional testing, results in lower mean radiation 
dose and shortens imaging time. 
 
As stated above it is crucial to obtain functional information in patients with anatomic 
stenosis. Although SPECT imaging is one of the modalities to assess the 
haemodynamic consequences of coronary stenoses, there is also a recent trend to use 
invasive pressure-derived FFR measurement for depicting ischaemia. FFR is a guide 
wire-based procedure that can accurately measure blood pressure and flow through a 
specific part of the coronary artery. Currently, many cardiologists consider FFR to be 
the most accurate test for depicting ischaemia, while also providing additional 
prognostic information. Previous studies have shown a moderate degree of 
concordance between conventional SPECT and FFR, however, the agreement between 
CZT SPECT and FFR is not known. In CHAPTER 3, we prospectively assessed the 
concordance between CZT-based SPECT imaging and invasive FFR measurement in 
100 stable patients with intermediate grade coronary stenoses. Thirty-one percent of 
the patients showed ischaemic SPECT findings, while FFR depicted ischaemia in 20%. 
The concordance between CZT SPECT and FFR was 73% on a per-patient basis and 
79% on a per-vessel basis. 
 This study shows a modest concordance between CZT SPECT and FFR which is 
comparable with previous results with conventional SPECT. In addition, most coronary 
stenoses of intermediate degree severity were found to be functionally irrelevant. 
 Therefore we conclude that the discordance between FFR and SPECT is intrinsic 
and that these tests measure two different phenomena: a pressure gradient over a 
stenosis measured with a catheter versus tissue perfusion measured with a flow tracer. 
Which of the two is ultimately correct remains controversial. 
 
Apart from the new type of SPECT camera studied in this thesis, we also studied 
clinical aspects of CCTA. In contrast to ICA, CCTA also shows several aspects of the 
myocardial wall, such as calcifications, but it may also detect congenital coronary 
anomalies including myocardial bridging. Myocardial bridging is caused by muscles 
overlying the intramyocardial course of an epicardial coronary artery and may cause 
chest pain by systolic compression of the tunnelled segment. However, studies 
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assessing the prevalence of myocardial bridging as detected by CCTA in symptomatic 
patients referred for the diagnostic work-up of stable CAD are scarce. In CHAPTER 4 
we studied therefore the prevalence and predictors of myocardial bridging in 934 
patients who underwent a clinically indicated CCTA. In 152 patients (16%) myocardial 
bridging could be observed. Patients with myocardial bridging were younger and had a 
lower prevalence of coronary sclerosis. The prevalence of myocardial bridging as 
detected by CCTA is higher as compared to the reported frequencies for ICA, and 
myocardial bridging could be an explanation for symptoms and ischaemia in some 
patients without obstructive CAD. 
 
In CHAPTER 5, we described the clinical experience of our individualized sequential 
approach combining SPECT, CACS and CCTA in the setting of the Isala Clinics, as a 
large secondary and tertiary referral hospital for cardiac patients. We performed hybrid 
cardiac SPECT/CT imaging in stable patients with suspected CAD. In total 2411 
consecutive patients without a history of CAD underwent simultaneous stress-first 
SPECT imaging and CACS. Normal stress SPECT results were found in 53% of 
patients in whom additional testing could be omitted. Among the 1144 patients who 
underwent additional rest imaging, 618 patients required additional CCTA. Obstructive 
CAD could be ruled out by CCTA in 71% of patients with abnormal stress-rest 
SPECT, including 49% of patients with ischaemic SPECT results. At follow-up after 
19 months these patients had an excellent prognosis.  
 This stepwise approach provides both anatomical and functional information and 
it appears that the combination of SPECT with CCTA, minimalizes shortcomings of 
either SPECT or CCTA. Therefore, this method can be preferred over SPECT or 
CCTA alone. It also is preferable to an approach with both stress and rest SPECT or to 
approaches with CCTA in all patients.  
 We believe that the Zwolle fast-track algorithm uses the techniques in a wise and 
conservative fashion, while yet producing all required clinical information in a single 
day. We chose the approach starting with SPECT as it fits best in the clinical protocols 
that have been applied here over the past 20 years based on a unique and sound 
cooperation between the departments of cardiology and nuclear medicine. Other 
approaches may also be possible, as long as both physiological and anatomical 
information is obtained. 
 
With our cameras being able to do SPECT with CT, calcium scoring with its relative 
simplicity was also performed routinely and studied in this thesis. This adds completely 
new information to SPECT and several aspects of the combination were studied. 
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Coronary artery calcifications are highly specific for the presence of coronary 
atherosclerosis and represent the total atherosclerotic plaque burden present in the 
epicardial coronary arteries.  
 
One aspect was our hypothesis that CACS may improve SPECT readings. Therefore, 
we investigated in CHAPTER 6 the influence of CACS knowledge on the visual 
interpretation of SPECT imaging in 151 patients referred for the diagnostic work-up of 
suspected CAD. SPECT images were visually interpreted in two separate sessions, first 
without and then with knowledge of the CACS. Overall, the addition of the CACS 
changed the interpretation of SPECT in 56 patients (37%). Importantly, the frequency 
of equivocal SPECT interpretations decreased from 21% without knowledge of CAC 
score to 9% with knowledge of CAC score (p=0.002). These findings show that 
knowledge of CACS has a major impact on the qualitative interpretation of SPECT, 
increasing the interpretative certainty. 
 
Another aspect of CACS was the study of the subgroup without any coronary calcium. 
CHAPTER 7 describes the ability of a zero calcium score to exclude flow-limiting CAD 
in a homogeneous population with stable anginal complaints and a low to intermediate 
pre-test likelihood. We included 868 stable patients without known CAD who 
prospectively underwent simultaneous SPECT imaging and CACS. Additional CCTA 
was performed in those with abnormal SPECT findings when feasible. SPECT was 
completely normal in 88% of patients, while additional CCTA (11%) or invasive 
coronary angiography (1%) ruled out obstructive CAD in those with abnormal SPECT 
findings. At a median follow-up of 17 months (25th–75th percentile: 11–24 months), no 
coronary events were recorded. The findings of this study show that a zero calcium 
score in stable low-intermediate risk patients may help exclude flow-limiting CAD. 
This supports the possibility of CACS as a simple and safe tool to select patients for 
additional testing or discharge.  
 
Besides the apparent strong clinical value of a zero calcium score, we were also 
interested in the opposite, the value of a very high CACS in patients referred for 
SPECT imaging.  
 Therefore, we assessed the impact of SPECT imaging in symptomatic patients 
with extreme coronary calcifications (defined as a CACS  >1000) in CHAPTER 8.  
We retrospectively identified 282 stable patients without a history of CAD who 
underwent simultaneous SPECT imaging and CACS, in whom a CACS >1000 was 
concurrently detected. SPECT was normal in 54%, equivocal in 10% and abnormal in 
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37%. We found more abnormal SPECT findings in males, smokers and those with even 
higher CACS. Ischaemia was demonstrated in approximately 30% of patients with 
CACS >1000, and ischaemia is a strong predictor of coronary revascularization (odds 
ratio 13.1; 95% CI 7.1, 24.3; p<0.001).  
 We concluded that the majority of symptomatic patients with a CACS >1000 had 
normal perfusion findings. However, as we have demonstrated, patients with normal 
SPECT findings but with extreme coronary calcification should be watched closely, as 
we demonstrated that persistent complaints are often still based on relevant CAD and 
many of such patients ultimately required revascularization. Therefore, the degree of 
suspicion for severe CAD during follow-up should remain high even with normal 
SPECT findings, and such patients with persisting complaints should be considered for 
invasive angiography. 
 
 
Future perspectives and directions 
 
The studies described in the present thesis explored the clinical value and potential role 
of non-invasive cardiac imaging including SPECT imaging with latest CZT detector 
technology and hybrid imaging combining SPECT, CACS and CCTA using a stepwise 
algorithm for patients with suspected stable CAD. However, several possibilities exist 
to extend the work described in this thesis.  
 
MYOCARDIAL PERFUSION IMAGING 
This thesis has shown the value of CZT SPECT imaging in clinical practice. However, 
future studies are needed to assess the long-term prognostic value of CZT SPECT and 
the incremental diagnostic value of dynamic myocardial blood flow quantification with 
high-speed CZT SPECT. Currently, the widespread use of PET for myocardial 
perfusion imaging is hampered by several factors including high costs and the 
necessity for an on-site cyclotron or Rubidium generator. However, new tracer 
development will facilitate dissemination of quantitative cardiac PET [4,5]. Prospective 
comparative studies between attenuation corrected CZT SPECT imaging and other 
non-invasive functional tests such as myocardial perfusion imaging with PET or MRI 
need to be conducted to assess diagnostic and prognostic value, and the cost-
effectiveness of these modalities. Furthermore, more studies are warranted in patients 
with discrepant myocardial perfusion results and FFR findings to determine optimal 
treatment strategy and long-term outcome. 
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MYOCARDIAL PERFUSION IMAGING WITH CALCIUM SCORING 
This thesis has also demonstrated the role of simultaneous CACS in symptomatic 
patients referred for SPECT imaging. However, future studies are needed to assess the 
diagnostic and prognostic value of myocardial perfusion imaging with simultaneous 
CACS. Furthermore, the long-term impact of clinical management based on CACS 
knowledge in patients with normal MPI findings need to be studied. 
  
ALGORITHMS FOR MULTIMODALITY AND HYBRID IMAGING 
Although we have showed the feasibility of a stepwise algorithm starting with stress 
SPECT imaging and CACS, different diagnostic algorithms can be used alternatively 
for multimodality or hybrid imaging. Future studies should assess the optimal initial 
test in different patient populations and the various imaging strategies require 
prospective comparison.  
 Possibly, initial CACS has the potential to determine optimal imaging strategy for 
a sequential approach. In such a strategy patients with a CACS <400 will most likely 
benefit from CCTA owing to the high negative predictive value, while patients with 
CACS >400 will benefit from a functional test. In addition, patients with extensive 
coronary calcification (i.e. CACS >700) may be referred for PET perfusion imaging 
when available due to the higher accuracy in detecting relevant CAD due to improved 
temporal and spatial resolution, more accurate attenuation correction, and the potential 
for absolute myocardial blood flow quantification [6,7].  
 Future studies will put more focus on combining CCTA with CT perfusion results 
and non-invasive FFR measurement derived from coronary CT, while CCTA images 
can also be fused into 3D hybrid images without additional radiation with MRI 
perfusion or stress echocardiography images [8,9]. Finally, the impact of multimodality 
and hybrid cardiac imaging on downstream ICA and coronary revascularization rates 
need to be studied. 
 The non-invasive diagnostic work-up of patients with suspected stable CAD has 
considerably improved in recent years, with rapid developments in various cardiac 
imaging modalities. At the same time, important advances have been made in the 
integration of different imaging modalities. Non-invasive testing will play an 
increasing role in which a patient-tailored approach is recommended to accurately 
exclude relevant CAD, and to improve selection of patients who may benefit from 
coronary revascularization to improve survival and to relieve persisting symptoms.
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Zowel anatomische als functionele informatie zijn nodig voor de optimale selectie van 
patiënten die baat kunnen hebben bij een invasieve behandeling van hun 
coronarialijden [1]. De risico’s, hoge kosten en lage diagnostische opbrengst van 
traditionele invasieve coronair angiografie benadrukken het belang van verbeteringen 
in de huidige niet-invasieve diagnostiek [2,3]. Iedere diagnostische modaliteit heeft 
zijn voor- en nadelen en vooralsnog is geen enkele techniek perfect geschikt voor alle 
patiënten. De niet-invasieve klinische beoordeling van coronarialijden en het hieruit 
volgende klinische beleid kunnen worden verbeterd middels de complementaire 
informatie verkregen door SPECT, CACS en CCTA. Initiële studies hebben de 
aanvullende diagnostische en prognostische waarde aangetoond voor multi-
modaliteitsdiagnostiek danwel hybride beeldvorming. Echter, de waarde in de klinische 
dagelijkse praktijk voor stabiele patiënten met een laag tot intermediair risico blijft 
onbekend. Voorts zijn de klinische consequenties van een eendaags stapsgewijs 
protocol voor cardiale hybride diagnostiek onbekend. Daarnaast is er nog weinig 
bekend over de klinische waarde van de recent geïntroduceerde SPECT camera’s met 
CZT detectoren. 
 De doelen van dit proefschrift waren derhalve om de klinische waarde en de 
potentiële rol van recent geïntroduceerde CZT SPECT camera’s en multimodaliteit-
diagnostiek te beoordelen. Hierbij hebben we gebruik gemaakt van een stapsgewijs 
algoritme voor SPECT, CACS en CCTA in de dagelijkse praktijk.  
 
In HOOFDSTUK 1 wordt een introductie van het onderwerp en de achtergrond van dit 
proefschrift gegeven.  
    
De laatste generatie gamma camera’s, die gebruik maken van CZT detectoren, leveren 
superieure beeldkwaliteit en maken een kortere scantijd mogelijk door de verbeterde 
sensitiviteit en beeldcontrast. Daarentegen zijn de CZT camera’s duurder en enkel 
geschikt voor perfusiescintigrafie van het hart, waarbij de toegevoegde klinische 
waarde van deze camera’s grotendeels nog moet blijken.  
 In HOOFDSTUK 2 hebben we de klinische consequenties van SPECT myocard-
perfusiescintigrafie van de nieuwe CZT SPECT camera vergeleken met die van een 
conventionele SPECT camera. In totaal hebben 456 patiënten een stress SPECT 
ondergaan. De eerste helft van de patiënten werden gescand met een conventionele 
SPECT camera (n=225), terwijl de andere helft een SPECT scan op de CZT camera 
kregen (n=231). Indien nodig geacht werd een aanvullende rust SPECT scan verricht, 
hetgeen nodig bleek in slechts 35% van de patiënten gescand met de CZT SPECT 
camera in tegenstelling tot 56% van de patiënten gescand met de traditionele SPECT 
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camera (p<0.001). De gemiddelde hoeveelheid toegediende radiotracer per patiënt was 
22% lager in de groep van patiënten gescand met de nieuwe CZT camera: 658±390 
MBq in de CZT groep en 840±421 MBq in de conventionele groep (p<0.001). Ook 
bleek de gemiddelde totale scantijd per patiënt significant lager met de nieuwe camera: 
6.39±1.41 minuten in de CZT groep en 20.40±7.46 minuten in de conventionele groep 
(p<0.001). De 1 jaars prognose in beide groepen was identiek.  
 Deze bevindingen tonen dat stress SPECT beelden gemaakt met een CZT camera 
vaker als normaal worden geïnterpreteerd. Hierdoor is een aanvullende rust scan 
minder vaak nodig voor patiënten gescand met een CZT camera, hetgeen resulteert in 
lagere stralingsdoses en kortere scantijden.  
 
Zoals reeds eerder werd vermeld is het essentieel om functionele informatie te 
verkrijgen in patiënten met kransslagadervernauwingen gedetecteerd middels een 
anatomische test. SPECT myocardperfusiescintigrafie is één van de modaliteiten om 
het hemodynamische belang van coronarialijden te beoordelen. Tegenwoordig wordt 
de invasieve FFR meting in toenemende mate toegepast om ischemie aan te tonen. FFR 
is een invasieve procedure om de bloeddruk en de doorstroming door een specifiek 
gedeelte van een kransslagader te meten. Momenteel wordt de FFR meting door vele 
cardiologen als de meest accurate test gezien voor de detectie van ischemie, waarbij 
tevens prognostische informatie wordt verkregen. Uit eerdere studies blijkt de mate van 
overeenkomst tussen traditionele SPECT en FFR matig te zijn, echter, de uitkomsten 
van de nieuwe CZT SPECT camera en FFR zijn nog niet eerder vergeleken. In 
HOOFDSTUK 3 hebben we de concordantie tussen de CZT SPECT uitslagen en 
invasieve FFR bepalingen bepaald in 100 stabiele patiënten met een intermediaire 
coronairstenose. Ischemische SPECT bevindingen bleken aanwezig in 31% van de 
patiënten, terwijl FFR ischemie detecteerde in 20% van de patiënten. De concordantie 
tussen CZT SPECT en FFR bedroeg 73% op patiënt niveau, terwijl de concordantie 
79% bedroeg bij analyse van alle coronairvaten waarbij een FFR werd verricht. 
 Deze studie toont een matige concordantie tussen CZT SPECT en FFR, hetgeen 
overeenkomt met eerdere bevindingen voor conventionele SPECT. Voorts bleken de 
meeste intermediaire coronairvernauwingen niet functioneel van belang te zijn.  
 Hieruit concluderen wij dat de discordantie tussen FFR en SPECT intrinsiek is en 
dat beide onderzoeken verschillende fenomenen onderzoeken: een drukgradiënt over 
een stenose gemeten met een katheter versus weefselperfusie gemeten met een flow 
tracer. Het blijft nog onduidelijk welke test uiteindelijk correct zal blijken.  
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Naast de nieuwe type SPECT camera, hebben we tevens de klinische aspecten van 
CCTA bestudeerd. In tegenstelling tot invasieve luminografie is CCTA tevens in staat 
om verschillende aspecten van de vaatwand te tonen zoals calcificaties, echter CCTA is 
ook in staat om congenitale anomalieën zoals myocardiale bridging te detecteren. Bij 
bridging verloopt een deel van de coronairarterie intramyocardiaal, waarbij pijn op de 
borst kan optreden door systolische compressie door het myocard. Voorts is er weinig 
studie gedaan naar de prevalentie van myocardiale bridging in symptomatische 
patiënten verwezen voor CCTA wegens een verdenking op stabiel coronairlijden. 
Derhalve hebben wij in HOOFDSTUK 4 onderzoek gedaan naar de prevalentie en 
voorspellers van myocardiale bridging in 934 patiënten die een klinisch geïndiceerde 
CCTA hebben ondergaan. Myocardiale bridging kon worden gedetecteerd in 152 
patiënten (16%). Deze patiënten met bridging waren jonger en hadden een lagere 
prevalentie van coronairsclerose. De prevalentie van myocardiale bridging 
gedetecteerd door CCTA is hoger in vergelijking met de gepubliceerde frequenties 
voor invasieve coronairangiografie, en de aanwezigheid van myocardiale bridging zou 
een verklaring kunnen zijn voor de symptomen in sommige van de patiënten zonder 
obstructief coronairlijden.  
 
In HOOFDSTUK 5 beschrijven wij de klinische ervaringen met ons geïndividualiseerde, 
stapsgewijze algoritme waarbij wij gebruik maken van SPECT, CACS en eventueel 
CCTA. Hybride cardiale SPECT/CT diagnostiek werd toegepast in patiënten met een 
verdenking op stabiel coronairlijden. In totaal ondergingen 2411 patiënten zonder 
coronaire voorgeschiedenis stress SPECT perfusiescintigrafie met gelijktijdig CACS. 
Een normale stress SPECT uitslag werd gevonden in 53% van alle patiënten, waarvoor 
aanvullende onderzoeken achterwege kon worden gelaten. Van de 1144 patiënten die 
een aanvullend onderzoek ondergingen werd een CCTA verricht in 618 patiënten. 
Door een aanvullende CCTA kon obstructief coronairlijden worden uitgesloten in 73% 
van de patiënten met een abnormale stress-rest SPECT, waaronder 50% van de 
patiënten met evidente ischemische SPECT bevindingen. Na een follow-up van 29 
maanden hadden deze patiënten een uitstekende prognose.  
 Dit stapsgewijze algoritme levert zowel anatomische als functionele informatie en 
het blijkt dat de combinatie van SPECT met CCTA de tekortkomingen van elk 
onderzoek afzonderlijk minimaliseert. Derhalve is deze methode te prefereren boven 
SPECT danwel CCTA als afzonderlijke test. Dit algoritme lijkt tevens te verkiezen 
boven een standaard stress-rest SPECT protocol, danwel een standaard compleet 
SPECT/CCTA protocol. 
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 Wij zijn van mening dat het ‘Zwolle fast track’ algoritme de modaliteiten op een 
verstandige en conservatieve wijze toepast, waarbij desalniettemin alle benodigde 
klinische informatie binnen 1 dag kan worden verkregen. We hebben gekozen voor een 
stapsgewijze benadering met initiële stress SPECT scintigrafie, wegens de 
toepasbaarheid hiervan in onze bestaande klinische protocollen, welke reeds ruim 20 
jaar gebaseerd zijn op een unieke en solide samenwerking tussen de afdelingen van de 
cardiologie en nucleaire geneeskunde. Andere algoritmes zijn uiteraard mogelijk, 
zolang zowel anatomische als fysiologische informatie kan worden verkregen.  
 
Met de 64-slice hybride SPECT/CT camera is het mogelijk om zowel SPECT als CT 
onderzoeken te verrichten. De relatief gemakkelijk te verkrijgen informatie van de 
CACS hebben we routinematig bepaald naast de SPECT perfusiescintigrafie in onze 
patiënten hetgeen we hebben bestudeerd in deze thesis. Dit levert nieuwe aanvullende 
informatie op bovenop de SPECT en hierbij werden diverse aspecten van 
gecombineerd SPECT en CACS diagnostiek bestudeerd. Coronaire calcificaties zijn 
zeer specifiek voor de aanwezigheid van atherosclerose in de coronairvaten.  
 
Een van dergelijke aspecten was onze hypothese dat CACS de SPECT beoordeling zou 
kunnen verbeteren. Derhalve hebben we in HOOFDSTUK 6 de invloed van CACS kennis 
op de visuele SPECT beoordeling onderzocht in 151 patiënten met een klinische 
verdenking op stabiel coronairlijden. De SPECT beelden werden beoordeeld in 2 
aparte sessies, eerst zonder kennis en nadien met kennis van de CACS. De kennis van 
de CACS bleek de SPECT beoordeling te beïnvloeden in 56 patiënten (37%). 
Noemenswaardig is het feit dat het aantal dubieuze SPECT uitslagen hierdoor afnam 
van 21% naar 9% (p=0.002). Hieruit blijkt dat kennis van de CACS een belangrijke 
impact heeft op de visuele SPECT beoordeling, waardoor de diagnostische zekerheid 
van de beoordelaars toeneemt.  
 
Daarnaast hebben we gekeken naar de subgroep van patiënten zonder enige 
detecteerbare coronair calcificaties.  
 HOOFDSTUK 7 beschrijft het vermogen van een calcium score van 0 voor het 
uitsluiten van functioneel relevant coronairlijden in een homogene populatie met 
stabiele angineuze klachten en een laag tot intermediaire vooraf kans. In deze studie 
werden 868 patiënten zonder coronaire voorgeschiedenis geïncludeerd, die zowel 
SPECT perfusiescintigrafie als CACS ondergingen. In patiënten met abnormale 
SPECT resultaten werd een aanvullende CCTA verricht indien mogelijk. De SPECT 
scan bleek volstrekt normaal in 88% van de patiënten, terwijl middels een aanvullende 
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CCTA (11%) of invasieve coronair angiografie (1%) de aanwezigheid van obstructief 
coronairlijden kon worden uitgesloten in de patiënten met een abnormale SPECT scan. 
Na een mediane follow-up van 17 maanden (IQR: 11–24 maanden) bleken er geen 
coronaire events te zijn opgetreden. De bevindingen van deze studie tonen dat een 
calcium score van 0 kan helpen om obstructief coronairlijden uit te sluiten in stabiele 
laag-intermediair risico patiënten. Dit ondersteunt de mogelijkheid van CACS als een 
simpele en veilige test om patiënten te selecteren voor eventueel aanvullend onderzoek 
danwel ontslag.  
 
Naast de relevante klinische waarde van een calcium score van 0, waren wij tevens 
geïnteresseerd in juist het tegenovergestelde, de waarde van een sterk verhoogde 
CACS in patiënten verwezen voor SPECT scintigrafie.  
 Derhalve onderzochten wij de impact van SPECT perfusiescintigrafie bij 
symptomatische patiënten met extreme coronaire calcificaties (gedefinieerd als een 
CACS >1000) in HOOFDSTUK 8.  
 Wij hebben 282 stabiele patiënten zonder coronaire voorgeschiedenis retrospectief 
geïdentificeerd die gelijktijdig een SPECT en CACS hebben ondergaan bij wie een 
CACS >1000 was gedetecteerd. De SPECT bleek normaal in 54% van de mensen, 
dubieus in 10% en abnormaal in 37% van de patiënten. Een abnormale SPECT uitslag 
werd met name gezien in mannen, rokers en de patiënten met een nog hogere CACS. In 
ongeveer 30% van deze patiënten met een CACS >1000 toonde de SPECT 
aanwijzingen voor ischemie, waarbij de aanwezigheid van ischemie een sterke 
voorspeller voor revascularisatie blijkt (odds ratio 13.1; 95%CI 7.1, 24.3; p<0.001).  
 Hieruit concludeerden wij dat de meerderheid van de symptomatische patiënten 
met een CACS >1000 een normale SPECT perfusiescintigrafie heeft. Echter, patiënten 
met normale SPECT bevindingen met extreme coronaire calcificaties dienen intensief 
te worden vervolgd, daar de persisterende klachten vaak toch gebaseerd zijn op 
relevant coronairlijden waarvoor uiteindelijk revascularisatie is vereist. Concluderend, 
de verdenking op ernstig coronairlijden bij deze patiënten dient hoog te blijven 
gedurende de follow-up ondanks de normale SPECT uitslagen. Bij dergelijke patiënten 
met persisterende klachten dient een invasieve coronair angiografie te worden 
overwogen.  
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Toekomstperspectieven 
 
De studies beschreven in dit proefschrift tonen de klinische waarde van CZT SPECT 
en hybride SPECT/CT diagnostiek in patiënten met een verdenking op stabiel 
coronarialijden. Het beschreven werk in dit proefschrift vormt een basis voor diverse 
nieuwe toekomstige onderzoeken.  
 
MYOCARDPERFUSIESCINTIGRAFIE  
Onze studies tonen de waarde van CZT SPECT diagnostiek voor de dagelijkse praktijk. 
Toekomstige studies zijn echter nodig om de lange termijn prognostische waarde van 
CZT SPECT aan te tonen. Daarnaast zal tevens de aanvullende diagnostische waarde 
van kwantitatieve myocardscintigrafie middels dynamische CZT SPECT verder 
onderzocht worden. Momenteel wordt het grootschalig gebruik van PET voor 
myocardscintigrafie beperkt door verschillende factoren, waaronder de hoge kosten en 
de noodzaak voor een cyclotron (= deeltjesversneller) of een Rubidium generator. De 
beschikbaarheid van recent ontwikkelde nieuwere PET perfusietracers zal het klinische 
gebruik van PET perfusiescintigrafie aanzienlijk doen toenemen [4,5]. Prospectief 
opgezette studies om CZT SPECT en andere non-invasieve functionele testen, zoals 
PET en MRI perfusiescintigrafie, te vergelijken, zullen de diagnostische en 
prognostische waarde onderzoeken, alsmede ook de kosteneffectiviteit van de diverse 
onderzoeksmodaliteiten. Bovendien zijn er meer studies nodig om de optimale therapie 
en de hiermee gepaard gaande lange termijn prognose te bepalen voor patiënten met 
discrepante FFR en perfusie resultaten.  
 
SPECT IN COMBINATIE MET CALCIUMSCORE 
Dit proefschrift beschrijft tevens de toegevoegde waarde van het gelijktijdig verrichten 
van CACS in patiënten verwezen voor een SPECT onderzoek. De toegevoegde 
diagnostische en prognostische informatie van CACS in deze patiënten dient verder te 
worden onderzocht. Daarnaast dient het effect van de gelijktijdige acquisitie van 
SPECT en CACS op de uiteindelijke therapiekeuze van de hoofdbehandelaar te worden 
onderzocht.  
 
NON-INVASIEVE CARDIALE HYBRIDE DIAGNOSTIEK 
In onze studie tonen wij de toepasbaarheid van een stapsgewijs algoritme beginnend 
met stress SPECT diagnostiek en CACS. Er zijn echter diverse alternatieve strategieën 
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mogelijk. In de toekomst dient de optimale initiële test te worden onderzocht voor 
verschillende patiëntenpopulaties.  
 Wellicht dat het verrichten van een initiële CACS kan helpen om de optimale 
strategie te bepalen. Hierbij zullen patiënten met een CACS <400 waarschijnlijk het 
meeste baat hebben bij een CCTA vanwege de hoge negatief voorspellende waarde van 
CCTA. Daarnaast kunnen patiënten met een sterk verhoogd CACS (bijvoorbeeld >700) 
geselecteerd worden om (indien beschikbaar) een PET perfusiescan te ondergaan 
vanwege de betere detectie van gebalanceerde ischemie [6,7].  
 Toekomstige studies zullen zich meer gaan focussen op het combineren van 
CCTA met CT perfusiescintigrafie en non-invasieve FFR metingen. Bovendien kunnen 
CCTA beelden tegenwoordig gefuseerd worden tot 3D hybride beelden zonder 
additionele stralingsbelasting door gebruik te maken van MRI perfusie of stress 
echocardiografie beelden [8,9]. Tot slot, dient de impact van multimodaliteit en 
hybride diagnostiek op therapiekeuze verder te worden onderzocht. 
 De detectie van stabiel coronarialijden is de afgelopen jaren aanzienlijk verbeterd 
met snelle ontwikkelingen van de verschillende beschikbare non-invasieve onderzoeks-
modaliteiten. Daarnaast is er een grote vooruitgang geboekt met de integratie van de 
verschillende diagnostische testen. Non-invasieve diagnostiek zal in toenemende mate 
een rol gaan spelen. Hierbij kan een patiënt-specifieke benadering worden aangeraden 
om zo accuraat mogelijk obstructief coronarialijden uit te sluiten, en daarnaast de juiste 
patiënten te selecteren voor een invasieve behandeling om de overleving te verbeteren 
en de klachten te verlichten. 
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Dankwoord 
 
 
 
Dit proefschrift is tot stand gekomen door een samenwerking tussen de afdelingen 
Cardiologie en Nucleaire Geneeskunde binnen de Isala te Zwolle.  
Hierbij zijn vele mensen betrokken geweest, die allen op hun eigen wijze een 
belangrijke bijdrage hebben geleverd. Een aantal personen wil ik derhalve hieronder in 
het bijzonder bedanken, wetende dat dit alles niet mogelijk was zonder hen. 
  
Allereerst wil ik mijn dankbaarheid uiten aan de gehele maatschap Cardiologie. Jullie 
vertrouwen, steun, geduld en oprechte belangstelling vanaf het allereerste begin is (en 
blijft) voor mij een belangrijke drijfveer om overal het beste uit te halen. 
  
Daarnaast wil ik de gehele afdeling Nucleaire Geneeskunde bedanken. Jullie hebben 
mij destijds opgenomen binnen 'jullie' groep, waarbij we gezamenlijk de start van een 
prachtig project hebben mogen ervaren. De geweldige sfeer die ik heb mogen proeven, 
zowel professioneel als ook zeker sociaal, heeft mijn waardering en respect voor jullie 
allen nog verder doen toenemen. Ik hoop dan ook nog vele jaren te kunnen participeren 
binnen 'onze' nucleaire cardiologie familie!    
  
Ik wil mijn copromotor dr. J.P. Ottervanger bedanken. Beste Jan Paul, jij was de 
persoon die mij destijds benaderde voor het onderzoek waarvan je zelf één van de 
grondleggers was, en hetgeen voor mij een unieke gelegenheid is gebleken. Sindsdien 
heb ik erg veel van je, maar ook over je mogen leren. Jouw vermogen om snel, helder 
en tegelijkertijd kritisch na te denken, alsmede ook je organiserend talent en een 
geduldig karakter zijn eigenschappen waar velen, mijzelf inclusief, jaloers op mogen 
zijn. Naast jouw indrukwekkende wetenschappelijke bijdrage, ben ik je tevens 
dankbaar voor je interesse in mij als persoon en het sociale karakter van onze 
contacten, waaruit ik reeds diverse levenslessen heb mogen halen.    
  
Daarnaast wil ik mijn andere copromotor, dr. S. Knollema, bedanken. Beste Siert, jij 
hebt voor mij veel meer betekend dan je wellicht zelf beseft. Jouw medisch 
inhoudelijke kennis, humor, oprechtheid en zakelijk inzicht, waarbij je weloverwogen 
risico's durft te nemen, maken je voor mij een onmisbare schakel binnen de Isala. Veel 
heb ik van je mogen leren tijdens de duizenden SPECT en CT beoordelingen de 
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afgelopen jaren. Daarbij hebben we samen vele mooie en gezellige momenten 
meegemaakt. Je adviezen op zowel professioneel als sociaal vlak, waarbij je mij tevens 
een enkele keer op subtiele wijze (terecht) een 'spiegel' voorhield, hebben mij als arts 
èn als persoon doen groeien. Nogmaals bedankt voor alles en dit is nog maar het begin! 
Op naar een volgende road trip in de VS! 
  
Mijn promotor, prof. dr. M.J. de Boer. Beste Menko-Jan, jouw liefde voor de nucleaire 
cardiologie werd beloond met de komst van een cardiale SPECT/CT scanner. Jouw 
enthousiasme heeft mijn liefde voor non-invasieve diagnostiek aangewakkerd, 
overigens zonder hierbij de meerwaarde van een invasieve strategie in de juist 
geselecteerde populatie uit het oog te verliezen. Behalve de cardiologie, delen we 
gelukkig meerdere gezamenlijke (sportieve en sociale) interesses. Ik hoop dan ook dat 
ik behalve je 'social skills' ooit ook je invasieve behendigheid zal beheersen. Ik was 
dan ook trots op je benoeming tot hoogleraar en ik vind het een eer dat je nu mijn 
promotor bent. Dank hiervoor!   
 Mijn tweede promotor, prof. dr. P.L. Jager. Beste Piet, inmiddels ben je zo 
belangrijk en onmisbaar voor ons als groep, dat ik bijna zou vergeten dat je er niet 
vanaf dag 1 bij was. Ik blijf dan ook de nucleaire groep complimenteren met het 
destijds binnenhalen van iemand van jouw kaliber! De klik die direct tussen ons beiden 
ontstond, is slechts het begin geweest van iets moois dat wat mij betreft nog lang mag 
voortduren. Inhoudelijk weet je altijd belangrijke aanvullingen te leveren, waarbij je 
mij vaak enorm hebt weten te inspireren. Vele uren en zelfs avonden van je eigen tijd 
heb je opgeofferd om mij optimaal te begeleiden. Jij hebt me laten zien dat je met 
humor en gezelligheid enerzijds, en hard werken en een kritische blik 
anderzijds, geweldige resultaten kunt behalen. Ik hoop in de toekomst meer van onze 
vruchtbare "Pietza" avonden te mogen meemaken. Gracias amigo!   
  
 De hooggeleerde heren prof. dr. W.M. Prokop, prof. dr. W.J.G. Oyen en prof. dr. F. 
Zijlstra wil ik danken voor hun bereidheid en deskundigheid het proefschrift op zijn 
wetenschappelijke waarde te beoordelen. 
  
Dr. Stoffer Reiffers, ook jou als de grondlegger van de huidige nucleaire 
geneeskunde wil ik hartelijk danken voor al je inbreng. Vele dagen hebben we de 
afgelopen jaren samen doorgebracht, waarbij we ook vele besprekingen en 
vergaderingen samen hebben bijgewoond. Ik heb altijd veel bewondering voor jouw 
visie gehad. Jouw aanvullende commentaren en je kritische blik hebben 
de leesbaarheid van mijn artikelen enorm verbeterd. Dank hiervoor! De woorden 'keep 
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it simple' heb ik veel horen vallen in jouw aanwezigheid en zullen ook in de toekomst 
nog veel gebruikt gaan worden.  
  
Mijn paranimfen dr. Jorik Timmer en dr. Rik Hermanides wil ik danken voor alles wat 
ze voor mij hebben betekend. Jorik, reeds vanaf het begin (nog voordat je cardioloog 
werd) heb je me enorm geholpen, waarbij je veel van je kennis omtrent non-invasieve 
diagnostiek, statistiek en het schrijven van manuscripten met mij hebt gedeeld. Dit 
alles met veel enthousiasme en gezelligheid. Dank voor alles!  
 Rik, woorden schieten tekort als ik jou moet danken voor alles wat je voor me 
hebt betekend. We hebben vele mooie momenten gedeeld en ik koester enorme 
bewondering voor je eerlijkheid en grenzeloze behulpzaamheid. Daarnaast weet ik ook 
je directheid (meestal) te appreciëren. Thanks Smikkie! 
  
Ik wil de opleider, dr. A.R. Ramdat Misier, bedanken voor al zijn vertrouwen en 
oprechte adviezen. Klinisch gestructureerd en logisch beredeneren is een gave die u als 
geen ander bezit, hetgeen we dagelijks mogen ervaren op de overdracht. De huidige 
structuur van de opleiding met zijn vele leer- en onderwijsmomenten maakt de Zwolse 
praktijk de perfecte leerschool voor aanstaande cardiologen. Trots ben ik dan ook op 
het voorrecht om hier tot cardioloog opgeleid te mogen worden.  
  
Dr. A.W.J. van 't Hof, ik kan me ons gesprek destijds tijdens mijn sollicitatie als de dag 
van gisteren nog herinneren. Hierin gaf ik reeds mijn voorkeur aan voor 
wetenschappelijk onderzoek naast de klinische praktijk, hetgeen uiteindelijk heeft 
geleid tot dit proefschrift. Bewonderenswaardig vind ik je als persoon, 
interventiecardioloog en wetenschapper. Dank voor het vertrouwen om mij aan te 
nemen en de interesse omtrent mijn voortgang. 
 
Tevens wil ik alle doktersassistenten, secretaresses, leidinggevenden, PA-ers en 
laboranten van de afdeling nucleaire geneeskunde hartelijk danken voor afgelopen 
memorabele jaren. Ik heb enorme bewondering voor jullie deskundigheid, flexibiliteit 
en betrokkenheid. Zonder jullie was dit alles niet mogelijk geweest! Evelien, jij 
bedankt voor alle extra inspanningen!  
 
De nucleair geneeskundigen Ad Oostdijk, Anneke Engelhage, Hester Arkies, dr. Jaep 
de Boer, en dr. Henk Stevens wil ik bedanken voor de prettige en vruchtbare 
samenwerking! Jullie zijn, net als de doktersassistenten en laboranten, essentieel voor 
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de invoer in onze geweldige database. Ad, dank ook voor het reviseren van mijn 
artikelen en je bereidheid te participeren in de onderzoeken.  
 
Ook de overige leden van de klinische fysica wil ik hartelijk danken, in het bijzonder 
Jochen van Osch en dr. Jorn van Dalen. Succes met alle aanstaande prachtige 
onderzoeken! 
 
De interventiecardiologen dr. J.H.E. Dambrink, dr. A.T.M. Gosselink, dr. E. Kedhi, 
drs. V. Roolvink, dr. S. Rasoul en dr. S. Somi wil ik hartelijk danken voor de 
aangename samenwerking. Dank ook voor jullie hulp bij het verrichten van de FFR-
metingen en voor alle terugkoppelingen! Tevens wens ik Vincent veel succes met zijn 
proefschrift en Wouter Remkes veel succes met zijn fellowship! 
  
De “EP boys” dr. Elvan, dr. Delnoy en dr. Smit wil ik danken voor hun betrokkenheid, 
de prettige samenwerking en het delen van hun geweldige elektrofysiologische kennis. 
Trots ben ik dan ook op jullie expertise en vooruitstrevende visie hetgeen reeds vaker 
heeft geleid tot een primeur van de Zwolse ritmegroep.  
 Tevens wens ik Abdul Ghani en Rypko Beukema veel succes met hun 
promotietraject. Dr. Ahmet Adiyaman, jij bent halverwege je opleiding naar Zwolle 
gekomen. Ik vind je een enorme aanwinst voor Zwolle, zowel professioneel als ook 
zeker sociaal. Dank voor je vriendschap, alle support en de (inmiddels ontelbare) 
gezellig dagen! Veel succes nog even met je fellowship en je verdere succesvolle 
carrière binnen de elektrofysiologie. 
  
De hoogleraren prof. dr. H. Suryapranata, prof. dr. A.H.E.M. Maas, prof. dr. J.C.A. 
Hoorntje, alsmede ook dr. E. de Kluiver wil ik danken voor de plezierige en leerzame 
samenwerking de afgelopen jaren. Dit geldt uiteraard ook voor dr. A. Breeman, drs. S. 
Yokota, drs. M. Veldhorst, drs. M. Waskowsky en voor de reeds gepensioneerde 
cardiologen drs. W.J. Louridtz en drs. H.A. Oude Luttikhuis. 
 
Dank ook aan alle secretaressen (maatschap, kliniek en polikliniek) voor al jullie 
ondersteuning en geduld! Windy, Anouck, Petra, Jennita en Heleen wil ik in het 
bijzonder bedanken voor hun hulp bij het regelen van de SPECT onderzoeken bij de 
FFR-patiënten. Samen met de collega’s van de nucleaire geneeskunde (Natascha, 
Birgul, Lenie, Bianca, Angela en wijlen Ria) hebben jullie allen uitstekend werk 
geleverd. Daar ben ik jullie allen zeer erkentelijk voor! 
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Veel respect en bewondering heb ik voor alle verpleegkundigen, laboranten (zowel 
invasief als non-invasief) en pacemakertechnici met wie ik de afgelopen jaren met veel 
plezier heb samengewerkt. Dank voor jullie interesse en steun!  
  
Vera Derks wil ik hartelijk danken voor haar waardevolle bijdrage bij het organiseren 
van de vergaderavonden voor de “SPECT-CT groep” en het corrigeren en submitten 
van alle abstracts en manuscripten. Vele Zwolse onderzoekers en promovendi zijn me 
voor geweest, maar ik weet dat we er unaniem over eens kunnen zijn dat we enorm 
boffen met een kracht zoals jij Vera! Dank voor al je hulp nogmaals. 
 
Tevens wil ik alle leden van de maatschap thoraxchirurgie hartelijk danken voor de 
prettige en leerzame samenwerking, alsmede ook jullie interesse omtrent mijn 
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